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ABSTRACT

The interaction of human cytomegalovirus ( H C M V ) with stimulated peripheral blood Tcells and T-cell clones was studied using the laboratory adapted strain (AD 169) and
clinical isolate (p72) of HCMV. PHA stimulated lymphocytes isolated from healthy
seronegative donors were found to undergo changes in the expression of several
functionally important T-cell markers following HCMV challenge. CD4 and CD8
expression were downregulated within 6 hours of viral challenge. By 24 hours post-

challenge, CD4 levels had recovered and CD 8 levels were found to increase. This abil
of HCMV to upregulate CD8 expression was shown using a CD4+ T-cell clone in which

it was found that HCMV challenge caused an inversion in the CD4 : CD8 cell ratio by 12
days post-challenge. It is proposed that the early changes seen in marker expression
due to a direct physical interaction of the virus with T-cells whereas later changes
to the virus inducing functional changes. HCMV challenge was found to cause an
increase in the number of CD8+UCHL-1 (CD45RO) cells in PHA stimulated T-cells
analysed at 48 and 96 hours post-challenge. In addition virus challenge resulted in
persistence of CD4+2H4+ (CD45RA) cells in these cultures when compared to mock-

challenged controls at 24-48 hours post-challenge. These latter cells have been propo
as being suppressor-inducers. These results suggest that HCMV challenge influences
functional populations of T-cells. The clinical isolate of HCMV was found to persist
cells stimulated with ConA+IL-2 , a mode of stimulation known to elevate levels of
CD4+CD8+ cells. Further HCMV was found to persist and to replicate, albeit at low
levels, in a CD4+CD8+UCHL-1+ T-cell clone up to 18 days post-challenge. HCMV
DNA was also found to be present in PHA stimulated and cloned T-cells of a memory
(UCHL-1+; CD45RO) phenotype at 96 hours and 21 days post-challenge. These results

suggest that HCMV may persist in a small subset of T-cells which may provide a possib
cell vector for blood transfusion related HCMV transmission. The effect of HCMV
challenge on the production of Interleukin-4 (IL-4) and EFN-ywas studied in a
CD4+CD8+ T-cell clone and in PHA and ConA+IL-2 stimulated peripheral T-cells. IL-4

production was found to increase in HCMV-challenged cells when compared to levels in
mock-challenged cells, thus providing a possible mechanism whereby H C M V alters
i m m u n e functions. IFN-y production in mixed populations of P H A and C o n A stimulated
T-cells increased marginally following challenge with A D 169 whilst challenge with the
clinical isolate resulted in suppression of _FN-y production when compared to mockchallenged cultures. This effect indicates a possible difference in the immunosuppressive
capacities between the two strains of virus.
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1.0

INTRODUCTION

1.1.0. Human cytomegalovirus

1.1.1. History and Classification

Cytomegalic cells were first reported in the tissue of infants following post-

mortem examinations in 1904. Similar cells were later found in the salivary glands o

guinea pigs with the factor responsible for this being found to be both filterable a

labile. In 1954 Smith isolated a virus from mouse salivary gland cells in culture an

shortly thereafter from human salivary glands leading to the name "salivary gland vi
(reviewed by Hamilton, 1982). The virus was later isolated by other workers from
human adenoid tissue and liver which resulted in the name being changed to
"cytomegalovirus" on account of the large size of the infected cells.

Cytomegalovirus was first classified by the International Committee for the
Nomenclature of Viruses (ICNV) in 1970 as a Herpesvirus due to the similar

morphological characteristics shared by these viruses. At this stage no precise viro

definition existed for cytomegalovirus and in 1973 the virus was classified as Human

herpesvirus 5. This classification remained until 1979 when the family herpesviridae
divided into 3 subfamilies, Alpha, Beta and Gammaherpesviridae. According to this
classification, the genus human cytomegalovirus and type species human (beta)
herpesvirus 5 (human cytomegalovirus) was defined as having the following main
characteristics : a double stranded DNA genome of molecular weight 150 x 106; the

virus is only recovered from humans and has a narrow experimental host range with be
growth in human fibroblasts (reviewed by Monto Ho, 1981).

2

1.1.2.

Physical and Molecular Properties of H u m a n

cytomegalovirus

1.1.2.1 Physical Properties

Human cytomegalovirus (HCMV) is the largest member of the human herpesvirus

family with an outside diameter of 200 nm. The virus has a 64 nm core which conta

the viral DNA. This core is enclosed by a 110 nm icosahedral capsid which is made

of 162 capsomeres. The capsid particle is enclosed by an envelope consisting of a
glycoproteins of which the 140 kilodaltons (kDa), 62 kDa and 57 kDa are the most
abundant (reviewed by Alford and Britt, 1985).

The HCMV particle is sensitive to a number of physical factors including heat,
ultra-violet light, low pH and lipid solvents (Golde, 1983; Rapp 1980 & 1983).
Treatment of HCMV with the mitogen phytohaemagglutinin (PHA) has been shown to

inactivate the virus and pretreatment of fibroblastoid cells with PHA reduces the

susceptibility to infection (Ito et al, 1978). The virus has been shown to be resi
trypsin (Kim and Carp, 1973).

1.1.2.2. HCMV Genome

HCMV is the largest member of the human herpesvirus family with a genome

50% greater in size and complexity than that of Herpes simplex virus (de Marchi e
1978). HCMV DNA was first isolated from purified virions by Huang et al in 1973.

The viral genome occurs as a linear double stranded molecule having nicks and gap

distributed over the entire genome which results in the molecule being fragile, r

careful manipulation during isolation. The size and molecular weight of the genom
been determined by electron microscopy and by velocity sedimentation. Two size

3

classes, of lengths approximately 49 (im and 75 jim (de Marchi et al, 1978), have been
isolated with molecular weights of 1.0 x 10 5 k D a and 1.5 x 1 0 5 k D a respectively. The
occurrence of two different sized D N A molecules has been correlated with infectivity.
Kilpatrick and Huang (1977) observed that the six unique zones resulting from adenine
plus thymidine (AT) and guanine plus cytosine (GC)richregions can only be succesfully
arranged if a genome size of 1.5 x 10 5 k D a is assumed. This suggests that the 1.0 x 10 5
k D a molecule m a y be a defective molecule. The accumulation of smaller (1.0 x 10 5 kDa)
D N A molecules in virions has been directly correlated with a decrease in infectivity as
evidenced by an increase in the particle-to-PFU ratio whereas virus preparations of a low
particle-to-PFU ratio contained predominantly large (1.5 x 10 5 kDa) D N A molecules
(Stinski et al, 1979).

The HCMV genome contains two pairs of inverted repeats which subdivide the
molecule into a large (L) and a short (S) segment. The L segment in the D N A of strain
A D 169 comprises a unique region (UL) of 175 kb which is flanked by a terminal repeat
(TrL) of 11 kb at the end of the molecule and an internal repeat (IrL) within the genome.
The S segment consists of a 38 kb unique region (US) flanked by an internal repeat (IrS)
of 2 kb and a terminal repeat of 800 base pairs. The L and S segments can occur in either
orientation resulting in four isomeric conformations of the H C M V genome which occur in
approximately equal proportions (La Femina and Hay ward, 1980)

Portions of the HCMV genome have been characterised with respect to structure
and transcription data as reviewed by Somogoyi et al (1986). The vast majority of this
work has been facilitated through the study of restriction profiles and through the use of
cloned fragments of the H C M V genome. Cloned libraries of the EcoRI and HindHI
restriction endonuclease fragments of the entire genome of the H C M V laboratory strain
A D 169 have been constructed by Tamashiro et al (1982) and O r a m et al (1982)
respectively. This work has also allowed for sequencing of segments of the H C M V
genome.
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1.1.2.3.

Proteins Encoded by H C M V

The literature on HCMV proteins has been extensively reviewed by Landini and
Michelson (1988). The entire HCMV genome has the coding capacity for 200 proteins
(Rasmussen, 1989). Transcription of the HCMV genome has been broadly defined as

consisting of three phases. An immediate early phase occurs up to 4 hours post-infec

during which time DNA transcription occurs in the absence of either de novo protein

synthesis or viral DNA replication. The majority of proteins transcribed during thi

period are phosphorylated DNA-binding proteins. The end of the immediate early phase

marks the beginning of the early phase which is characterised by viral DNA replicat

Early proteins transcribed during this period consist of phosphoproteins, glycoprot
and enzymes which are mainly regulatory in function. The late period occurs from 36

48 hours postinfection and coincides with the production of viral structural protei
the release of infectious virus (Alford and Britt, 1985).

It must be noted that the rigid classification of viral proteins into early nonstructural proteins occuring before DNA replication and structural proteins being

produced after viral DNA replication is not strictly applicable to HCMV. This is du

the fact that low levels of several structural proteins are transcribed prior to DN

synthesis and that several immediate-early and early proteins persist through the l
of viral replication.

Sequencing data for the HCMV genome has revealed that the viral genome

encodes for a number of proteins which show homology to important cellular proteins.
DNA sequence analysis has shown that the HCMV genome encodes a glycoprotein

homologus to MHC class-I antigens of eucaryotes and it is suggested that this may p
role in infectivity of the virus (Beck and Barrel, 1988). The HCMV genome has also

been found to encode three proteins containing regions homologus to G protein-coupl
receptors (GCRs). Cellular GCRs are important in signal transduction and regulation
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homeostasis and it is suggested that the ability of H C M V to produce these m a y provide a
pathway for virally transformed cell proliferation (Chee et al, 1990).

1.1.3. Biological Properties

1.1.3.1. Cytopathology of HCMV In vitro

The development of cytopathic effects (CPE) in permissive cells has been studied
using several strains of adapted and wild type HCMV. The rate of CPE development is

found to vary with both strain and the multiplicity of infection (MOI) used. In general,
HCMV capsids are seen within the nucleus as early as 5 minutes after the initiation of

penetration. Cell rounding and cytoplasmic inclusions are seen by 5 hours post-infectio
These inclusions undergo extensive modifications during the 5 to 120 hour period.

Nuclear inclusions are first seen at 48 hours postinfection and these form distinct bea
like structures which increase in size up to 72 hours post-infection. These are then
broken-down in the period beginning at 96 hours post-infection (Albrecht et al, 1980)
Cell lysis occurs between 5 and 30 days post-infection depending upon both the strain
and MOI used. Cells infected with a wild type strain rapidly develop show extensive

CPE with little infectious virus being produced. In contrast, cultured fibroblasts infe
with a laboratory adapted strain survive for a long period and release large amounts of
infectious virus (Kanich and Craighead, 1972).
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1.1.4.

H u m a n Cytomegalovirus and Disease

1.1.4.1. Epidemiology

The occurrence of HCMV infection varies widely according to geographic and
socio-economic factors and it is estimated that between 28% and 100% of a given
population over 35 years of age will be seropositive for HCMV (Krech et al, 1971). The
prevalence of HCMV is relatively low in western Europe and Australia (40%-54%) whilst

in central Africa it is as high as 100% (Krech, 1973). The pattern of positivity also v
with age. In a study of a given population, Wentworth and Alexander (1971) found an

increase in seropositivity occuring at a rate of approximately 1.3% per year from age 5
until ages in the mid-forties. Thereafter levels remain constant with about 70% of the
older population being positive.
The acquisition of HCMV infection has been the topic of a recent review by

Forbes (1989). Natural routes of HCMV acquisition are varied. Intrauterine infection i
estimated to occur in between 0.2 to 2.5% of all live births with this transmission
believed to occur transplacentally. The majority of congenital infections are found to
occur in infants borne of women under the age of 30. This under 30 category of woman
are the major group of women found to be shedding virus from the cervix or in urine.

There is increasing evidence to suggest that sexual transmission is responsible for th
increase of HCMV infections in young adults. Viral titres in semen are 100 000 times
higher than those in urine and a high incidence of HCMV infection has been observed
amongst women attending clinics for sexually transmitted disease. Perinatal infection
occurs in 8% to 60% of infants with virus usually being acquired from a maternal
source, infection via breast milk is the most common route. Following the perinatal

period infection is found to occur mainly through sexual transmission or as the result
prolonged contact with infected persons such as may be found at day-care centres for
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children. H C M V is frequendy transmitted in the clinical setting with virus being
acquired following blood transfusion and organ transplantation.
1.1.4.2. Disease Characteristics

Diseases and symptoms resulting from HCMV infections have been exhaustively
reviewed by a number of authors. The following summary contains salient points
derived from a review by Alford and Britt (1985).

The severity of HCMV infection is largely dependent upon the age and immune

status of the infected individual. Infections acquired in utero pose one of the greates
dangers, with cytomegalic inclusion disease resulting in >90% of infants developing
mental and/or perceptual defects within the first 2 years following delivery. In more
than 80% of cases microcephaly coupled with severe intellectual defects is observed.
Severe hearing loss and ocular abnormalities are found in 25-30% of these individuals.

Perinatal infections, usually resulting from transmission via breast milk, are most

often subclinical with seronegative individuals being more likely to develop disease t
seropositive individuals. HCMV has been implicated as a cause of pneumonia in infants
between 1 and 6 months of age. The fact that it is virtually impossible to distinguish
HCMV-associated pneumonia from other pneumonias in young infants makes it difficult
to conclusively attribute these cases of pneumonia to HCMV infection.

Infections in adults are mainly asyptomatic although HCMV is the cause of 8% of
cases of infectious mononucleosis. Symptoms of HCMV mononucleosis are malaise,

myalgia, protracted fever, liver function abnormalities and lymphocytosis with an exces
of atypical lymphocytes. Symptoms are usually mild with a minority of cases showing
debilitating illness. Complications which may occur in rare cases of HCMV
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mononucleosis include pneumonia, subclinical myocarditis, pericarditis,
thrombocytopenic purpura, hemolytic anemia, retinitis and epidermolysis.

Immunocompromised individuals are at the greatest risk following primary or
recurrent infection. Younger individuals show greatest susceptibility to primary

infections which are somewhat more virulent than reactivated infections. The population
which are at greatest risk are those undergoing transplants in which immunosuppressive

drugs are adnainistered or those with malignancies which are treated using chemotherapy

The need for large quantities of blood or blood products increases the exposure of thes

individuals to HCMV. Infection in these individuals is most often manifested in the for
of a mononucleosis syndrome in which the main symptom is a short lived fever.
Pneumonia is the second most prevalent manifestation of HCMV infection in
immunocomprimised individuals and may accompany the mononucleosis syndrome.
This pneumonia may resolve spontaneously or result in death. Mortality resulting from
HCMV infection is highest in bone marrow transplant recipients with rates as high as
40% being observed.

The severity of HCMV infections are enhanced in immunocompromised
individuals. These individuals are often at risk of acquiring a HCMV mononucleosis
syndrome or pneumonia. In addition infection with HCMV increases the susceptibility of

these individuals to infection with opportunist pathogens suggesting that the virus its
immunosuppressive. HCMV has been isolated from the peripheral blood leucocytes of

clinically infected individuals (Saltzman et al, 1988). Cell types which have been found
to be infected with HCMV include polymorphonucleocytes (Fiala et al, 1975),
monocytes (Turtinen 1987) and T-lymphocytes (Garnett, 1982). A number of studies
have observed an effect of HCMV on monocyte function (Dudding, 1986; Kapasi and

Rice, 1986) but the question still remains as to whether the interaction of HCMV with T
lymphocytes could perturb immune functions.
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1.2.0.

T-LYMPHOCYTES

1.2.1 Introduction

T-lymphocytes form an integral part of the immune system acting as both

regulatory and effector cells in the humoral and cytotoxic arms of the immune respons

The multi-functional ability of T-cells is due to the large number of diverse subsets
cells which include natural-killer (NK), cytotoxic, helper-inducer and suppressor-

inducer cells. Many of these cells can be identified by the differential expression o
variety of surface antigens.

1.2.2. Development of T-lymphocytes

T-lymphocytes develop from precursor bone marrow cells called prothymocytes.
These cells migrate to the thymus gland where they mature becoming functionally

competent before being exported to the peripheral lymphoid compartment which includes
the spleen, lymph node and blood (Reinherz and Schlossman, 1980). The development
of T-lymphocytes both within the thymus and in peripheral blood has been the subject
extensive study. Study of T-cell development has been facilitated through the use of

monoclonal antibodies identifying a wide variety of cell surface antigens occuring du
development.

The molecular events occuring during T-cell development, as reviewed by
Fowlkes and Pardoll (1989), may be divided into three stages:

1. The first stage involves early genetic events which lead to T-cell receptor (TCR)
development The rearrangement of TCR gene segments results in mRNA synthesis
and TCR surface expression. The majority of TCR gene rearrangements occur within
CD4_CD8"CD3" precursor cells that are in a state of rapid cell division. It is likely
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each prothymocyte entering the thymus has the capability to give rise to progeny with
potentially diverse T C R expression

2. The second stage involves cellular selection based on the form of TCR expressed.
Selection is achieved by the negative selection of thymocytes expressing self-reactive
T C R s and positive selection for thymocytes expressing T C R s that recognize foreign
antigen in association with self-MHC molecules.

3. The final stage, which occurs after selection, is the acquisition of mature effect
functions including helper, suppressor, cytotoxic and natural-killer functions.

1.2.3. Functionally Important Molecules Acquired During T-cell
Development and Maturation

1.2.3.1 The T-Cell Receptor

The TCR and associated chains of the CD3 complex enable T-cells to recognize
and respond to foreign antigens in association with products of the major
histocompatibiUty complex. The majority of T-cells (>95%) express a form of the
receptor which consist of a clonally distributed disulfide-linked a|3 heterodimer, the
subunits of which are encoded by sets of rearranging gene segments. The remaining 2 %
to 5 % of T-cells express a second heterodimeric T cell receptor termed T C R ye, the clonal
diversity of which is also generated via gene rearrangement.

Diversity is achieved by recombination of different non-continguous variable (V),
joining (J) and diversity (D) gene segments which generates n e w and unique structures.
The choice of V , D, and J segments is random and the rearrangement is similar to that
employed in B-cells. All chains of the T C R are members of the immunoglobulin
supergene family. The extracellular portion consists of two domains involved in
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recognition whilst a transmembrane portion anchors the receptor in the cell membrane. In
addition there is a short cytoplasmic tail (reviewed by Caccia and M a k , 1989).

1.2.3.2. The CD3 Complex

The CD3 complex is a 20 kDa surface molecule expressed on all T-cells and is
acquired during late intrathymic ontogeny at the same time that immunologic competence
is acquired. This complex appears to consist of at least three structurally distinct peptides:
a 20-28 k D a y chain, and two 20 k D a chains designated a and e. The y and a chains are
glycoproteins whilst the £ chain does not contain oligosaccharides. Although the T C R
and C D 3 molecular complexes are closely associated physically they are not covalently
linked in the T-cell membrane (Fitch, 1986).

1.2.3.3. CD4 and CD8 Molecules

Expression of the CD4 and CD 8 molecules occurs early in thymic ontogeny.
Thymocytes can be divided into four separate sub-populations based upon their
expression of the C D 4 and C D 8 antigens. Within the thymus, C D 4 ~ C D 8 " (double
negative) cells give rise to C D 4 + C D 8 + (double positive) cells which comprise up to 8 0 %
of the total intra-thymic population. These C D 4 + C D 8 + cells are thought to then give rise
to single positive C D 4 + C D 8 - and C D 4 _ C D 8 + cells which are the mature cells found in
the peripheral blood (reviewed by Bierer et al, 1989).

The genes encoding human CD4 and CD8 have been cloned which has allowed
extensive study of the nature of these molecules. Both molecules are integral membrane
proteins which share significant amino acid and structural homologies with members of
the immunoglobuUn supergene family. Each molecule consists of an N-terminal domain
resembling an iinmunoglobulin variable region. The complete molecule has an

extracellular domain, a transmembranous region homologus to that of the M H C Class II
(3 chains and an intracytoplasmic domain.

The CD4 molecule is a 55 kDa glycoprotein with four extracellular domains. The
cytoplasmic domain contains 3 serine residues that m a y serve as substrates for
phosphorylation by protein kinase C. The highly conserved nature of the cytoplasmic
domain of C D 4 suggests that this domain m a y be important for the function or expression
of this molecule.

The CD8 molecule exists in homodimers or homomultimers of a single 34 kDa
sub-unit on peripheral T-cells. O n thymocytes the C D 8 molecule can form disulfide
hetrodimeric complexes with C D 6 which is a 46 k D a peptide (reviewed by Fitch, 1986).

1.2.3.4. MHC Molecules

The interaction of MHC complex molecules with the T-cell receptor is
fundamental to T-cell recognition of antigen. M H C molecules are glycoproteins and are
antigen-presenting molecules. They usually bind peptides within cells and target these to
the plasma membrane where the complex of M H C plus peptide is sampled by the
receptors of circulating lymphocytes. Class I molecules bind peptide from endogenously
synthesized protein whereas class II molecules bind peptide from exogenous proteins that
have entered the cells by endocytosis. The phenotype of the responsive cell correlates
with the presented antigen. That is T-cells expressing the class I binding protein C D 8 are
triggered by class I presented antigen whilst T-cells expressing the class II binding
protein C D 4 are responsive to antigens presented by class II molecules (Lawlor etal,
1990).

Structurally the extracellular parts of the molecules consist of two
immunoglobulin-like domains and two peptide binding domains which have a protein
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fold towards each other. These domains combine to form the peptide binding groove and
the site of interaction with the T C R . Class I molecules have one immunoglobulin-like
domain, the ct3, which is involved in the interaction with C D 8 . The peptide binding
domains al and a2 are contributed by the single class I heavy polypeptide chain. This
chain is encoded by the M H C and provides a membrane bound hydrophobic anchor. The
second immunoglobuhn-like domain is contributed by a second smaller polypeptide called
P2-microglobulin (P2m). This polypeptide is not coded by the M H C and is not
membrane bound. Class II molecules are more symmetrical with two polypeptides, the a
and P chains. These are both M H C encoded and contain one immunoglobulin-like
domain which is combined with the transmembrane and cytoplasmic domains (Lawlor et
al, 1990).

1.2.3.5. The Leucocyte Common Antigens

The leukocyte-common antigen (LCA) family consists of a group of high
molecular weight glycoproteins which range from 180-240 k D a and are expressed on all
leukocytes and their haematopoietic progenitors (Thomas, 1989). There are six to eight
different isoforms of the C D 4 5 antigen, showing differential expression on leukocyte
sub-populations in m a m m a l s (Powrie and Mason, 1988). These isoforms exist as a
result of alternative splicing of three exons within the L C A gene which maps to
chromosome 1 in humans (Ralph et al ,1987). The differential splicing of exons 4, 5 and
6 givesriseto eight potentially different m R N A molecules (Thomas, 1989).

Structurally the LCA glycoprotein consists of three domains, an internal
cytoplasmic domain, a trans-membrane segment and a variable external domain. The
cytoplasmic domain, which remains identical between isotypes, consists of 705 amino
acids corresponding to an approximate molecular weight of 83 kDa. The large size of the
cytoplasmic domain suggests a role in trans-membrane signalling. The cytoplasmic
domain is highly conserved between species, with an 8 5 % level of homology existing
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between human, mouse and rat sequences (Thomas, 1988). The transmembrane

segment of 22 amino acids is identical between different isotypes. The external domai

varies from 400 to 550 amino acids depending upon the isotype. This domain appears to

be divided into three subdomains : an O-linked variable region and two cysteine clus
of approximately 100 and 220 amino acids each (Thomas, 1988).

Antibodies have been raised against the different isotypes of the LCA family.
These antibodies were clustered into the CD45 group at the Third International
Workshop on Human Leukocyte Differentiation Antigens held in Oxford during 1986.

There are two types of antibodies to LCA, the CD45 antibodies which recognize epitope
common to all members of the LCA family and the CD45R antibodies which recognize

restricted epitopes found on some isoforms but not all members of the family. The CD4
group of antibodies consisted of 25 monoclonal antibodies, at that time, which
recognized all the different isotypes of the LCA family. These antibodies therefore
precipitated LCA isotypes with molecular weights of 220, 205, 190 and 180 kDa. The
CD45RA group was comprised of 16 monoclonal antibodies which recognize an extra
portion of the LCA molecule with found on proteins with molecular weights of 220 and
205 kDa. The monoclonal antibody which has been most widely used for studying
CD45RA expression is the 2H4 antibody which recognizes antigens of 220 and 200 kDa
(Morimoto et al, 1985). One antibody was assigned to the CD45RB group. This
antibody precipitates proteins of molecular weights of 220,205 and 190 kDa. The
CD45RO group consists of two antibodies which precipitate an LCA protein with a
molecular weight of 180 kDa (Terry et al, 1988). The UCHL-1 antibody has been
widely used for the study of CD45RO expression.

1.2.3.6.

The Interleukin-2 Receptor

The Interleukin-2 receptor (IL-2R) is composed of at least 2 polypeptide chains (i)
a 55 k D a chain, k n o w n as the T A C antigen, a-chain or p55 component and (ii) a 70-75
k D a chain k n o w n as the P-chain or p75 component. Each chain binds interleukin-2
(IL2) with either a low (p55) or intermediate (p75) affinity. The IL-2R p55 component
has no signal transducing ability although it appears that p75 component does (Takeshita
etal, 1989).

The expression of the p55 and p75 components has been studied on unstimulated
peripheral blood lymphocytes (PBL) by Ohashi et al (1989). C D 4 + T-cells were found to
express significant amounts of p55 but little or no p75 whereas C D 8+ cells were found
to express significant amounts of p75 but little p55. P H A stimulation caused expression
of both components in C D 4 + cells. Other cell types expressing IL-2R components were
C D 14+ monocyte populations which expressed p75 but no p55 and C D 2 0 + B-cells
which expressed low levels of p55 but no p75.

1.2.4. Stimulation of T-lymphocytes

1.2.4.1. Stimulation In vivo

Helper T-cells are activated to initiate an immune response after having recognised
antigen presented in context with major histocompatibnity complex ( M H C ) antigens on
the surface of dendritic cells, macrophages or B-cells. This activation proceeds via a
series of sequential steps. These are triggered by binding of antigen to the T C R / C D 3
complex which transduces antigen-specific extracellular stimuli across the plasma
membrane. These stimuli generate intracellular signals which include the activation of
protein kinase C and cause an increase in the concentration of intracellular calcium ions
(Ca 2 + ) which is consequent to G protein-dependent activation of phospholipase C.
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Signal transduction events further downstream trigger a series of biochemical reactions in
the nucleus resulting in the production of a battery of lymphokines that mediate the
numerous effector functions of T-cells (Miyajima et al, 1988).

1.2.4.2. T-cell Stimulation In vitro

T-cells may be stimulated in vitro by a number of different strategies which
include mitogenic stimulation, antigenic stimulation and mixed leukocyte reactions.
Antigenic stimulation and MLR are most frequently used for the generation of T-cell

clones with a desired specificity against the particular antigen or target cell selecte

this way it is possible to generate helper and cytotoxic T-cell clones. These clones ar
then selected and maintained for extended periods by the addition of exogenous growth
factors such as Interleukin-2. Maintenace of clones often requires further stimulation
regular intervals with either the original antigen and/or mitogen.

Mitogens are used to stimulate T-cells into entering mitosis, thus becoming
rapidly dividing cells. This effect was first observed by Hungerford et al in 1959. The
most commonly used mitogens are the plant proteins Concanavalin A (Con A),
Phytohemagglutinin (PHA) and Pokeweed mitogen (PWM). Of these mitogens, ConA

is the most specific for T-cells with PHA and PWM having the ability to stimulate B-cel

in addition to T-cells. Each of these mitogens binds to a specific receptor on the cell
surface with the receptors for ConA and PHA having being demonstrated in experiments
using the competitive sugars for each of the mitogens. Both ConA and PHA cause leukoagglutination soon after addition to cultures. ConA binds to mannoside and glucoside
receptors while PHA binds to the receptor for the sugar N-acetyl-D-galactosamine
(Barret, 1983). On T-cells PHA and ConA have been shown to bind to the CD3-TCR

receptor complex although this binding is not exclusive to this complex (Chilson et al,
1984). CD2 has been implicated as a receptor for PHA, however there is still some
debate as to whether PHA binds to CD2 or CD3 (Serke et al, 1989). The quantity of
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mitogen added to T-cell cultures is crucial for the stimulation of these cells since high
levels of C o n A have been found to result in sub-optimal stimulation (Stobo, 1978) and
supraoptimal levels of P H A result in cell death (Crumpton et al, 1976). Binding of the
mitogen alone is not sufficient to stimulate T-cells and binding must be linked with certain
intracellular signals in order for cell division to take place.

Binding of the mitogens PHA and ConA is virtually complete within 30 minutes
and a pulse of as little as three hours is sufficient to induce clonal proliferation of
lymphocytes. The first events following mitogen binding are increases in adenyl
cyclase/cAMP levels. Since high levels of c A M P are k n o w n to inhibit the proliferative
response, it is beleived that these increases m a y be localised and involved in early
signalling (Hadden, 1988). These are followed within 120 minutes by enhanced uptake
and transport of small molecules and increased membrane pemeability (Ling and Kay,
1975; Naspitz and Richter 1968). T h e second event is the capping and endocytosis of the
mitogen bound receptors (Smith and Hollers, 1970), with a progressive increase in
cytoplasmic size beginning at 24 hours post-stimulation which is followed by arisein
protein and D N A synthesis at 36 hours post-stimulation. It should however be noted that
the mitogens do not have to enter the cell in order for transformation to take place, since
insolubilized lectins such as P H A and C o n A are able to induce transformation in the
absence of receptor or ligand internalization (Hadden, 1988).

Although lectin mitogens induce cells to leave the resting (Gl) phase and enter
into blastogenesis (Gl), a second signal provided by IL-1 is required to induce IL-2
synthesis and IL-2R expression. T h e cells are then able to complete the cycle, with
subsequent cell divisions requiring only the presence of IL-2.
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1-2.5.

Functional Delineation of T-cells Based Upon Surface
Antigen Expression

1.2.5.1. Relationship of CD45R Expression to Function

The functional significance of CD45R expression has drawn a lot of attention but
as yet no consensus has been reached. It has been suggested that loss of C D 4 5 R A (2H4)
expression and gain of C D 4 5 R O (UCHL-1) expression is an indication of the transition
of cells from a naive to memory state. This view is supported by observations from
various laboratories that cells activated with P H A or C o n A show an increased expression
of U C H L - 1 and decreased 2 H 4 expression (Sanders et al, 1988). Akbar et al (1988)
found human peripheral blood T-cells to be 4 0 % U C H L - 1 positive and 58-65% C D 4 5 R A
positive with < 1 % co-expressing the antigens. Activation with P H A resulted in up to
4 0 % of cells co-expressing C D 4 5 R A and C D 4 5 R O (UCHL-1) by day 3 with 9 3 % of
cells expressing U C H L - 1 and 2 1 % expressing C D 4 5 R A by day 7. This change was
shown to be uni-directional from C D 4 5 R A to C D 4 5 R O (UCHL-1) over a period of 7
days in culture. A further study of changes in the surface expression and C D 4 5 m R N A
production in human T-cells was performed by Deans et al (1989) in which it was found
that by 24 hours post-stimulation, 5.4 kb C D 4 5 m R N A is lost with only 4.8-kb m R N A
being detectable. The level of 4.8 kb m R N A increases until 3 days post-stimulation at
which time a plateau is reached which is maintained until 7 days post-stimulation. This
work when compared to surface expression of the various C D 4 5 R isoforms, suggests
that on the basis of m R N A levels, the transition from high to low molecular weight C D 4 5
isoforms occurs rapidly and that persistence of the C D 4 5 R A + phenotype m a y due to slow
turnover of surface C D 4 5 R A glycoprotein. Further evidence that cells expressing low
quantities of C D 4 5 R O are memory cells has been obtained in murine systems. Cells
expressing high levels of C D 4 5 R A were found to be the major responding cells in
unprimed animals following stimulation with soluble antigen or allogeneic cells as
determined by limiting dilution analysis. Priming resulted in an increase in the number of
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cells with low levels of C D 4 5 R O , suggesting that these represent m e m o r y cells (Lee and
Vitetta, 1990).

The evidence presented thus far suggests a unidirectional transition from CD45RA
(2H4) expression to C D 4 5 R O (UCHL-1) expression following stimulation. There is
however evidence to suggest the conversion of C D 4 5 R A (2H4) or C D 4 5 R B cells to
C D 4 5 R O (UCHL-1) cells is not unidirectional. In the murine system, transferral of
C D 4 5 R A + or C D 4 5 R A - allotype-marked C D 4 + cells into athymic nude rats has revealed
that both subsets routinely generate cell of the opposite phenotype with a function that
follows phenotype and not parentage (Bell and Sparshot, 1990).

1.2.5.2. Role of CD45 in T-Cell Signalling and Activation

The extracellular segment of the CD45 antigen is highly glycosylated and cysteine
rich (Clark and Ledbetter, 1989). The cytoplasmic domain of C D 4 5 has been shown by
Tonks et al (1988) to be a protein tyrosine phosphatase (PTPase) leading to the
suggestion that it m a y interact with other membrane associated proteins (Clark and
Ledbetter, 1989). C D 4 5 has been found to be a potent regulator of signal transduction
and co-aggregation of C D 4 5 with C D 2 , C D 3 or C D 2 8 has been shown to result in an
increase in cytoplasmicfreeC a 2 + in resting cells. This effect is abolished by crosshnlring of these receptors on the cell surface (Ledbetter and Clark, 1989). It has also
been shown that w h e n C D 4 5 is brought into close proximity to C D 4 there is a resultant
enhancement in C D 4 signalling (Ledbetter ,1986)

The UCHL isoform is specifically active as a phosphotyrosine-phosphatase of
molecules involved in signal transduction. Rapid dephosphorylation of the molecule m a y
result in blockade of an otherwise efficient proliferative stimulus. This blockade is
independent of anti-UCHL monoclonal antibody binding since similar results have been
obtained with CD8+Leul8- cells (Sclunck et al, 1990).
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1.2.5.3.

Functional Delineation of C D 4 + and C D 8 + T-cells

It was once thought that expression of the CD4 and CD8 markers was a mutually

exclusive phenomena which allowed for the subdivision of T-lymphocytes into T-helper

and T-suppressor/cytotoxic cells respectively. This view has changed over the years
the function of these cells has been revealed to be far more complex than a simple

bidirectional subdivision would allow. Pawelec et al (1983) showed that T-helper ce

with their hmited proliferative capacity ultimately reverted to action as T-suppres

This observation is supported by a similar observation made by Fleischer et al (1981

who showed that in cultures of mature T-cells the entire cytotoxic population is CD8
with no cytotoxicity residing in the CD4+ population. However the CD4+ cells were
found to gradually acquire cytotoxic activity with increasing age of the cultures.

Further delineation of the CD4 and CD8 populations into functional subsets has
been made possible based upon the expression cf CD45R isotypes on these cell types.
CD4 and CD8 cells are seen to change in their expression of CD45 isoforms following

activation. Activated CD4 cells tend to express lower molecular weight forms whilst
cells tend to express the higher molecular weight forms. The antibodies UCHL-1 and

2H4, which recognize low and high molecular weight forms respectively, have been use
to identify reciprocal subsets with corresponding functional phenotypes. The 2H4
antibody recognizes an epitope in exon 4 whilst the UCHL-1 antibody recognizes a
sequence encoded by the junction of exon 3 and exon 7. The observation that these

antibodies identify different functional cell types indicates that functional diffe
occur with different exon usage (Thomas, 1989).

The percentages of cells positive for the 2H4 antigens in normal peripheral blood
have been found to be 41% for CD4+ 2H4+ cells and 54% for CD8+2H4+ cells
(Takeuchi, 1987; Morimoto 1988). The UCHL-1 antibody stains a total of 40% of all
mature T-cells with these being divided into 70% CD4+ UCHL-1+ and 35%

C D 8 + U C H L - 1 + cells. The majority of IL-2 dependent cells lines and P H A blasts
express the U C H L - 1 antigen and expression has also been found on all monocytes and
granulocytes (Smith et al, 1986). Expression of the U C H L - 1 antigen on T- and B- cells
is reciprocal to expression of the 2 H 4 antigen. Co-expression of the U C H L - 1 and 2 H 4
antigens has been found to occur on only two myeloid cell lines and an erythroleukemia
cell line (Terry et al, 1988).

CD4+ T-cells have been characterised into suppressor-inducer and helper-inducer
subsets using the 2 H 4 ( C D 4 5 R A ) and 4 B 4 (CDw29) monoclonal antibodies.
Suppressor-inducer cells are defined as being C D 4 + C D 4 5 R A + (2H4+). These cells m a y
also be defined as being C D 4 + 4 B 4 - ( C D 4 + C D w 2 9 _ ) cells although it should be noted
that the C D w 2 9 antigens recognised by the monoclonal antibody 4 B 4 are not C D 4 5
isoforms. This suppressor-inducer subset proliferates maximally following stimulation
with concanavalin A (ConA) but proliferates poorly in response to soluble antigen
stimulation and provides poor help to B-cells for pokeweed-mitogen ( P W M ) induced
immunoglobulin (Ig) synthesis. It is not clear as to whether the C D 4 + C D 4 5 R A + (2H4+)
subset induces C D 8 + cells to become effector populations directly or via activation of
other lymphocyte subsets. It has been established that these cells are the major
responders in the A M L R although it is not known whether C D 8 + suppressor cell
generation occurs in the A M L R . Further characterization of the C D 4 5 R A + (2H4+)
subset by Takeuchi et al (1987) has revealed that it plays an important role in the
induction of suppression. C D 4 + C D 4 5 R A + (2H4+) cells activated in an A M L R
(autologous mixed leukocyte reaction) were suppressive suggesting that the
C D 4 + C D 4 5 R A + (2H4+) subset is the major functional subset in the A M L R system. The
suppression induced by these cells does however require the presence of C D 8 + cells, in
the absence of which no suppression was observed, thus indicating that the inducers of
suppression are distinct from the suppressor effector cells. Treatment of these cells with
the monoclonal antibody to the 2 H 4 antigen blocked the suppressor-inducer function of
these cells, suggesting that there m a y be a role for the 2 H 4 antigen in either transmiting

suppressor inducer signals between T-cell subsets or by regulating the suppressor inducer
function of the 2 H 4 cells themselves. The human helper-inducer subset has been
identified using the 4 B 4 monoclonal antibody with these cell showing a C D 4 + 4 B 4 +
phenotype. These cells were found to proliferate poorly upon stimulation with C o n A and
autologus cell antigens in an A M L R . They did however respond well following exposure
to soluble antigens and provided a good signal for P W M induced Ig synthesis (Morimoto
etal, 1985)

Further characterisation of CD4+ cells on the basis of CD45 isoform expression
has shown that the U C H L - 1 monoclonal antibody recognises a reciprocal subset of C D 4 +
T-cells to the C D 4 + 2 H 4 + suppressor-inducer subset described by Morimoto etal
(1988). The U C H L - 1 monoclonal defines a subset which proliferates maximally to
soluble antigen and provides m a x i m u m help for P W M stimulated Ig synthesis. Both
U C H L - 1 + and U C H L - 1 - cells proliferate equally to P H A (Smith et al, 1986). Activation
with C o n A causes C D 4 + C D 4 5 R A + (2H4+) cells to express C D 4 5 R O (UCHL-1) and
lose C D 4 5 R A (2H4). However, approximately 4 0 % of the initial C D 4 + C D 4 5 R A + cells
continue to express C D 4 5 R A in a stable fashion up to day 21 post-activation. These latter
cells continued to demonstrate suppression of IgG synthesis and did not provide help
indicating that they did not change functionally. The C D 4 5 R A + cells grew faster than
did the C D 4 5 R O cells which maintained a slow rate of cell division, indicating that it is
unlikely that C D 4 5 R O expansion is due to outgrowth of the population. These results
thus support the theory that increased C D 4 5 R O expression is due to loss of C D 4 5 R A
expression on activated cells. P H A stimulation of C D 4 + C D 4 5 R A + cells results in a
greater loss of the C D 4 5 R A phenotype than does C o n A stimulation (Rosenthal et al,
1990).

According to the naive-memory hypothesis conversion should be both phenotypic
and functional. Lymphokine production has been studied for the C D 4 + C D 4 5 R A +
(naive) and C D 4 + C D 4 5 R O (memory) cell populations. Stimulation of cells separated
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according to these phenotypes with either P M A and calcium ionophore or
phytohaemagglutinin (PHA) results in C D 4 + C D 4 5 R A + cells producing high levels of
IL-2 with only trace levels of IL-4 and IFN-y whereas C D 4 + C D 4 5 R O cells produce high
levels of m R N A for all three lymphokines. After 14 days of continuous culture following
stimulation, the C D 4 + C D 4 5 R A + (2H4+) cells lose the expression of the C D 4 5 R A (2H4)
antigen but gain expression of the C D w 2 9 (4B4) antigen and simultaneously acquire the
ability to synthesize IL-4 m R N A . This observation suggests that althoughfreshvirgin
and primed peripheral blood T-cells show a clear resolution of lymphokine production
this does not allow for a simple subdivision of human C D 4 + clones on the basis of
lymphokine production (Salmon et al, 1989).

Time course studies of lymphokine production have been performed using
peripheral human T-cells stimulated with combinations of P H A and 12-0tetradecanoylphorbol or calcium ionophore. These studies have shown that the
C D 4 + C D 4 5 R O (UCHL-1) subset produces maximal amounts of IL-2 within 24 hours of
stimulation and IFN-y within 72 hours whereas the C D 4 + C D 4 5 R A + (Leu 18+) cells
produced no IL-2 by 24 hours and only trace amounts of IFN-y by 96 hours poststimulation. B y 48 hours post-stimulation, the C D 4 + C D 4 5 R A + cells produced
significant amounts of IL-2 and after 72-96 following stimulation, these cells proliferated
more vigorously than C D 4 + C D 4 5 R O cells.(Dohlsten et al, 1988).

CD8+ cells have been studied with respect to function and their CD45 phenotype.
C D 8 + C D 4 5 R A + (2H4+) cells are suppressor effectors whereas C D 8 + C D 4 5 R O
(UCHL-1 +) cells are class I restricted alloantigen specific killer effector and precursor
cells. Activation with C o n A causes a rapid increase in C D 8 + C D 4 5 R A + (2H4+) cells
whereas C D 8 + C D 4 5 R O (UCHL-1+) cells maintain a stable phenotype following C o n A
activation (Sohen et al, 1990) with these C D 8 + C D 4 5 R 0 (UCHL-1+) showing a high
proliferative response to high doses of C o n A (Takeuchi et al, 1989). The response of
C D 8 + U C H L - 1 - cells to P H A stimulation has been shown to be strong when compared to
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C D 8 + C D 4 5 R A + ( U C H L - 1 + ) cells which show a minimal response with average counts
per minute ( C P M ) values being 6 fold lower for these cells despite the fact that the
C D 8 + C D 4 5 R A + ( U C H L - 1 + ) cells show a 1.5 fold greater C a 2 + influx. It has been
suggested that this effect m a y be due to a transient elevation of C a 2 + which is insufficient
for induction of proliferation.

CD8+CD45RA+ (2H4+) cells are primarily responsible for suppressor function
following A M L R activation and it has been suggested by Beverley et al (1988) that
C D 4 5 R O (UCHL-1+) cells which continue to express the 2 H 4 antigen m a y be involved
in the mediation of suppression.

1.2.6 Cytokine Production bv T-lymphocytes

Cytokines are low molecular weight (<80 kDa) secreted proteins which are often
glycosylated and are involved in regulation of the amplitude and duration of responses
during immunity and inflammation. They are produced locally and often act in picomolar
concentrations. They interact with cells by means of high affinity cell surface receptors
which leads to altered patterns of cellular R N A and protein synthesis, thereby altering cell
behaviour (Balkwill and Burke, 1989). The major cytokines produced predominantly by
T-cells are described in the following sections.

1.2.6.1. Interleukin-2

Interleukin-2 (IL-2) or T-cell growth factor (TCGF), as it was first known, was
first described by Morgan et al in 1976. IL-2 is produced by activated T-cells with
C D 4 + cells being the major producers and C D 8 + cells producers to a lesser extent. The
mature species of IL-2 is a 14-16 k D a glycosylated polypetide which is coded for by a
gene on chromosome 4.

25

Although IL-2 was originally defined as a T-cell growth factor it has since been
found to have other functions. IL-2 stimulates both T-cells and N K cells to produce
IFN-y (Numerof et al, 1988). In N K cells it causes growth and activation of
tumouricidal activity (Handaef al, 1983). In B-ceUs IL-2 has been found to augment
growth and IgG production. IL-2 has been shown to induce IL-loc and IL-lp production
by P B M C with monocytes being the major producers of IL-1 activity (Numerof et al,
1988).

IL-2 activity is initiated through binding of the molecule to a specific receptor on
the target cell, the structure of which has been reviewed in section 1.2.3.6. IL-2
stimulates T-cell proliferation by promoting progression of cells from the late G l phase
into the S phase of the cell cycle. The specificity and level of the IL-2 response is
maintained at the level of receptor expression which is dependent upon antigen/mitogen
stimulation and possibly a second signal provided by soluble factors. The concentration
of IL-2 and the number of receptors per cell and the degree of affinity of these receptors
determine the level of response. The receptor-ligand complex, formed by binding of the
IL-2 molecule to the receptor, is internalised and the IL-2 is degraded via a lysosomal
pathway (Jothy et al, 1989). IL-2 activity can be inhibited via a number of pathways
which include inhibition of EL-2 production, interference with receptor binding or
downregulation of the EL-2 receptor. Interestingly, it has been found that although Tcells have an absolute requirement for the presence of a m i n i m u m of 1 % monocytes in
order to produce IL-2, they can also be inhibited by high levels of monocytes. This
being due to the release of inhibitory monokines by these monocytes (Chouiab and
Fradelizi, 1982).

1.2.6.2. Interleukin-3

Interleukin-3 (IL-3), which is also known as multi-colony stimulating factor
(CSF) is encoded by a gene on chromosome 5 and is produced predominantly by

activated T-cells. The EL-3 molecule binds specifically to a receptor with K D of « 5x 101

1 M . Studies of metabohc inhibition suggest that IL-3 is intemaUsed upon binding

which causes a promotion of glucose uptake resulting in a shift in the energy balance of
responsive cells. IL-3 has the broadest target range of all haemopoeitins showing effects
on all cell lineages derived from pluripotential hemopoietic stem cells, with the exception
of lymphocytes (Schrader, 1988)

1.2.6.3. Interleukin-4

Interleukin 4 (IL-4), also known as B-cell stimulating factor (BSF-1), T-cell
growth factor-2 (TCGF-2) and mast cell growth factor (MCGF-2), is a complex
glycoprotein with a molecular weight of 15-20 kDa. The IL-4 gene encodes a protein
of 153 amino acids which includes a putative 24-amino acid signal peptide. H u m a n 11-4
has one major peak of activity migrating with a pi of 6.5 to 6.9 (Howard et al, 1984).
EL-4 appears to be the product of a subset of T-lymphocytes. The study of in
vivo derived murine C D 4 + T-cells has shown that the frequency of 11-2 and E-4
producing cells after activation with P H A and C o n A was approximately equal (30-40
% ) whereas after activation with P W M the number of C D 4 + cells producing EL-4 was
two-fold greater (78%) than those producing 11-2 (30%). Maximal levels of IL-2 gene
expression occured 24 hours after mitogen stimulation whereas maximal levels of IL-4
m R N A were not detected until 48 hours after mitogen stimulation These studies also
showed that the majority of C D 4 + cells produce exclusively either IL-2 or EL-4 m R N A
except in the case of cells stimulated with P M A and ionophore which express both IL-2
and IL-4 m R N A (Carding et al, 1989). These results indicate that the production of
IL-2 and IL-4 is independently regulated in the majority of cells and appears to be
stimulus dependant.
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The production of IL-4 m R N A has been studied in human C D 4 + C D 4 5 R A +
(virgin) and C D 4 + C D 4 5 R O (primed) T-cells following mitogenic stimulation. It was
found that when stimulated with either P M A and calcium ionophore or P H A ,
C D 4 + C D 4 5 R A + cells produced high levels of IL-2 with trace levels of EL-4 and IFN-y
whereas C D 4 + C D 4 5 R O cells produced high levels of m R N A for all three lymphokines.
After 14 days of continuous culture, the C D 4 + C D 4 5 R A + cells lost the expression of
the C D 4 5 R antigen but gained expression of the C D w 2 9 antigen and simultaneously
acquired the ability to synthesize IL-4 m R N A (Salmon et al, 1989) These results
suggest that although there is a clear resolution between C D 4 + C D 4 5 R + (virgin) and
C D 4 + C D 4 5 R - (primed) lymphokine production, this does not allow for a simple subdivision of C D 4 + cells on the basis of lymphokine production. Thus lymphokine
production m a y be related to cell maturity and not subset.
Several T-cell lines of both human and murine origin have been described which
produce IL-4 upon stimulation with Con A or with a combination of antigen and antigen
presenting cells. A characteristic of these lines is that they require IL-2 supplementation
in order to grow, whereas IL-2 producing lines could be maintained by periodic
stimulation with antigen and antigen-presenting cells without any requirement for
exogenous IL-2 (Paul and Ohara, 1987).
In a study utilising human CD4+ and CD8+ T-cell clones, it was shown that
9 5 % of C D 4 + clones were able to produce IL-2, IL-4 and IFN-y upon stimulation
whereas only 2 6 % of C D 8 + clones were able to produce IL-4. Significant levels of
IL-2, IL-4 and IFN- y were found by 8 hours after stimulation of both cell types with
Con A , with maximal levels of IL-2 and IL-4 occuring by 20 hours followed by a
gradual decrease. Levels of IFN-y continued toriseup to 40 hours post-stimulation
before levelling off. These studies indicate that clones isolated from human peripheral
blood cannot be categorised according to EL-4 production as has been shown for the
Th-1 and Th-2 subsets in the mouse system. It is suggested that this m a y be due to the
fact that mice T-cells are generally isolated from the spleen whereas human T-cells are

obtained as peripheral lymphocytes and m a y represent precursor lymphokine producers
which must undergo further differentiation into the lymphoid organs (Paliard et al,
1988).

The effect of IL-4 on T-cells has drawn some attention in recent years. IL-4
enhances T-cell proliferation and causes resting T-cells to undergo enhanced
proliferation w h e n exposed to other co-stimuli such as phorbol myristate acetate (Paul,
1987). In a study utilizing h u m a n thymocyte T cells and T cell clones, the growth
promoting effect of IL-4 on preactivated T cells was not inhibited by monoclonal
antibodies to the IL-2 receptor. IL-4 was shown to induce a low proliferative response
in thymocytes and blood T-cells with the response being considerably enhanced by
preactivation of the thymocytes or peripheral blood T cells. The response to EL-4 was
found to be relatively short lasting and regulated by activation signals such as those
provided by P H A , C o n A and T P A . In all cases the response obtained with IL-2 was
greater than that obtained for EL-4, with IL-4 exhibiting a maintenance effect on T cell
clones 10 days after stimulation with feeder cells. It is suggested that an activation
signal m a y enhance the expression of IL-4 receptors on the cell surface allowing for
growth promotion by the lymphokine.

IL-4 was found to enhance the response of

cells to IL-2 (Spits et al, 1987).
Growth of purified human T-cells, depleted of all accessory cells, in serum-free
culture in the presence of P H A and IL-2 or IL-4 resulted in cell proliferation
accompanied by a marked stimulation of thymidine uptake and expression of the cell
surface activation markers Trf R and IL-2 R. The simultaneous addition of EL-4 and
anti-IL-2 neutralizing monoclonal antibodies did not modify the effects induced by IL-4
alone. It was also shown that IL-2 was not present in cultures grown in the presence of
P H A and IL-4 alone. These results indicate that EL-4 acts on T-lymphocytes
independently of IL-2 (Habetswallner et al, 1988). The IL-2 independent action of IL4 has been demonstrated in resting T-cells which were stimulated to snthesize D N A by
IL-4 and P M A in the absence of 11-2 production as evidenced by the lack IL-2 m R N A
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and IL-2 in culture supernatants and neither could the proliferative response be blocked
by anti-IL-2R antibody or cyclosporin A (Brown et al, 1988).

IL-4 has been shown to have a selective inhibitory effect on certain human T-cell
sub-populations by inhibiting the IL-2 induced proliferation of C D 4 + (helper/inducer)
and C D 4 5 R A + (virgin) T cells but not that of C D 8 + (suppressor/cytotoxic) and
C D 4 5 R O (memory) T cells. The production of IFN-y by IL-2 stimulated T cells is
strongly inhibited by IL-4 whereas it does not have this effect on cells stimulated via the
CD3-dependant pathway. The growth dependent effect of IL-4 on cells stimulated via
the C D 3 pathway is not confined to any one subset of cells (Damle and Doyle, 1989).
Interleukin 4 has been shown to induce the synthesis of the CD8 antigen on
C D 4 + C D 8 - T-cells resulting in C D 4 + C D 8 + double-positive cells. These double
positive cells did not arise due to an outgrowth of an existing double positive
population in the original culture. C D 8 m R N A was induced in T-cell clones after
weekly stimulation for a period of three weeks in the presence of IL-4. This expression
remained stable during the presence of IL-4 in the culture medium with the addition of
IL-2 resulting in a decrease in C D 8 m R N A expression. It has been suggested that the
C D 8 expression induced by IL-4 m a y be associated with function since a monoclonal
antibody to the C D 8 molecule inhibited anti-CD3-mediated cytotoxicity by a double
positive T cell clone (Paliard et al, 1988). H-4 induced C D 8 expression was not found
to occur on C D 8 + C D 4 - cells activated and cultured in EL-4.
Interleukin-4 has also been shown to have an anti-inflammatory effect. Human
monocyte/macrophages stimulated in vitro with L P S and IFN-y are found to produce
tumour necrosis factor-a (TNF-ct), interleukin-1 (IL-1) and P G E 2. Cotreatment of
these cells with IL-4 has been shown to dramatically block the the increased levels of
these mediators with this blocking being at the m R N A level for TNF-ct and IL-1 (Hart
etal, 1989).
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EL-4 plays an important role in isotype differentiation of B-cells in the murine
system. In humans IL-4 can selectively increase IgE synthesis by h u m a n peripheral
blood B cells although there is evidence that IL-4 down-regulates h u m a n peripheral
blood B cell responses to certain mitogens (Strober and James, 1988).

1.2.6.4 Interferons

Interferons .(IFN), which are produced by T-lymphocytes, are broadly
characterised as substances which inhibit viral replication. In addition to this the
interferons are modulators of lymphocyte activity either directly through natural killer
activity or indirectly through modulation of M H C antigen expression. There are three
types of I F N : a, P and y. IFN- a and P are antigenically similar and are often referered
to as type 1 I F N whereas IFN-y, which is distinct from a and P IFN, is k n o w n as type
2. E F N a and p are produced by most cells in response to viral stimulation whereas IFNy is produced exclusively by lymphocytes upon mitogenic stimulation or class II restricted
antigenic stimulation in the presence of accessory cell function.

The anti-viral effect of the interferons is as a result of the induction or activation
several cellular enzymes which block the synthesis of viral proteins and eradicate virus
infected cells. EFN- a and P upregulate the expression of class I M H C expression whilst
IFN-y upregulates class I and class II M H C expression. IFN-y also activates
macrophages for tumour cell cytotoxicity and for respiratory burst In this w a y the IFNs
indirectly increase both allogenic and virus-specific T-cell cytotoxicity.

Nylon wool fractionation of T-cells has been found to result in a 10-15 fold
increase in IFN-y production w h e n the cells were stimulated with P H A . These levels
were maintained w h e n the autologus serum concentration was reduced. Although EFN-y
production in nylon woolfractionatedcultures was qualitatively similar to unfractionated

cultures with m a x i m u m production occuring at 2-4 hours after induction, normal cells
ceased production by 24 hours whereas the nylon wool fractionated cells continued with
maximal levels of IFN-y being produced until 48 hours post-stimulation after which a
decline occured during the 72 -96 hour period (Van Reis et al, 1984). IFN-y has been
shown to augment T-helper cell activity and its o w n production (Morris, 1988).

1.3.0

Effect of H C M V

on T-lymphocytes

1.3.1 T-cells and HCMV in Transplantation

HCMV infection following transplantation is frequent. Infections are mostly
symptomless although HCMV infection may be accompanied by hepatitis or pneumonitis

which can be fatal (Glenn, 1981). The virus has also been implicated in graft loss (May
et al, 1978). Interstitial pneumonia related to HCMV infection is a serious problem

following bone marrow transplantation with up to 50% of patients developing the disease
(Neiman et al, 1973). Infection with HCMV following bone marrow transplantation is

often associated with perturbations in the relative proportions of T-cell subsets. Schr
et al (1982) reported a decrease in the Leu 3 : Leu 2 (CD4 : CD8) ratio in bone marrow
transplant recipients. Although bone marrow transplant recipients generally show an
increase in CD8+ numbers relative to the CD4+ numbers during the early posttransplantation period, patients infected with HCMV demonstrate a marked decrease in
the CD4 : CD8 ratio due to a decrease in CD4+ cells and a marked increase in the
numbers of CD8+ cells (Schroff et al, 1982; Persson et al, 1987). In patients with a
previous HCMV infection the increased level of CD 8+ cells was found to persist for
several months following transplantation (Persson et al, 1987)

T-cell repopulation has been studied in patients following transplantation of
marrow with an average depletion of 98% of T-lymphocytes and the results compared to
normal (non-depleted) individuals. In HCMV sero-positive patients, CD8+ numbers
remained within the normal range after T-cell depleted transplantation whereas they
increased to supranormal levels by 150 days post-transplant following nondepleted BMT.
In HCMV sero-negative patients CD8+ cell numbers are sub-normal by 100 days after a
T-cell depleted transplant and have reached normal levels in non-depleted transplant
recipients.
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Studies of patients with active H C M V infection have shown that there is an

increase in CD8+ T-cells expressing the natural killer cell marker, HNK1, between 6 a
12 months following transplantation. In HCMV sero-negative patients following

transplantation of T-cell depleted marrow, there are a sub-normal levels of CD4+ cell

9 to 12 months post-transplant. The CD4+ levels in sero-positive individuals receivin
cell depleted marrow are within normal range by 6 months post-transplant which is
similar to the levels observed in non-depleted bone marrow transplant recipients
irrespective of their HCMV sero-status (Gratama et al, 1987).

In a study of lymphocyte populations in patients suffering from graft-versus host
disease (GVHD) it was found that patients with GVHD without a preceding HCMV
infection had lowered levels of CD4+ cells whereas those GVHD patients who had a
preceding HCMV infection had lowered CD4 : CD8 ratios which was as a result of a
decrease in CD4+ cells and a marked increase in CD8+ cells. An increase in the number
of T-cells carrying the CD2 and CD38 markers, which are found predominantly on
immature thymocyte populations, was found in patients suffering from GVHD (Persson
era/, 1987).

HCMV infections are common after renal transplantation.with between 43% and
92% of renal transplant recipients developing active HCMV infection Primary HCMV
disease usually occurs when a HCMV antibody-negative patient receives a kidney from a
HCMV sero-positive donor. (Glenn, 1981).

Immunosuppressive therapy has been studied with respect to the effect on T-cell
populations in patients in the absence and presence of HCMV infection. In a group of
renal transplant recipients without HCMV infection and receiving cyclosporine and
predinisone, both immunosuppressive drugs, there was a decrease in the CD4 : CD8
ratio, primarily due to CD8+ lymphocytosis (Dafoe et al, 1987). HCMV infection in

cyclosporine treated renal transplant patients was found to cause a decrease in the L
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Leu 2 ( C D 4 : C D 8 ) ratio due to increase in Leu 2 + (CD8) and a moderate decrease in Leu
3+ (CD4) T-cells. The immunosuppressive effects of HCMV in cyclosporine treated
renal transplant recipients differed markedly from the long term immnosuppression
associated with HCMV infection in other patients treated with conventional
immunotherapy in which persistently elevated levels of suppressor cells are present. The

effect of cyclosporine treatment alone is that it inhibits certain T-cells whilst permitt
other T-cell functions. (Rinaldo et al, 1986).

Grundy et al (1988) studied HCMV reinfection and reinactivation following renal
transplant in which it was found that reinfection in seropositive recipients is more
common than reactivation of infection with symptoms occuring more frequently
following reinfection than they do following reinactivation. The results of this study

suggested that reinfection with donor virus may suppress reinactivation of latent recipie
virus. The frequency of reactivation of latent recipient virus was determined from the
observation that HCMV infection occured in 27% of seropositive recipients receiving
kidneys from seronegative donors. In a group of seronegative recipients, transplantation
of a kidney from a seropositive donor resulted in 79% of patients acquiring a primary
infection with 91% of these patients showing symptomsof HCMV infection.

In cardiac transplant recipients a significant decline in the CD4:CD8 cell ratio was
found after the onset of HCMV infection in patients who had viremia or symptoms of
viral infection. In most patients there was continual HCMV shedding in this period
(Dummer et al, 1984).

These transplantations studies reveal that HCMV infection is frequently associated
with a perturbation of the CD4: CD8 cell ratios. This perturbation would, in the majority
of cases, appear to be due to an increase in the numbers of CD8+ cells which is often
associated with immunosuppression.

1.3.2

T-lymphocyte Subsets during H C M V Mononucleosis

T-cell subsets and function have been studied during HCMV mononucleosis.
Carney et al (1981) found that lymphocyte proliferative responses to ConA are
cuminished during acute mononucleosis (11-35 days after onset of symptoms) with a
return to normal during the convalescent stage. Acute HCMV infection was accompanied
by a reversal in the CD4 : CD8 cell ratio due in part to an increase in the numbers of

CD8+ cells. This change persisted for a period of up to 10 months during convalescence.
In a follow up to this work Carney et al (1983) studied the in vitro reactivity of
lymphocytes from patients with mononucleosis. It was found that the predominant cell
type in peripheral blood from these patients was a hyporesponsive CD8+ cell. In vitro

culture of ceUs isolated from the peripheral blood of these patients resulted in a sele
loss of CD8+ and Ia+ cells. Lymphocyte responses after selective depletion of CD4+ and
CD8+ cells showed that CD8+ enriched populations spontaneously incorporated 3 fold as
much thymidine as CD4+ enriched populations although the CD8+ cells remained
markedly less responsive to Con A. The convalescent period was marked by a return of
the Con A responsiveness of the CD8+ cells

Rinaldo et al (1983) extended this work in a bid to determine whether the CD8+
cells observed during mononucleosis were suppressive in function. They found that the
numbers of CD8+ suppressor cells during acute mononucleosis were 3 fold above normal
levels and there was a two fold decrease in the numbers of CD4+ helper T-cells. The
increase in CD8+ cells was apparently not related to direct viral replication since no
infectious virus could be isolated from these cells. An unusual third lymphocyte
subpopulation of CD5+CD4-CD8" cells was found following in vitro culture of cells
isolated from the peripheral blood of patients suffering from mononucleosis. The CD5
marker is present on the majority of T-cells with the density of the marker increasing

the maturity of these cells. The majority of cases of B-cell chronic lymphocytic leukem

have been found to express easily detectable levels of CD5. The possibility of the cell

36

observed being B-cells was not excluded although the expression of the C D 3 antigen
indicated that they were T-cells.

1-3.3. T-lvmphocvtes and HCMV seroposirivitv

The effect of congenitally acquired HCMV infection on lymphocyte populations
has been studied by Pass et al (1983). It was found that increases in the proportion of
suppressor cells only occurs in infants w h o are less than one year of age and have
symptomatic infections. Levels of suppressor cells in individuals with asymptomatic
infections did not differ significantly from those in healthy controls.

Homosexual men are considered to be a high risk group for acquisition of both
H C M V and human immunodeficiency virus (HIV) infection. Between 2 5 % - 7 6 % of this
population have abnormal C D 4 : C D 8 cell ratios. A study by Drew et al (1985)
correlated H C M V seropositivity with abnormal C D 4 : C D 8 ratios, with a reversal in the
C D 4 : C D 8 ratio being found in 33 out of 67 (49%) of homosexual m e n seropositive for
H C M V . Abnormally low ratios occured in m e n w h o had symptomatic H C M V infections
with less marked changes being seen in asyptomatic individuals. These results suggest
that H C M V m a y play an important role in the onset of the acquired immunodefficiency
syndrome (AIDS).

The effect of HCMV carrier status on T-cell subsets has been studied by Gratama
et al (1987). H C M V seropositive individuals were found to have higher numbers of
C D 3 + C D 8 + and H N K 1 + cells than did seronegative individuals. The A D C C and N K
functions of cells from both seropositive and seronegative individuals were found to be
similar. In a separate study similar increases in the levels of C D 4 + and C D 8 + cells coexpressing the H N K 1 antigen were found in HCMV-seropositive individuals. The
numbers of these were proportional to H C M V antibodytitreswhich suggests an effect of
H C M V load on the levels of these cells (Gratama et al, 1987).
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1.3.4.

Persistence and Latency of C M V in T-lymphocytes

It is not been established where the exact site of HCMV persistence is in vivo.

However, a number of studies have implicated lymphocytes as a potential site of latenc

St. Jeor and Weisser (1977) showed that HCMV infection of lymphocytes does

not produce the typical replicative cycle which is seen in fibroblasts. Virus was foun
persist in PHA stimulated T-cells up to 168 hours post-challenge. Further, virus was

detected in lymphoblastoid cells pretreated with 5-iodo-2'-deoxyuridine up to 240 hour
post-challenge. The number of cells infected was found to be low with approximately
4% of cells undergoing DNA synthesis and a total of 1.5% of cells producing infectious
centres.

Furukawa (1979) showed that HCMV could persist in B-lymphocytes (SB line)
originating from a leukemic patient. The HCMV infected culture persistently yielded
HCMV titres of 2 x 10 to 3 x 10 PFU/ml for over a year, a persistent infection being

maintained through a balance between the release of virus and growth of uninfected cel

HCMV has also been detected in a small number (3 per 106) of T-cells isolated
from the blood of renal transplant recipients 3 months after transplantation. In this
virus was not detected in B-cells (Garnett, 1982).

Einhorn and Ost (1984) studied HCMV infection of bone marrow leukocytes and

peripheral blood leukocytes using both the laboratory strain AD 169 and a clinical iso
Infection with AD169 resulted in very few (0% to 0.01%) of the cells producing early

antigens whereas infection with a clinical isolate resulted in >2% of these cells expr
early antigen (EA). The frequency of EA expressing cells dropped 10 fold in cultures
depleted of monocytes whilst the frequency increased 5 to 10 fold in monocyte enriched

cultures. It was found that of the cells expressing E A up to 8 5 % of these had the
morphological characteristics of monocytes.

Rice et al (1984) showed that HCMV was able to infect B-cells, T-cells, NK
cells and monocytes. Virus expression was limited to immediate early proteins with no
infectious virus progeny being produced. Between 1 and 15%, depending upon the
viral strain used, with an average of 3% of peripheral mononuclear cells (PBM)
expressed the major 72K immediate early protein which was detectable within 24 hours

of infection and persisted for as long a 6 days post-infection. Monocytes appeared to
the most susceptible to infection with up to 10% of these cells expressing EA. In
different T-cell subsets it was found that 1.6% of CD4+ and 3.0% of CD8+ cells were
EA positive. The mitogenic responsiveness of PBM to PHA was completely abrogated
following infection with a low passage clinical isolate whereas infection with HCMV
strain AD 169 was considerably less suppressive even when 100 fold greater
concentrations of virus were used. These effects were found with cell free and cell
associated virus thus excluding any interactions between fibroblastoid cells and the
cells.

Schrier et al (1985) detected HCMV immediate early (IE) RNA in a small number
of T-lymphocytes from the peripheral blood of healthy sero-positive indivduals.
Phenotypic analysis of these T-cells revealed that 2.4% CD4+ and 0.8% CD8+ cells
contained HCMV EE mRNA transcripts.

Braun and Reisser (1986) studied the replication of HCMV in human peripheral
blood T-cells using the strain AD 169. HCMV replication was found to occur in cells
which had been adequately activated with IL-2 as evidenced by viral DNA synthesis
using dot-blots and by late antigen synthesis using immunofluorescent studies and
western blot analysis. A 68 kDa protein corresponding to the major capsid protein of
HCMV was isolated, providing additional evidence of a complete replicative cycle.
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Infectious centre assays indicated that H C M V replicates in a small subset of infected
lymphocytes with an average number of 0.08% of T-cells forming infectious centres.
This subset was characterised and found to consist primarily of cells of a CD3+CD8+
phenotype. CD4+ and CD8+ cells were separated into enriched populations prior to
infection and it was found that virus was able to replicate in both cell types. These

results suggest the possibility that primary CD4+ cells are converted to CD8+ cells du

the infectious cycle. Replication in the cell subsets was restricted to no more than 0
of the cells suggesting an additional marker may be required for permissiveness. The

state of activation was found to be an important factor in viral replication with maxi
replication occuring in T-cells stimulated in allogeneic mixed lymphocyte culture. A
requirement for EL-2 was found since cultures grown in the presence of IL-2 supported
viral replication whereas cultures grown without IL-2 did not produce progeny virus.
The inability of abortively infected cells to replicate HCMV could be restored by the
addition of IL-2 to the media whereas cells stimulated with PHA alone did not support

viral replication. These results indicate that mitogen stimulation or rapid DNA synthe

is not sufficient for permissiveness to HCMV infection and that active cell division is
required for viral replication.

HCMV has been isolated from the tonsilar lymphocytes of 4 HCMV seropositive
individuals from a total study group of 30 patients. This number was still fairly low
23 out of the 30 were HCMV seropositive (David et al, 1987).

Danker et al (1990) found that HCMV DNA occured rarely in T-lymphocytes
with HCMV RNA or DNA occuring in <0.01% of lymphocytes isolated from three
actively infected patients. HCMV RNA or DNA was detected in 1-10% of peripheral
blood mononuclear leukocytes with the percentage of positive monocytes from these
patients ranging from 0.01 to 1.0%.

1.3.5.

Effect of H C M V Challenge on T-cells In vitro

Challenge of lymphocytes with H C M V in vitro has been performed by a number
of workers. Kim Sing and Garnett (1984) studied T-cells isolated from the peripheral
blood of seronegative donors. Cells were challenged with viable or UV-inactivated
HCMV strain AD 169 at an MOI of 5 pfu/cell and the PHA responsiveness of these cells
determined following addition of PHA at 3 and 6 hours post-challenge. Challenge with

viable virus caused a drop in the stimulation index of cells stimulated at 3 hours post

challenge. A slight increase was seen in the stimulation index of cells stimulated at 6

hours post-challenge. Challenge with UV-inactivated virus did not affect the stimulati
index. The suppressive effect of virus challenged cells was tested in an AMLR.
Challenge cells were found to suppress thymidine uptake by PHA stimulated fresh

responder cells at suppressor responder ratios of 5:1 and 2.5:1. No detectable suppres
activity was observed with non-infected cells nor with infected cell and unstimulated
responder cells. No suppressor activity was observed when either unstimulated or PHA

stimulated were cultured in the presence of supernatant fluid from infected cell cultu

thus indicating that direct cell to cell contact may be required for induction of supp
T-cells which had been stimulated with PHA for 60 hours were challenged with virus and
CD4, CD8 numbers determined at various times following challenge. An inversion in the
CD4: CD8 ratio was seen to occur by as early as 6 hours post-challenge which persisted
up to 24 hours post-challenge. Rice et al (1984) challenged unstimulated T-cells with

HCMV at MOIs' ranging from 0.1 to 1 pfu/cell and after 3 to 4 days recultured these cel

in the presence of PHA for a further 4 days. No loss in cell viability or change in CD3
CD4 or CD8 phenotype was reported after the first 3 days following challenge. In
addition no increase in suppressor cell or NK-cell activity was observed in cells

challenged with AD 169. However challenge with a clinical isolate resulted in increased

T-cell mediated suppression with a loss in NK activity. Challenge with ultra-violet li
(UV) or heat inactivated HCMV was found to abrogate the immunosuppressive effect.
The work of Rice et al (1984) contradicts that of Kim Sing and Garnett (1984) in that
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changes in C D 4 : C D 8 ratios were not observed following H C M V challenge. This is

possibly due to the stimulatory status of the cells at time of challenge. Kim Sing and
Garnett (1984) used T-cells which had been PHA stimulated for 65 hours prior to
challenge whereas Rice et al (1984) challenged unstimulated cells and added PHA at 3

days post-challenge before analysing subsets at a later time. From this it would appea

that the effect of HCMV challenge on T-cells is dependent upon the activity of the ce

and infection of T-cells may be cell cycle dependent. This suggestion is further supp
by the work of Braun and Reisser (1986), described above, which showed that HCMV
was only able to replicate in cells which had been adequately stimulated with IL-2.

The effect of CMV infection on T-cells is similar in murine systems. Sell et al
(1985) found that infection of B ALB/c mice with murine CMV (MCMV) resulted in a
decreased Lyt 1.2+ to Lyt 2.2+ lymphocyte ratio by 24 hours post-infection.
Responsiveness to the mitogen ConA was diminished by 3 days post-infection with this
hyporesponsiveness persisting through to day 16 post-infection. Brideau and Nicholas
(1989) showed a decreased ratio of helper to suppressor cells and a reduction in the
number of cells expressing Thy-1 or L3T4 antigens in murine systems. These changes
were accompanied by a decreased response to both mitogen and IL-2.

1.3.6. Effect of CMV on T-cell Lymphokine Production

1.3.6.1. Interleukin-2 Production

Infection of human peripheral blood T-cells has been found to reduce both the

production and proliferative response of T-cells to EL-2. The addition of exogenous I

to cultures with a low MOI (0.015) was able to reconstitute the proliferative response

However in the case of cells challenged with a high MOI the proliferative response co

not be restored. There was no evidence of an IL-2 inhibitor being present in these cul
suggesting that the defect was at the level of response (Kapasi and Rice, 1988).
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The effect of H C M V challenge of IL-2 dependent lymphocytes has been studied
by Numazakiefa/ (1988). Co-incubation of cloned T-cells with H C M V resulted in 405 0 % of these cells expressing H C M V late antigens in the absence of viral D N A
replication following 12 days of exposure. H C M V inhibited the response of these T-cells
to exogenously added IL-2 in a dose dependent fashion However it was found that the
cellular proliferative response to IL-2 could be reconstituted by the addition of high levels
(20% v/v) of exogenous EL-2 . Expression of the low affinity p55 ( T A C ) component of
the IL-2R was reduced on these cells from an initial 6 8 % positive cells to 20-24%
positive by 120 hours post-infection . N o effects were seen with heat-inactivated virus.
These results suggest that H C M V affects the responsiveness of T-cells to IL-2 possibly
through changes in EL-2 receptor expression.

1.3.6.2. Interferon Production

The production of IFN-a and p (Type 1) and IFN-y (Type 2) has been studied
following stimulation of leukocytes with either crude or purified H C M V antigen. Crude
preparations stimulated type 1 E F N production in both seronegative and seropositive
donor peripheral blood T-cells. Purified antigen stimulated the production of type 2 IFN
only in the case of seropositive donors. T-cells from seropositive donors were also
found to undergo blastogenesis following stimulation with crude or purified antigen
whilst cells from seronegative donors did not (Starr et al, 1980).

In the murine system both normal and sensitized T-lymphocytes were found to
produce murine IFN-a when cultured with M C M V infected fibroblast Peak production
was found at 24-48 hours post-infection. In addition, sensitized lymphocytes produced
EFN-y which was found to occur at late periods after the peak of the blastogenic response.
These results suggest that different T-cell populations are responsible for production of
IFN-a and -y (Kelsey et al, 1982).

1.4.0.

SCOPE OF THIS STUDY

The information reviewed in the preceding sections illustrates that H C M V is able
to cause a number of perturbations in both the phenotype and function of lymphocytes
even though few cells support productive infection with a m a x i m u m of 3 % of T-cells
expressing early antigen.

HCMV mononucleosis in vivo is characterized by an initial period of acute
mononucleosis during which time there is an increase in the number of mitogen
hyporesponsive C D 8 + cells apparently associated with immunosuppression. The period
of acute mononucleosis is followed by a period of convalescence during which the
numbers of C D 8 + cells are reduced and mitogen responsiveness gradually returns
(Rinaldo et al, 1987). In vitro studies have shown that augmentation of the responses
of T-cells with freshly prepared monocytes is only achieved if the T-lymphocytes are
obtained from patients during the convalescent stage of mononucleosis and not from
patients in the acute stage of mononucleosis (Carney and Hirsch, 1981). This
information indicates that a mechanism independent of H C M V infection of monocytes
m a y exist whereby T-cell functions are perturbed during the acute stages of
mononucleosis.
Rinaldo et al (1980) found that an active suppressor mechanism is needed for
mitogen hyporesponsiveness and the effects of H C M V infection are greater following
infection by blood transfusion. These results suggest that the virus m a y influence Tcells in a direct w a y since removal of virus from the system, achieved either by in vitro
culture of these cells or as a result of viral clearing, causes a return to a normal i m m u n e
response in the absence of any other suppressor mechanisms. Certainly the rapidity
with which H C M V is able to induce changes in T-cells is illustrated by the work of K i m
Sing and Garnett (1984) in which increased immuno-suppression, mitogen
hyporesponsiveness and a complete reversal in the C D 4 to C D 8 cell ratio were found by
6 hours post challenge were observed.
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The aim of the work in this study was to focus on the interaction of H C M V with
T-lymphocytes. Such studies m a y provide a means of elucidating the mechanisms
whereby the virus is able to directly modify the functions of these cells. This study has
been facilitated through the testing of two general hypotheses :

1. The virus interacts with the entire T-cell population resulting in changes in the r
proportions of T-cell subpopulations. which m a y cause alterations in immune function.
The C D 4 and C D 8 marker were chosen for study based upon numerous reports of
changes in the proportions of these populations seen following H C M V infection both in
vivo and in vitro. Antigens from the C D 4 5 R group were chosen for study due to the
increasing importance being placed on these makers as indicators of both T-cell function
and maturity. This study focuses on the interaction with stimulated T-cells since previous
results suggest that activated cells are most susceptible to changes following H C M V
challenge.

2. The virus interacts with a regulatory population of T-cells. which by means of facto
production m a y bring about changes in i m m u n e function. The approach taken was to
probe for the presence of H C M V D N A in a variety of T-cells including peripheral blood
T-cells subjected to different stimulation protocols prior to in vitro challenge and in T-cell
clones and peripheral blood T-cells challenged and isolated according to marker
expression. T h e levels of two lymphokines IL-4 and IFN-y were assayed in H C M V challenged T-cell supernatants to determine whether virus challenge either modifies or
blocks the ability of T-cells to produce these factors.

2.0

MATERIALS A N D M E T H O D S

2.1.0.

Preparation of Virus Stocks

2.1.1. Propagation and Purification of HCMV

Two strains of HCMV were used in this study, the common laboratory strain AD 169
was obtained from The American Type Culture Collection (ATCC, Rockviile, MD) and a low

passage clinical isolate p72 was obtained from the State Health Laboratory Services (P
Western Australia). Virus was propagated in low passage mycoplasma free human
embryonic fibroblasts (HEF) cultured in CMRL 1969 medium (Appendix A) supplemented
with 2% heat-inactivated foetal bovine serum (FBS, Appendix A), 2mM glutamine

(Appendix A) and without antibiotics at 37°C. Fibroblast monolayers, when 80% confluent
were infected with HCMV at an MOI of 1 PFU/cell. When cells began to die, medium was

harvested at regular intervals until extensive cell death occured at which stage all c
removed by scraping. Intracellular and cell associated virus was liberated by repeated

thawing. Cell debris was removed by low-speed centrifugation at 800g for 10 minutes an
extracellular virus was then concentrated by centrifugation at 20 OOOg for 2 hours at

onto a 90% w/v sorbitol cushion. Virus was harvested from the top layer of the sorbitol
cushion and diluted in equal volumes of unsupplemented CMRL 1969 and 70% w/v sorbitol

to make a final volume of 1 ml. Cells and virus stocks were regularity tested and foun
negative for mycoplasma using two commercial screening systems (Mycotrim TC, Hana
Biologies; Dapi staining, Boehringer-Mannheim; Appendix C).

2.1.2.

Titration of H C M V Stocks.

Virus stocks weretitratedusing a modification of the plaque assay described by
Wentworth and French (1974). HEF were seeded into 24-well trays and when semiconfluent the monolayers were washed twice with Ca2+ and Mg2+ free hanks balanced salts
solution (HBSS, Appendix A) and infected with virus diluted in CMRL medium without

FBS to a final volume of 200 \il. Following a 90 minute absorption period at 37°C, the c
were washed twice with HBSS and maintained on CMRL + 2% FBS for 2 days at 37°C.
After 2 days the medium was replaced with fresh CMRL 1969 + 2% FBS medium containing

0.33% agarose (Bio-Rad, USA; Low gel temperature electrophoresis grade) and incubated a
37° C for a further 7 days before refeeding with fresh medium containing agarose. Cells

monitored on a daily basis for the presence of cytopathic effects (CPE). When clear foci

infection were observed the cells were fixed and stained (Dip Quick staining, Appendix D

and plaques enumerated. Viral titres were expressed as the number of plaque forming unit
(PFU) per ml of virus suspension.

2.1.3 UV-Inactivation of HCMV

Virus was inactivated by exposure to ultra-violet (UV) light. Virus samples diluted
to a final volume of 200 |il in unsupplemented CMRL 1969 medium were placed in sterile
polypropylene tubes and irradiated with 80000 ergs/mm2 of mid-range (250-400 nm) UV-

light at 21° C. UV-inactivation was verified by infecting HEF monolayers in 24 well pla

with inactivated virus at an MOI of 5 PFU/cell based upon viral titre prior to inactivat

The monolayers were studied over a 10 day period for indications of virus induced CPE wi
a negative result taken as an indication of successful inactivation of the virus.
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2.2.0.

T-lymphocytes : Preparation, Culture and
Challenge

2.2.1. Preparation of T-Lvmnhocvte^

Mononuclear cells were prepared according to the principles outlined by B0yum
(1974). Heparinised (10 U/ml) venous blood samples were obtained from healthy H C M V
IgM and IgG seronegative blood donors with blood letting being performed between 08H0009HOO in order to minimize circadian effects. Whole blood was layered onto an
equiproportionate quantity of Mono-poly Resolving M e d i u m (Flow Laboratories, Australia)
in 50 ml polypropylene centrifuge tubes (Falcon, U S A ) and centrifuged at 300g for 30
minutes at 17° C. The upper bandingfractionconsisting of ~ 5 6 % lymphocytes and ~ 3 8 %
monocytes was harvested using siliconised glass pasteur pipettes and transferred into a fresh
50 ml centrifuge tube prior to washing twice with C a 2 and M g ^ free H B S S . Washing
steps were performed by centrifugation at 300g for 8 minutes. The washed pellet was
resuspended in 10ml R P M I 1 6 4 0 ( R o w Laboratories, Australia; Appendix A ) supplemented
with 1 0 % heat inactivated F B S , l O m M glutamine, penicllin G (CSL, Australia) and
streptomycin (CSL, Australia) at 100 |J.g/ml. This medium shall hereafter be referred to as Tcell culture medium. Monocytes and other adherent cells were removed from the cell
suspension by incubating the cells at 37° C in R P M I 1640 + 1 0 % F B S for 90 minutes in
tissue grade quality petri plates (Nunc, Denmark). A s a rule, one petri plate was used for the
isolation of monocytes from the equivalent of 50 ml whole blood. The supernatant
containing B and T lymphocytes was aspirated, the cells pelleted at 300g for 10 minutes and
resuspended in 5 ml of R P M I 1640 culture medium. This cell suspension was then applied
to a nylon wool column (Appendix E) and incubated at 37°C for 30 minutes in an atmosphere
containing 5 % CC_. T-cells were eluted from the column in a drop-wise fashion with 10 ml
of unsupplemented R P M I 1640 medium into afresh50 ml polypropylene centrifuge tube
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(Falcon, U S A ) , pelleted at 300g for 10 minutes and resuspended at final concentration of 10 6
cells/ml in R P M I 1640 + 1 0 % F B S medium.. This method routinely yielded a T-cell
population showing 1-2 % with a m a x i m u m of 5 % non-specific esterase activity (Appendix
D ) with > 9 5 % cells expressing the C D 3 marker.

2.2.2. Culture of T-lymphocytes

Freshly isolated T-lymphocytes were cultured according to the principles outlined by
Moorhead et al (1967). In all experiments T-cells were cultured at afinalcell concentration
of 10 6 cells/ml in T-cell culture medium at 37° C in a humidified atmosphere containing 5 %
C 0 2 . Experiments using cell quantities up to a total of 2 x 10 5 cells were performed in either
round or flat-bottomed 96-well trays ( N U N C , Denmark). Cell quantities greater than 2 x 10 5
and up to a m a x i m u m of 2 x 10 6 cells were cultured in 10ml round bottomed tissue culture
tubes ( N U N C , Denmark). T-cell clones and isolated T-cells in quantities greater than 5 x 10 6
cells were cultured in upright 75 c m 2 tissue culture flasks ( N U N C , Denmark).

2.2.3. Mitogenic Stimulation of T-lvmphocytes

In all experiments, unless otherwise indicated, T-cells were stimulated with the
mitogens P H A or C o n A prior to H C M V challenge. T-cell proliferation in response to
concentrations of the mitogen P H A , varying from 0-10 (J,g/ml, in combination with varying
concentrations of monocyte conditioned medium were tested for cells obtained from the
donors used for the duration of this study. In all cases, T-cells were found to be maximally
stimulated following a 65-72 hour culture period in T-cell culture medium supplemented with
2.5 ng P H A and 10 % monocyte conditioned medium.
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Stock solutions of purified P H A (Wellcome Diagnostics, England) were m a d e to a
final concentration of 1 |ig/|il in sterile distilled water and added directly to cultures.
Monocyte conditioned medium was obtained by stimulating moncytes (5 x 105 cells/well of a
24-well tray) in RPMI 1640 + 10% FBS (lml/well) in the presence of an optimum
concentration (20 }ig/ml) of lipopolysaccharide (LPS; Difco, Detroit MI) and culturing at
37°C for 24 hours in an humidified atmosphere containing 5% CC_. Conditioned medium
was harvested at 12 hours post-stimulation and replaced with fresh medium which was

harvested after a further 12 hours of culture. All harvested medium was pooled and clarified
by low speed centrifugation at 300g for 15 minutes. The clarified supernatant was filtered
through a 0.22 |im filter (Millipore, England) and aliquoted into 1ml quantities which were
then stored at -70°C until use.

T-cell proliferation was assesed by measuring the incorporation of exogenous tritiated
thymidine (3H-thymidine; ljiCi/well; Specific activity 3.777 GBq/ml) into T-cell DNA over
the last 18 hours of a 65 hour culture period. Cells cultured in 96-well trays (2 x 105
cells/well) were harvested onto glass fibre filter paper discs (Skatron, England) using a
Titertek multi-weU harvester (Flow Laboratories). Filter discs were dried and each disc was

added to 5ml of a premixed scintillation cocktail and disc solubiser (Scintisol: Isolab, Ohi
USA). Cellular 3H-thymidine incorporation was measured using an LKB liquid scintillation

counter (Linbrook International, NSW, Australia). All tests were performed in triplicate and
results expressed as mean CPM ± 1 SD values. Standard errors for the means of triplicate

cultures were calculated and the significance of difference between samples determined usin
the students t -test with a p < 0.05 being considered significant.

Stimulation with the mitogen concanavalin A (ConA) was performed according to the
protocol described by Blue etal (1988). T-cells were cultured at a final concentration of
106 cells/ml for 5 days without feeding in the presence of a combination of 62 |j,g/ml ConA
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(Sigma Chemicals, U S A ) and 20 U/ml rIL-2 (Boehringer-Mannheim, W.Germany). Aliquots

of stock solutions containing 2 mg/ml ConA in sterile distilled water were added direc
culture medium.

2.2.4. Maintenance of T-cell Clones

A T-cell clone co-expressing the CD4 and CD8 markers was used in this study. The

clone was obtained as gift from Dr. M.L. Blue (Dana-Farber Cancer Eistitute, Boston, M
and is described by Blue et al (1988).

Cloned T-ceUs were routinely cultured in RPMI 1640 medium supplemented with
10% FBS, 30 U/ml rIL-2 (Boehringer-Mannheim, W.Germany), lOmM glutamine and
streptomycin and peniciUin G (100 (ig/ml; CSL, Australia). Cell concentrations were
maintained at 1-5 x 106 cells/ml in a total volume of 10ml appropriately supplemented
RPMI1640 medium in an upright 75 cm2 flasks at 37°C in a humidified atmosphere
containing 5% CO2.

Cloned T-cells were stimulated every 2-3 weeks using a combination of irradiated (60
Gray) allogeneic stimulator cells (2:1), 0.25 ng/ml PHA and 10% monocyte conditioned
medium. At 4 days post-stimulation the cells were pelleted, at 300g for 8 minutes, and
resuspended in fresh RPMI1640 + 10% FBS supplemented with 30 U/ml rIL-2. Cells were

then fed every 3 days by removing 50% of existing medium and replacing with appropriat
supplemented RPMI 1640 medium.

2.2.5.

H C M V Challenge of T-lvmphocvtes.

The same protocol was used for the virus challenge of all T-cells used throughout this

study. Purified T-cells were washed 3 x in HBSS containing the competitive sugar for PHA,
n-acetyl-d-galactosamine (20mM; Sigma Chemicals, USA). The cells were resuspended at a
final concentration of 5 x 106 cells/ml in RPMI without FBS prior to challenge. Virus
diluted in FBS free RPMI1640 to provide the required MOI in a 100 |il volume was added
directly to cells. An adsorption period of 90 minutes at 37°C was allowed with gentle

agitation at 15 minute intervals. Cell quantities in excess of 1 x 106 cells were challen

10ml round bottomed tissue culture tubes (NUNC, Denmark) whilst cell quantities less than
1 x 106 cells were challenged in round bottomed 96-well trays. Following the adsorption

period, the cells were diluted with an excess of fresh RPMI 1640 and the cells pelleted a
300g for 10 minutes. Excess medium was removed with a pasteur pipette to a point just

above the cell pellet and cells were again resuspended in an excess of RPMI1640 medium an

pelleted at 300g for 10 minutes before the addition of fresh culture medium to yield a f
concentration of 106 cells/ml. Control mock-infected ceUs were challenged in a similar
manner except that the virus suspension replaced with 100

JLXI

FBS-free RPMI 1640

containing 30% w/v sorbitol.

Following viral challenge, cells were cultured in RPMI 1640 culture medium
additionally supplemented with 20 U/ml rIL-2 (Boehringer-Mannheim, W.Germany) and
10% T-cell conditioned medium which was harvested from the same stimulated cultures
immediately prior to challenge.

2.3.0.

Immunochemical Techniques

2.3.1. Monoclonal Antibodies
Table A : Monoclonal antibodies used in this study

CD
Designation

Antibody

Mr of
Antigen
(Daltons)

IgG
Composition

Conjugate

Supplier

CD3 (i)

Anti-Leu-4

22-28 kDa

IgGl-kappa

No conjugate

CD3 (ii)

Anti-Leu-4

22-28 kDa

IgGl-kappa

FITC

BectonDickinson
Bee tonDickinson

CD4 (i)
CD4 (ii)

Dako-T4
Anti-Leu-3A

55 kDa
55 kDa

IgGl-kappa
IgGl-kappa

No conjugate
PE

Dakopatts
BectonDickinson

CD8 (i)
CD8 (ii)

Dako-T8
Anti-Leu-2b

32,43 kDa
32,43 kDa

IgGl-kappa
IgGl-kappa

No conjugate
FITC

Dakopatts
BectonDickinson

CD25 p55

Anti-IL2R

55-60 kDa

IgGl-kappa

FITC

BectonDickinson

CD25 p72

TU27

70-75 kDa

Mouse IgG

No conjugate

Dr. S. Taki,
Ajinomoto
Co.Inc. Japan.

CD45RA

2H4

220 kDa

FITC

Coulter
Immunology

CD45RO

UCHL1

180 kDa

No conjugate Dr. M . Cooley,
Centre for
Immunology.
St, Vincents
Hospital,
Sydney,
Australia.

Table A continued...

No _
Designation

Dako-HLAABC

45 kDa

No cluster
Negative
Controls

Dakopatts

IgGl-kappa

FITC

Dakopatts

IgGl-kappa

PE

Dakopatts

No cluster

FTTCconjugate

Mouse IgG

Goat IgG

FITC

Sigma

No cluster

PE-conjugate

Mouse IgG

Goat IgG

PE

Sigma

No cluster

Normal Mouse Serum

Sigma

Cluster of Differentiation as determined at Fourth International Workshop on H u m a n Leucocyte

Different_ationantigens-Viennal989.
2

No conjugate

Glucose
oxidase

No cluster

1

IgG2-kappa

Fluorescein Isothiocyanate

3 Phycoerythrin

2.3.2.

Selection of T-cell subsets using monoclonal antibodies.

Three different methods were used for the selection of specific T-cell subsets. Earlier
experiments were performed using cell subsets obtained using T-cell panning. In later
experiments two different types of immunomagnetic beads were used, Dynabeads™ (Dynal,
Denmark) and Amerlex-M™ reagent (Amersham, Australia). Dynabeads™ proved to be the
easiest to work with and yielded better quality preparations with low levels of reagent
contamination than did the Amerlex-M reagent. In flow cytometric analyses contamination
with dynabeads was easy to detect due to the uniform size of the beads which gave them a
distinct FALS-L900 LS profile.

1. T-cell Panning:

T-cells were enriched for either CD4 or CD8 positive ceUs using a modification of the

T-cell panning technique described by Tsoi et al (1982). Bacteriological grade petri plat
were precoated with poly-L-lysine (Sigma Chemicals, USA) by incubating the plates with

10ml of a poly-L-lysine solution (40 Jlg/ml in 0.05M Tris-HCl pH 9.4) per 50cm2 for 1 ho
at room temperature. The plates were then washed 3x with sterile PBS (Appendix A)
followed by the addition of 100 |ig goat anti-mouse IgG in 0.05M Tris-HCl per 50cm2 and
incubated overnight at 4°C. The plates were then washed 3x with PBS followed by the
addition of PBS containing 5% bovine serum albumin (BSA; Sigma Chemicals, USA) and
incubated for 1 hour at room temperature before washing 3x with PBS. The quantities given
are sufficient for the panning of a total of 2 x 107 cells. Panning of the T-cells was
accomplished by adding 20 (ig of either anti-CD4 (Dakopatts; Table A) or anti-CD8

(Dakopatts; Table A) monoclonal antibody to the prepared petri plate and incubating at 4°
for 30 minutes. The plates were then washed 3x with PBS prior to addition of T-cells.

Washed T-cells were resuspended in 5ml of RPMI 1640 containing 5% heat-inactivated fetal
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bovine serum and incubated in the coated petri dishes for a further 60 minutes. FoUowing
incubation the plates were filled with R P M I + 5 % F B S and rotated gently before removing the
solution containing non-adherent cells. The non-adherent cells obtained from the first two
washes were retained with the three subsequent washes being discarded to avoid
contamination with loosely adherent cells. Adherent cells were removed by adding fresh
culture medium to the plate and incubating for several hours at 37° C in 5 % C 0 2 after which
cells could be removed with a m i n i m u m amount of hydrostatic pressure. Purified
populations were analysed for purity by fluorescence microscopy and found to be > 8 5 % pure
for the desired cell type.

2. Dynabeads™ :

Immunomagnetic Dynabeads™ M-450 (Dynal A.S., Norway) with affinity purified
sheep anti-mouse IgG covalently bound to the bead surface were used for both positive
selection and negative depletion of cell populations. This was the method of choice when
subsequent long-term culture of cells was required. Beads were coated with either anti-CD4
(Dakopatts, Table A ) or anti-CD8 (Dakopatts, Table A ) monoclonal antibody by mixing 75 jxl
bead suspension with 50 jig of the desired mouse IgG in a sterile screw-capped
polypropylene tube (Nunc, Denamark). After a one minute adsorption period, 950 p.1 of P B S
+ 1 % F B S was added and the tube placed on a blood-wheel overnight at 4° C. The beads
were then washed (4x) in 50 m l P B S with continuous rotation for 30 minutes at 4°C. Beads
were then stored at 4° C until use.

Cell selection was accomplished by mixing 2 x 107 cells with all the beads from the
initial 75 nl solution in afinalvolume of 1ml P B S + 1 % F B S in a sterile 1ml tube and
incubating at 4° C for 30 minutes with gentle mixing. Beads with adherent cells were
removed using a magnet and washed 2x in 50ml P B S in order to remove non-adherent cells.

56

Positively selected cells were removed from beads by incubating in culture medium overnight
at 37°C. The purity of selected populations was determined by flow-cytometric analysis of
samples labelled with directly conjugated anti-CD4 or anti-CD8 monoclonal antibodies (Table
A). This methodroutinelyyielded cell populations with a m a x i m u m of 9 0 % of cells positive
for the selected marker.

3. Amerlex™ beads:

Amerlex-M sheep anti-mouse beads (Amersham, Australia) were used for further
negative depletion of selected cell populations when subsequent culture of cells was not a
priority. Cells were selected by incubating 2 x 10 6 T-cells in 500ul R P M I 1 6 4 0 + 1 % F B S
containing a saturating concentration of monoclonal antibody against the subset to be
removed for 30 minutes at 4° C. The cells were pelleted and resuspended in 1ml
P B S + 1 % F B S . A 3 m l aliquot (6 fig of beads) of Amerlex™ reagent was pelleted, washed
and resuspended in 50 jil P B S before addition to the cell suspension. The solution was
incubated on a blood wheel for 45 minutes before exhaustive removal of the Amerlex™
reagent and adherent cells with a magnet Non-adherent cells were removed with a
siliconised glass pasteur pipette, washed twice in Hanks B S S (Appendix A ) and then
resuspended in appropriately supplemented R P M I 1640 culture medium. Cells positively
selected using the Amerlex™ reagent were discarded. This method routinely yielded depleted
populations of 9 0 % purity.

2.3.3.

Analysis of Surface Antigen Expression bv Fluorescence Microscopy

T-cell samples were analysed for CD4 and CD8 expression using fluorescence
microscopy. Phycoerythrin (PE) conjugated C D 4 and fluoroscein isothyocyinate (FTTC)
conjugated C D 8 antibodies (Becton-Dickinson, Australia; Table A ) were used for doublelabelling of samples.

Samples of 105 cells were removed from culture, washed and pelleted in 96 well
round bottomed trays. The cells were resuspended in 50 (J.1 of P B S + 1 % F B S + 0 . 1 % sodium
azide and incubated with a 1: 50 dilution of the required monoclonal antibody for 30 minutes
at 4°C. Thereafter the cells were washed with P B S + 1 % F B S + 0 . 1 % sodium azide and
resuspended in 50 (ll washing buffer containing paraformaldehyde fixative (Appendix D ) and
fixed at room temperature for 10 minutes before being washed and resuspended in 100 JLII
P B S + 5 % F B S . Samples were loaded into cytocentrifuge blocks with 1 drop of 2 2 % B S A in
P B S being added to each block. The cells were spun onto poly-L-lysine coated glass slides
(Appendix D ) at 600rpm for 2 minutes in a Shandon Cytospin 2 cytocentrifuge (Shandon,
England). Slides were air-dried and coverslips mounted using Fluoromount mountant ( B D H
Chemicals, Australia).
Slides were coded before counting. Subset ratios were determined by counting a m i n i m u m of
200 positive cells per slide. Filters were selected so as to allow for independent identification
of P E and F I T C fluorescing cells. Only cells exhibiting clearringfluorescence were
considered positive, with low and negative fluorescent cells being scored as null cells.

2.4.

F l o w Cytometric Analysis of Surface Antigen Expression

2.4.1 Instrument Specifications and Settings

All flow cytometric analyses were performed by the candidate using a Coulter Epics V
cell sorter equipped with a 5W argon-ion laser. Start-up procedures were performed
according to the manufacturers instructions. A half-hour laser warm-up period was allowed
prior to peaking of the laser at the final laser power of 450 mw which was used for all
analyses. Instrument performance was monitored prior to all analyses by running
Immunocheck™ standard fluorescent beads (Coulter Instruments, Australia) at predetermined
constant instrument settings for forward angle light scatter (FALS), log 90° light scatter
(L90°LS) and fluorescence photomultiplier tubes (PMT). A full optical realignment was
performed if a half coefficient of variation (V2 CV) greater than 3% was obtained for the
FALS histogram of data for 10 000 beads. A record of all checks was kept to ensure that
optimal instrument performance was maintained over an extended period.

Fluorescent light was directed to the 90°LS PMT through a 488nm dichroic filter.
Light to fluorescent PMTs was passed initially through a 488 nm laser blocking long pass

filter and a 515 nm long pass filter to a second filter block where it was further split u
550 nm short pass narrow band dichroic filter and directed to the red PMT through a 530nm
short pass filter and to the green PMT via a 590nm long pass absorbance filter.

FALS and 90° Light Scatter high voltage (HV) settings were standardised for all Tcell samples. These settings were obtained by running a selection of T-cell samples and
determining which settings gave optimal separation of T-cells from other material present
the samples. These settings were then used throughout the study with only minor
adjustments being made in HV or bit-map positions to allow for minor fluctuations between
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samples. H V settings for the red and green P M T s ' were set so as to provide an optimal
signal to noise ratio thereby eliminating electronic and low level fluorescence background
noise.

Red and green HV were adjusted at the discretion of the operator to accommodate for
the different fluorescent intensities of the antigens studied. It must be noted that these
settings were then strictly adhered to for analyses involving comparisons between samples

stained for the same antigen. In cases were it was necessary to study antigen expression ov
a long time period, the HV settings for the red and green PMTs were recorded and used for
each analysis. Instrument performance was monitored by running Immunocheck™ (Coulter,
Australia) standard immunofluorescent beads and determining the mean fluorescence channel
number of the beads at the chosen setting. In this way it was possible to monitor PMT
performance and to ensure that any changes in mean channel number were due to a change in
antigen intensity and not fluctuations in instrument performance.

Electronic subtraction was performed using the electronic subtraction module
incorporated into the Coulter EpicsV instrument Subtraction levels were set so as to
minimize spillover between red and green fluorescence whilst simultaneously ensuring a
minimal loss of the positive fluorescent signal. The subtraction module was switched off
when single-colour analysis was performed.

2.4.2 Sample Analysis

Direct labelling of samples was accomplished using saturating concentrations of the
required directly conjugated monoclonal antibodies. Samples consisting of 105 cells were
washed twice with PBS and then resuspended in 50 |J.l of PBS+1%FBS+ 0.1% sodium

azide and added to a fresh tube containing 2 jil of the required antibody and mixed. Antibody

solutions were pipetted using an Eppendorf 0.1-10 p.1 micropipette (Eppendorf, West
Germany). Following a 20 minute incubation period at 4° C the cells were washed once in
PBS+1%FBS+0.1% sodium azide and resuspended in 400 ul PBS+1%FBS+0.1% sodium

azide for immediate analysis. In the rare event of analysis not being performed within 15
minutes of staining, the cells were then fixed with paraformaldehyde (Appendix D) and
stored at 4° C for a maximum period of 24 hours.

For indirect staining, the cells were stained with the first antibody as described above
and following the first wash were then incubated for 10 minutes in the presence of a 10
excess of purified mouse IgG (Normal mouse serum, Sigma, Table A), compared to original
quantity of antibody added. Fluorochrome conjugated antibody (Table A) was then added
without washing and the cells incubated for a further 15 minutes at 4°C. The cells were
pelleted and resuspended in 400 |ll PBS+1%FBS+0.1% sodium azide solution for analysis.

Negative controls were prepared for each sample. The procedure followed was as for

the direct labelling of cells except that isotypic negative control antibodies (Table A)
used.

2.4.3 Data Analysis

Data analysis was performed using the MDADS II software which is supplied with
and run on the MDADS computer system supplied by Coulter Electronics. In all cases the

relevant histograms for a minimum of 5000 cells were collected and stored. In the case of

samples requiring detailed analysis, information was collected and stored on list-mode a
analysed at a later time.
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Positive distributions were determined by comparison with negative control
distributions using the histogram overlay function included in the Tmmuno' programme. In
cases where the positive and negative cell distributions were distinct from each other the
positive gates were set on cells which had been mock challenged so as to exclude all
negatively staining cells. In cases where overlap between positive and negative populations
occured subtraction was performed. This was achieved by performing a total subtraction of

the negative distribution from the positive distribution and then selecting the cells withi
positive gate determined using a mock challenged population. It must be noted that although
the 'Immuno' programme is provided for this purpose, it was not used since it was found
that varying results could be obtained depending upon subtraction parameters chosen.

Kolmongorov-Srnirnov values for the comparison of two histogram distributions
were determined using software supplied with the MDADS II unit The principles of this test
are described by Young (1977).

2.5.0.

Nucleic Acid Techniques

2.5.1 Plasmid Purification

The HCMV specific probe used in this study was the HindlH O-fragment cloned by
Oram et al (1982) into E.coli using the/? AT153 plasmid vector. This probe was chosen

due to low cross-reactivity with cellular DNA and on the basis of the observation that H

IB O-fragments isolated from a wide variety of laboratory adapted and clinical strains t
migrate during agarose electrophoresis (Chandler and McDougall, 1986) Two methods were
employed for the preparation of the probe used in this study.

1. FPLC:

In essence this technique consists of alkaline lysis of bacterial cells followed by
precipitation of chromosomal DNA and RNA and final FPLC separation of plasmid DNA.
Bacteria from a slant culture were inoculated into 10 ml Luria broth (LB, Appendix F)
supplemented with ampicillin (50 |ig/ml) and incubated overnight with shaking at 37° C.

overnight culture was transferred into 50 ml of identical culture medium and incubated f

further 5 hours or until an O.D.600 of 0.6 was reached before being transferred into 500 m
LB. After a further 4 hours of incubation, chloramphenicol (170 |ig/ml) was added. The

cells were harvested after a further 14 hours of culture at 37 °C. All centrifugation st
described were performed in either a Sorvall SS-34 rotor for quantities less than 30 ml

Sorval JA-14 rotor for quantities exceeding 30 ml. The cell pellet was resuspended in 25
of Solution 1 (Appendix F). Lysozyme, 10 mg in 1 ml of solution 1 was added and cells
incubated at room temperature for 10 minutes. Thereafter 50 ml of solution 2 (Appendix F)
was added and following vigorous mixing a further 37.5ml of cold (4° C) solution 3

(Appendix F) was added and the solutions left on ice for 20 minutes. Cell debris was pel
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at 800g for 30 minutes at 4° C. The cleared supernatant was removed and 2 volumes of

cold ethanol was added and the solution kept on ice for 10 minutes prior to centrifugat

800g for 5 minutes. Resultant pellets were air dried and resuspended in 10 ml of solutio

(Appendix F), transferred to a 30 ml polypropylene centrifuge tube and incubated on ice
15 minutes after the addition of 2g ammonium acetate (Sigma Chemicals, USA). After

centrifuging at 1500g for 10 minutes at 4°C the supernatant was collected and 2 volumes

ethanol was added. The tube was kept on ice for 10 minutes and then centrifuged at 1500g

for 2-3 minutes at room temperature. The pellet was resuspended in 1 ml of solution 4 an
10 |J.g/ml ribonuclease A (RNaseA, Appendix F) was added. The sample was incubated at
room temperature for 1 hour prior to injection into a superose column. Superose 6 prep
grade (Pharmacia, Sweden) packed in an HR 16/50 column (Pharmacia, Sweden) was used
for the separation. Before use the column was rinsed with 400ml 0.2M NaOH at 1 ml/min

and equilibrated with 150 ml elution buffer (Appendix F). The sample was run through the

column at a rate of 0.25-1.0 ml/minute using solution 4 (Appendix F). Fractions contain
the plasmid peak at an absorbance of 260 nm were detected using an LKB 2138 Uvicord S
UV-monitor (LKB, Denmark) were collected and stored at -20°C.

2.0uiagen Columns:

Quaigen-pack 100 columns (Diagen, Germany) were used as an alternative method

for the isolation of plasmid DNA. Bacterial cultures were prepared as described in sect

above. Cells were harvested and the pellet resuspended in 7.2 ml of an ice-cold solutio
50mM Tris-Cl, pH 7.4 and 0.8 ml 20 mg/ml lysozyme, prepared in the same buffer, and
incubated on ice for 10 minutes. Thereafter 2 ml of a 0.5 M EDTA (pH 8.0) solution was

added and incubated for 10 minutes before adding 4001_1 of a 2% Triton X-100 solution a

mixing thoroughly. After centrifugation at 20 000 g for 45 minutes at 4° C the supernat
was treated with RNase A (Appendix F) added to a final concentration of 20 ng/ml for 30
minutes at 30° C. Proteinase Kwas added to a final concentration of 10 |lg/ml and the

solution incubated for a further 30 minutes at 37° C before centrifuging at 20 OOOg for

minutes. The supernatant was transferred to a fresh tube and 2.0 ml of 5M NaCl and 1.0 m
of 1M MOPS (3-[N-morphohno]propanesulfonic acid; pH 7.0; Appendix F) was added. A
quiagen pack 100 column was then equilibrated with 2 ml of buffer A (Appendix F). The
DNA was then adsorbed to the cartridge by forcing the sample through at a maximum flow
rate of 0.5 ml/min. The cartridge was washed with 5ml of buffer C (Appendix F) in more
than three minutes to remove proteins, RNA and other contaminants. The plasmid DNA was
eluted with 2ml of buffer F (Appendix F) at a flow rate of 1 mVmin. Plasmid DNA was
precipitated with 0.8 vol isopropanol for 2 hours at -20° C.

2.5.1.1. DNA Quantitation and Integrity

Plasmid DNA was quantitated and the purity determined by reading the O.D. 260 and

O.D. 280 as outlined in Maniatis and Fritch (1982), one O.D. 260 unit being equivalent t
DNA concentration of 50 |ig/ml.

Plasmid integrity was determined by running a 0.5 jig sample of plasmid D N A on a
0.8% agarose gel in T B E buffer containing 5 |ig/ml ethidium bromide. The mini-gel was
formed in a Pharmacia mini-gel apparatus and run at 11 volt/cm for 2 hours. Plasmid bands
were then visualised in the gel using a UVP-transilluminator. Preparations showing distinct
plasmid bands with low levels of R N A contamination and an O.D. 260/280 ratio of > 1.8
were considered to be a pure.

2.5.2 T-cell DNA Sample Preparation

Specific samples of T-lymphocytes were washed free of medium components twice
using P B S and centrifugation at 300g for 8 minutes. After washing, cell number and
viability was determined by trypan-blue stairiing (Appendix D ) . Samples of 10 5 viable cells
were transferred into sterile 1ml polypropylene tubes (Eppendorf, W.Germany),
resuspended in 50 (ll T E buffer (Appendix F) and stored at -70° C. In all cases, sample
viability was > 8 5 % . W h e n sufficient samples had been collected whole cell D N A extracts
were prepared and bound to nylon membrane.
A sheet of Zeta-Probe® nylon membrane (Bio-Rad, USA) was pre-wet with distilled
water and placed into a Schleicher &Schuell Minifold II slot-blotter (Schleicher and Schuell,
West Germany) blotting apparatus. Cell samples were thawed and heated in 0.5 ml of 0.4M
N a O H , 10 m M E D T A at 100° C for 10 minutes. Samples were then added to the wells and
vacuum filtered. The vacuum was released and 0.5 m l of 0.4M N a O H was added to each
well and vacuum filtered. The filter was removed andrinsedin 2xSSC (Appendix G ) . In all
cases membranes were used for hybridisation immediately following blotting without
storage.

2.5.3

Nick Translation and Hybridisation

Plasmid D N A was labelled with 3 2 P using an Amersham Nick Translation Kit
N.5500 (Amersham, Australia). The nick-translation mixture consisted of 1 \ig plasmid
D N A , 20 |il of nucleotide buffer, 500 picomoles of [a " 3 2 p ] d C T P , 10 |il enzyme solution
and sufficient water to bring thefinalvolume to 100 fil. The mixture was incubated at 15° C
for 3 hours.

Unlabelled nucleotides were removed from the labelled plasmid preparation using
Nick-columns™ (Pharmacia, Sweden). The column wasrinsedand equilibrated with 3 m l of
T E buffer and after the buffer had completely entered the gel bed, the sample was added. A
further 400 }il T E buffer was added and allowed to enter the gel bed before eluting the sample
with 400 |il T E buffer. The probe was then denatured at 100° C for 5 minutes and chilled on
ice before addition to the hybridisation mixture.

The specific activity of the probe was determined by removing 1 |il of the final probe
suspension and spotting onto a glass fibre filter disc (Skatron, England) and drying. The
disc was then added to 5ml of a premixed scintillation cocktail and disc solubiliser (Scintisol;
Isolab, Ohio, U S A ) , and 3 2 P incorporation determined using an L K B liquid scintillation
counter (Linbrook International, Australia). The D N A specific activity of the probe was then
determined. Probe specific activities of >1 x 10 8 dpm/|ig were obtained on a regular basis.

Hybridisation was performed in a PR 800 hybridisation chamber (Hoefer Scientific
Instruments, U.S.A.) using an A m e r s h a m Rapid Hybridisation System (Amersham,
Australia; Appendix G ) . The nylon membrane was prehybridised for 60 minutes at 65° C
with 10 ml rapid hybridisation solution (Amersham, Australia). Denatured probe, 0.5 |ig in
500 |il T E buffer, was added and hybridisation allowed to proceed for 2 hours at 65° C. The

nylon membrane was then removed from the manifold and washed 2 x 10 rninutes in excess
2 x SSC+0.1% (w/v) SDS room temperature. This was followed by 1 x 15 minute in excess
1 x SSC+0.1% (w/v) SDS at 65° C. Final washes of 2 x 15 minutes in an excess of 0.7 x
SSC+0.1% (w/v) SDS were performed at 65° C. The membrane was rinsed and blotted
lightly to remove excess solution and wrapped in Saran-wrap prior to autoradiography.

2.5.4. Autoradiography and Densitometry

Membrane wrapped in Saran-wrap was enclosed in an envelope made from light

weight blotting paper. The envelope was sandwiched between 2 sheets of Kodak X-Ray fil

(Kodak, Australia) and placed in a Kodak X-omatic cassette fitted with intensifying sc

Film was exposed for an initial period of 8 hours at -70° C before removing one sheet
and developing in Kodak D-19 developer (Kodak,Australia) for 4 minutes followed by

fixation in Kodak rapid-fix(Kodak,Australia) for 5 minutes. The second film was expose
for a longer period depending upon results obtained with the first film. To allow for

comparison of autoradiograph band densities of multiple blots in any one hybridisation
experiment the autoradiographs were exposed for equal time periods. Densitometry of
developed films was performed using an LKB model laser densitometer (LKB, Sweden).

2.6.0.

Determination of Cytokine Production by H C M V - and M o c k -

Challenged T-lymphocytes

2.6.1 Generation of T-cell Supernatants

2.6.1.1. Supernatants from MitogenicaUy Stimulated Peripheral Blood T-cells

Supernatants were obtained from cultures of peripheral blood T-cells which had been
stimulated with either PHA or ConA prior to mock- or HCMV-challenge. The supernatants
were harvested from these cultures at various times post-challenge.

Freshly isolated peripheral T-cells were stimulated with PHA (2 |ig/ml) in RPMI
1640 + 10% FBS + 10% monocyte conditioned medium for 65 hours at 37°C. Populations
containing heterogenous mixtures of both CD4 and CD8 cells were used. In addition, CD4+
cell enriched populations were prepared using Dynabead™ as described in section 2.3.2.

yield populations >90% pure for CD4+ cells. All populations were set up in tissue cultur

tubes (Nunc, Denmark) with a total of 2.5 x 106 cells/tube and either mock challenged or

challenged at an MOI of 5 pfu/cell with AD 169 or the clinical isolate according to the
described in section 2.2.4. Following challenge cells were maintained on RPMI 1640

medium supplemented with 10% FBS + 20 U/ml rEL-2 at a final cell density of 106 ceUs/ml.
Samples of 500

JLII

were taken at 0, 3,24, 48 and 96 hours post-challenge. Before removin

each sample, the cells in the culture were resuspended. The ceU concentration was

maintained as close as possible to 1 x 106 cells/ml for the entire sample period. Sample

were then clarified in 1 ml polypropylene tubes (Eppendorf, W.Germany) by centrifugatio
at 800g for 10 minutes to remove the lymphocytes and supernatants transferred to fresh
for storage at -70°C.
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Peripheral blood T-cells stimulated with C o n A according to the protocol in section
2.2.3. were treated in the same w a y as described above except that C D 4 + enriched
populations were omitted.

2.6.1.2. Supernatants from a CD4+CD8+ T-cell Clone

Samples were obtained from cultures of the CD4+CD8+ T-cell clone which were stimulated 4
days, as described in Section 2.2.3., prior to mock-challenge and challenge with either
H C M V strain A D 169 or the clinical isolate at an M O I of 5 pfu/cell according to the protocol
described in section 2.2.3.4.
Experimental cultures of 2.5 x 1 0 6 ceUs were set up intissueculture tubes and 500 |il
samples containing supernatant and resuspended cells were taken at 0,24,48 and 96 hours
post-challenge. These samples were clarified by centrifugation at 800g for 10 minutes to
remove the lymphocytes and the clarified supernatant was then stored at -70°C.
Samples were also taken from long-term cultures which had been challenged and established
as described above. N o supernatants were removed from these cultures at early times
allowing the cultures to be expanded into 75 c m 2 upright flasks and maintained for longer
periods with cell densities being checked at regular intervals to ensure a cell concentration of
between 1 to 5 x 10*> cells/ml was maintained. Cells were fed at 3 day intervals with medium
supplemented as described in section 2.2.3. Samples were removed from these cultures
immediately prior to feeding on days 12 and 18 post-challenge, thus representing samples for
the 9-12 and 15-18 day period post-challenge. These samples were clarified as described
above and stored at -70°C.

2.6.2.

Determination of IL-4 production

E-4 levels in supernatant were determined using a commercial IL-4 ELIS A kit (British
Biotechnology; Appendix I). Undiluted T-cell supernatants were tested in duplicate
according to the manufactures instructions. Quantities of 100 |il of IL-4 standard or
supernatant sample were added to microtitre plate wells which were precoated with a murine
antibody against EL-4. The wells were then covered and the plate incubated for 2 hours at
room temperature. Each well was then aspirated and washed four times with 400 |il of wash
buffer supplied with the kit A 100 |il quantity of a polyclonal antibody against IL-4,
conjugated to horseradish peroxidase, was then added to each well and the plate covered and
incubated for 2 hours at room temperature. The wells were again aspirated and washed as
described above before the addition of 100 |il of a 50 : 50 mixture of two substrate colour
solutions supplied with the kit The plate was covered and incubated for 20 minutes at room
temperature before the addition of 25 |il of a supplied stop solution. The optical density of
each well was determined at 450 n m using an ELIS A plate reader with colour correction set at
540nm. A standard curve was constructed by plotting the optical density for the standards
against the concentrations of the standards on log/log paper and obtaining the best curve from
these points. Concentrations of unknowns were read directly off the curve and the mean
concentrations for duplicate samples determined.

2.6.3. Determination of Interferon-YProduction

IFN-y levels were determined using a commercial IFN-y RIA kit (Endogen; Appendix
I). Undiluted T-cell supernatants were tested in duplicate according to the manufactures
instructions. Beads coated with mouse anti-IFN-y monoclonal antibody were dispensed into
reaction wells and 100 |il quantities of standard EFN-y samples and supernatant samples
added to the wells. The wells were covered and incubated for 2 hours at room temperature.

The wells were then aspirated and washed three times with a total of 3 mis glass distilled
water. A 100 [il quantity of 1251 (<0.9 uCi/ml) mouse anti-IFN-y monoclonal antibody was
then added to each well, the wells covered and incubated for 2 hours at room temperature.
The wells were then aspirated and washed as described above before transferral of beads to
counting tubes. The C P M for each tube was determined over a 10 minute period using a
g a m m a counter. C P M vs concentrations for the IFN-y standards were plotted on rectilinear
graph paper and the straight line equation for these points determined. IFN-y concentrations
in unknown samples were then determined using the straight line equation, and the mean
IFN-y concentrations for each duplicate sample determined.

3.0

RESULTS

3.1.0.

Establishment of Optimal Conditions for T-cell Stimulation

and Culture at Times Pre and Post-Viral Challenge.

3.1.1. Determination of Population Purity and Optimization of Bit-Map Settings
for Flow-Cvtometric Analysis of T-cell Populations

The purity of all T-cell preparations resulting from purification by sequential

hypaque-ficoll gradient centrifugation, plastic adherence and nylon wool separation wer
determined using CD3 expression and non-specific esterase activity as indicators of Tlymphocytes and monocytes respectively. T-cells were labelled with FITC-conjugated
anti-CD3 monoclonal antibody and analysed using a Coulter Epics V flow cytometer.

In populations which had been PHA stimulated for 65 hours prior to analysis, cells were
routinely found to be 95% positive for CD3 expre ;sion (Figure 1 B). Non-specific

esterase staining of these populations revealed that 1% of cells, with a maximum of 5%,

had non-specific esterase activity. Similar results were obtained using freshly isolate
unstimulated T-cell populations.

Optimal bit-map settings for flow-cytometric analysis of T-cells were established
using a method similar to that which has recently been described by Loken et al (1990).
FALS, L90°LS and fluorescence information for 10000 cells labelled with FITCconjugated anti-CD3 monoclonal antibody was collected and stored on list mode. This
information was then replayed through list-mode and a FALS-L90°LS profile obtained
with gates set on the CD3+ population. In this way the resulting FALS-L90°LS profile
showed the distribution of CD3+ ceUs alone. A bit-map was drawn around this
population and these settings were used in all subsequent analyses with constant
instrument settings for FALS and L90°LS being used (Figure 1 A). Minor adjustments
were made in the position of the map to accommodate slight shifts which occured with

Figure 1 A
Forward Angle Light Scatter vs Log 90° Light Scatter profile obtained for an ungated
population of P H A stimulated T-lymphocytes. The lymphocyte bit-map shown was
generated through list-mode analysis of data collected from a C D 3 stained population.
Gates set on the C D 3 + cells were used to generate a FALS-L90°LS profile for T-cells
alone thereby allowing the identification of the scatter profile for T-lymphocytes.

Figure 1 B
Histogram showing C D 3 + expression in a P H A stimulated T-cell population. T-cells
were directly stained with FITC-conjugated anti-CD3 monoclonal antibody.
Fluorescence information was then collected from T-cells using the FALS-L90°LS
lymphocyte bit-map shown in Figure 1 A.

Figure 1 A : FALS-L90°LS profile for P H A stimulated T-cells
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different T-cell samples. This technique also proved useful for assessing the stimulatory
status of populations since unstimulated T-cells being smaller in size displayed different
F A L S profiles than the larger stimulated ceUs.

3.1.2. Optimization of Conditions for T-cell Stimulation

The T-cell populations used in this study were primarily CD3+ cells with «1% of
cells showing non-specific esterase activity. It was important to rninimize monocyte
contamination of preparations due to the possible effects of H C M V challenged monocytes
on T-cells. It is widely acknowledged that T-cells require the presence of monocytes or a
monocyte produced factor for optimal proliferation in response to mitogenic stimuli. The
initial step in this work was therefore to establish the optimal concentrations of mitogen
and monocyte conditioned m e d i u m which would yield the m a x i m u m proliferative
response under experimental conditions.

The proliferative response of T-cells to varying concentrations of monocyte
conditioned m e d i u m and the mitogen P H A was tested usingfreshlyisolated T-cells which
were cultured in flat-bottomed 96 well trays (2xl0 5 cell/well) for 65 hours at a final
concentration of 1 0 6 cells/ml. R P M I 1 6 4 0 culture medium supplemented with
combinations of P H A and monocyte conditioned medium, generated as described in
section 2.2.3., and ranging in concentration from 0 to 10 |ig/ml for P H A and 0 to 1 0 %
for monocyte conditioned m e d i u m was added to the respective test wells. The cells were
cultured for 65 hours at 37°C in an atmosphere containing 5 % C O 2 with 3H-thymidine
(l|iCi/well) being added for the last 18 hours of culture. Cells were then harvested and
thymidine incorporation was determined by liquid scintillation counting.

T-cells did not respond to either PHA or monocyte conditioned medium alone
(Table 1). Concentrations of 1 0 % and 5 0 % monocyte conditioned m e d i u m in
combination with P H A resulted in maximal levels of stimulation with a concentration of
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Table 1.

Proliferative response of T-lymphocytes to P H A in medium supplemented
with varying concentrations of monocyte conditioned medium.

PHA

Thymidine incorporation by T-cells (CPM)2 at 65 hours poststimulation

(U-g/ml)

0%

1%

10%

50%

Monocyte Conditioned Medium*

0

44±3

4075±530

4282±460

6763±684

2

101±19

155493±1015

184947±8683

187193±1635

5

56±8

127493±1051

164889±5904

187242±3898

10

56±7

7377±4668

96113111045

156373±2361

1. Monocyte conditioned medium was derived from L P S stimulated monocytes within the first 12 hours
following stimulation as described in Section 2.2.3.
2. C P M values are the m e a n values ± S.D. obtained for three identical cultures. Similar results were
obtained using T-cells isolated from two different donors.
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1 0 % monocyte conditioned medium being the lowest concentration to give a maximal

proliferative response. PHA concentrations equal to or greater than 5 |ig/ml were seen t

have an inhibitory effect on T-cell proliferation when compared to the levels obtained w

a PHA concentration of 2 jig/ml (Table 1). On the basis of these results, T-cells used in
subsequent experiments were optimally stimulated by culturing 106 cells/ml for 65 hours
in culture medium containing 10% monocyte conditioned medium and 2 |ig/ml PHA.

3.1.3. Effect of HCMV Challenge on T-cell Proliferation and Viability

The effect of HCMV challenge on the proliferation of PHA stimulated T-cells was

determined using 3H-thymidine uptake as a measure of the proliferative response of cells
Cells were stimulated in flat-bottomed 96-well plates for 65 hours in RPMI1640 culture
medium containing 2 |lg/ml PHA and 10% monocyte conditioned medium and thereafter
challenged with HCMV strain AD 169 and the clinical isolate, as described in Section
2.2.5., at an MOI of 5 PFU/cell. These cells were subsequently cultured in RPMI 1640
culture medium supplemented with 20 U/ml rIL-2 and 10% filtered T-cell conditioned
medium harvested from the same cultures prior to challenge. 3H4hym_dine was added at
3 hours post-challenge and incorporation determined after a further 18 hours of culture.

Cells which had been washed and mock-challenged showed a drop in proliferation
when compared to control cells which had not been manipulated (Table 2). Although this

drop was found to be significant using the students t -test (p<0.01) the magnitude of the

drop was not considered to be large enough to indicate a failure of the cells to prolife

Challenge with AD 169 did not significantly affect the proliferative response of the cel

when compared to mock-challenged cells whilst challenge with a clinical isolate caused a
decrease in the proliferation of the cells which was found to be significant using the
students t -test (p< 0.01). However, the magnitude of the drop in

Table 2.

Proliferative response of P H A stimulated T-lymphocytes following

mock- and HCMV- chaUenge at 65 hours post-stimulation.

Challenge
Status

Thymidine incorporation (CPM)l in first 18 hours
following chaUenge
Experiment l 2

Experiment 2

Control

169298±1434

190770±1976

Mock

132567±1487

152653±1542

AD169

135466±1172

153584±6043

Clinical

124974+974

142942+3575

1. M e a n C P M ± S.D. for triplicate cultures.
2. Experiments 1 and 2 refer to two independent experiments performed using T-cells isolated from
different donors.
3. Control cells were not manipulated at time of challenge and were maintained in their original culture
medium.

proliferation between mock-challenged and cells challenged with the clinical isolate was
not considered to be of a magnitude large enough as to indicate a total loss of the
proliferative response of these cells since all counts remained above 120 000 CPM (Table
2).

The viability of T-cells was determined at regular intervals following viral
challenge using trypan blue dye exclusion and ethidium bromide - acridine orange
staining (Appendix B) as indicators of cell viability. Challenge with either HCMV strain
AD169 or the clinical isolate at MOI of <1 and 5 did not result in a significant drop in
culture viability when compared to mock challenged cells using the students r-test
(p<0.01). All cultures routinely showed >80% viability following HCMV challenge
(Figure 2). This result was obtained for peripheral T-cells stimulated with PHA or with
ConA and for the CD4+CD8+ double positive T-cell clone used in this study.

Figure 2
Viabilities of T-cells in cultures challenged with HCMV strain AD169and a clinical
isolate at MOI's of 5 and <1 PFU/cell. Viabilites were determined using trypan blue dye
exclusion and ethidium bromide- acridine orange staining. Results show the mean values
± S.D. obtained for three separate experiments. No significant differences were found
between mean values obtained for mock and HCMV-challenged populations when
compared using the students t -test.

Figure 2 A : Viabilities in cells stimulated with PHA (2.5 |ig/ml) for 65 hours prior to
HCMV chaUenge.
Figure 2B : Viabilities in cells stimulated with ConA (62 {ig/ml) + rIL-2 (20 U/ml) for
120 hours prior to HCMV challenge.
Figure 2C : Cells from a CD4+CD8+ double-positive T-cell clone were stimulated
with PHA (0.25 |lg/ml) and irradiated allogeneic stimulatoi cells for 4-6 days prior to
HCMV chaUenge.
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Figure 2 A : ViabiUty in P H A stimulated T-ceU cultures foUowing H C M V chaUenge
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3.2.0.

Effect of H u m a n Cytomegalovirus Challenge on the
Expression of the C D 4 and C D 8 T-cell Surface Antigens

HCMV chaUenge of PHA stimulated T-ceUs in vitro has been shown to cause
changes in the expression of the C D 4 and C D 8 markers on these ceUs (Kim Sing and
Garnett, 1984). T o extend upon this study, the expression of these markers on ceUs
contained in cultures consisting of mixed or C D 4 - and C D 8 - enriched cell populations
was studied. Cells were chaUenged with either viable or UV-inactivated variants of
H C M V strain A D 169 and the clinical isolate and marker expression analysed using
fluorescence microscopy and flow cytometry. T-cell populations, maximaUy stimulated
with P H A , were used in all experiments.

3.2.1. CD4 and CD8 Expression in a Mixed Population of T-cells following
H C M V Challenge

T-cells, maximally stimulated with PHA for 65 hours, were chaUenged with
viable and UV-inactivated H C M V as described in section 2.2.5. CeU samples were
double stained for C D 4 and C D 8 and the percentages of C D 4 and C D 8 positive ceUs
determined at various times post-chaUenge using fluorescence microscopy as described in
section 2.3.3. CeUs showing clear ring fluorescence were regarded as being positive for
the respective markers whilst those showing dull or no fluorescence were scored as being
nuU ceUs.

ChaUenge with viable HCMV resulted in a reduction in the CD4 : CD8 ceU ratios
when compared to mock-chaUenged cells at 0, 6,24 and 48 hours post-challenge (Table
3A). H C M V chaUenge was seen to have an effect on the percentages of both C D 4 and
C D 8 cells by 0 hours post-challenge, however it should be noted that these samples were
taken foUowing a 90 minute virus absorption period. The reduction in the C D 4 : C D 8
ratios were in part due to a decrease in the absolute numbers of C D 4 + ceUs at these times
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and an increase in the absolute numbers of C D 8 + cells. The increase in C D 8 + cells was
most evident at 24 and 48 hours post-challenge. No significant changes were seen in the
percentages of null cells between time intervals in HCMV-challenged cultures and when
comparing HCMV- to mock-chaUenged cells using the students r-test (p<0.05). The
magnitude of the changes in both CD4 and CD 8 numbers was larger in cells which had
been chaUenged with the clinical isolate when compared those challenged with strain
AD169.

The drop in CD4 : CD8 ratio by 6 hours post-challenge was due to a significant

decrease in the percentages of CD4+ ceUs and a significant increase in the percentages
CD8+ ceUs when compared to mock-challenged cultures using the students r-test
(p<0.05). These changes in CD4 and CD8 numbers were seen to persist in HCMV
challenged cultures at both the 24 and 48 hour time intervals (Table 3A).

Challenge with UV-inactivated virus also caused a drop in the CD4 : CD8 ratios in
HCMV challenged cultures by 6 hours post-challenge. This change was due to a
significant decrease in the percentages of CD4+ ceUs and a significant increase in the

percentages of CD8+ cells when compared to mock-challenged cultures using the students
Mest (p<0.05). Both CD4 and CD8 numbers in cultures chaUenged with AD169 and the

clinical isolate tended to return to the o time levels. The percentages of CD4+ and CD8+
ceUs in UV-inactivated HCMV-chaUenged cultures at 24 hours were comparable to levels

in the same cultures at 0 hours however they remained significantly different (Student
test; p<0.05) from those in mock-challenged cultures (Table 3 B).

Table 3 A . Antigen expression following challenge of a mixed population
of PHA stimulated T-lymphocytes with viable HCMV.

HCMV
Challenge

Cell Percentages1 at

Antigen

Hours Post-challenge

Status of

Status

T-ceUs

0

6

24

48

Mock

CD4

51.8 ±1.2

49.2 ±2.3

52.6 ± 0.4

51.3 ±0.4

CD8

40.3 ±1.5

43.6 ±2.4

38.8 ± 1.1

41.1 ± 4.3

Null

8.0 ±0.3

7.3 ±0.1

8.6 ±0.7

CD4:CD8

1.3

1.1

1.4

1.2

CD 4

46.8 ± 2.1

44.2 ± 0.4

43.1 ± 0.1

41.5 ± 0.6

CD8

46.0 ±2.2

47.0 ±0.4

48.7 ±0.1

49.2 ± 0.5

Null

7.3 ±0.1

8.9 ±0.0

CD4:CD8

1.0

0.9

0.9

0.8

CD4

43.1 ±0.4

41.8 ±0.3

39.0 ± 2.5

38.9 ± 2.9

CD8

48.7 ±0.4

48.7 ±0.4

51.7 ± 3.3

51.4 ± 2.7

Null

8.6 ±0.4

CD4:CD8

0.9

A D 169

Clinical

9.5 ±0.2
0.9

8.2 ±0.1

9.3 ± 0.7
0.8

7.7 ± 4.0

9.4 ±0.1

9.8 ± 0.2
0.8

1. Percentages are mean values ± S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students t-ttst (p<0.05).

Table 3 B . Antigen expression following challenge of a P H A stimulated mixed
CD4 /CD8 positive cell population with UV-inactivated HCMV

HCMV

Antigen

Cell percentages1 at varying

Challenge

Status of

Hours Post-challenge

Status

T-ceUs

0

6

24

Mock

CD4

51.8 ± 1.2

49.2 ± 2.3

52.6 ± 0.4

CD8

40.3 ±1.5

43.6 ±2.4

38.8 ± 1.1

Null

8.0 ±0.3

7.3 ±0.1

CD4:CD8

1.3

1.1

1.4

CD4

46.9 ± 4.5

42.3 ± 2.5

47.7 ± 1.3

CDS

44.6 ±4.0

49.2 ±2.0

43.1 ±0.8

Null

8.6 ± 0.5

8.6 ± 0.5

9.3 ± 0.5

CD4:CD8

1.1

0.9

1.1

CD4

47.9 ±0.1

39.6 ±1.3

43.9 ± 0.5

CD8

43.6 ± 0.3

53.5 ± 0.8

47.5 ± 0.7

Null

8.6 ± 0.4

7.0 ± 0.6

9.2 ± 0.5

CD4:CD8

1.1

0.7

0.9

AD169

Clinical

8.6 ±0.7

1. Percentages are mean values ± S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students t-test (p<0.05).
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3.2.2.

Effect of H C M V Challenge on C D 4 and C D 8 Enriched

Populations

PHA stimulated T-cells were enriched, after 65 hours in culture, for either CD4+
or CD8+ cells by negative depletion using the panning method described in Section
2.3.2. Populations of T-cells containing 80% CD4+ cells or 85% CD8+ cells were
obtained and chaUenged with HCMV strain AD 169 and a clinical isolate at MOI of 5
PFU/cell. The expression of CD4 and CD8 antigens was determined in two-colour
stained samples using fluorescence microscopy.

ChaUenge of a CD4-enriched population with viable HCMV resulted in a

significant (Students r-test; p<0.05) decrease in the absolute percentage of CD4+ cells
6 hours post-chaUenge when compared to both mock-challenged cultures and the
percentages obtained at 0 hours post-challenge. This change persisted up to 24 hours
post-chaUenge (Table 4 A). The drop in CD4 expression was accompanied by a rise in
the numbers of nuU cells. Mock-chaUenged cultures displayed a small, although
insignificant, loss in CD4+ ceUs with time in culture.

ChaUenge of CD4+ enriched populations with UV-inactivated HCMV resulted in a

significant (Students r-test; p<0.05) loss of CD4+ cells when compared to levels in mock
challenged cultures and to the levels at 0 hours post-chaUenge. A significant (Students
test; p<0.05) increase in CD8+ percentages was observed by 6 hours post-challenge,
which were significantly different to levels seen in mock-challenged cultures (Table 4
The changes did not persist and by 24 hours post-challenge a recovery in both CD4+ and
CD8+ cell numbers was seen. The numbers of each of these cells at 24 hours did not

differ significantly from levels in mock-chaUenged cultures nor were they significantly
different from levels seen at 0 hours post-chaUenge. A shmiar drop in the apparent
expression of CD4 had been seen in the mock-challenged population.

Table 4 A . Antigen expression following challenge of a P H A stimulated C D 4
positive cell enriched population with viable HCMV

HCMV

Antigen

CeU percentages1 at varying

Challenge

Status of

Hours Post-challenge

Status

T-ceUs

0

6

24

Mock

CD4

70.6 ± 6.4

67.8 ± 9.9

68.4 ± 10.0

CD8

20.1 ± 6.0

23.8 ± 10.5

23.8 ± 9.4

Null

9.4 ± 0.4

8.4 ± 0.6

7.9 ± 0.6

CD4:CD8

3.5

2.8

2.9

CD4

69.3 ± 1.2

51.8 ± 1.1

55.1 ± 1.4

CD8

21.9 ±2.3

29.2 ±1.8

26.4 ±2.1

Null

8.9 ±1.1

19.1 ±0.7

CD4.CD8

3.2

1.8

2.1

CD4

66.4 ±3.9

51.5 ±2.1

50.2 ± 1.2

CD8

22.9 ± 4.9

18.2 ± 2.9

24.2 ± 4.2

Null

10.8 ±1.1

30.4 ±0.8

25.7 ±3.0

CD4:CD8

2.9

2.8

2.1

AD169

Clinical

18.6 ±0.8

1. Percentages are mean values ± S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students /-test (p<0.05).

Table 4 B . Antigen expression following challenge of a P H A stimulated C D 4
positive cell enriched population with UV-inactivated HCMV

HCMV

Antigen

CeU percentages1 at vaiying

Challenge

Status of

Hours Post-challenge

Status

T-ceUs

0

6

24

Mock

CD4

70.6 ± 6.4

67.8 ± 9.9

68.4 ± 10.0

CD8

20.1 ±6.0

23.8 ±10.5

23.8 ± 9.4

Null

9.4 ± 0.4

8.4 ± 0.6

7.9 ± 0.6

CD4:CD8

3.5

2.8

2.9

CD4

67.4 ± 3.3

52.9 ± 1.6

66.7 ±1.3

CD8

23.4 ±3.5

31.6 ±1.6

26.1 ±0.3

Null

9.2 ±0.3

15.6 ±3.3

7.3 ± 1.1

CD4:CD8

2.9

1.7

2.6

CD4

65.7 ± 1.6

50.2 ± 0.9

65.8 ± 4.0

CD8

25.0 ± 1.6

32.3 ± 3.0

25.6 ± 4.9

Null

9.4 ±0.1

17.6 ±2.1

8.7 ±0.8

CD4:CD8

2.6

1.6

AD169

Clinical

2.6

1. Percentages are mean values ± S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students r-test (p<0.05).
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Challenge of C D 8 + enriched populations with viable H C M V resulted in a decrease
in the expression of CD8 antigen by 6 hours post-challenge (Table 5 A) with CD8 levels
in both AD 169 and clinical isolate chaUenged cultures being significantly different
(Students r-test; p<0.05) from those seen in mock-challenged cultures. The levels of
CD4+ cells in cultures chaUenged with the clinical isolate were significantly lower
(Students r-test; p<0.05) than levels seen in mock-challenged cultures. By 24 hours
post-chaUenge, a recovery in percentages of CD4+ cells was seen for both AD 169 and
cUnical isolate chaUenged cultures. The levels of CD8+ cells were also seen to recover by
24 hours post-chaUenge although they did not reach levels comparable to those at 0 hours
post-chaUenge and these CD8 levels remained significantly lower than those seen in
mock-challenged cultures as determined using the students r-test (p<0.05).

ChaUenge of CD8+ enriched populations with UV-inactivated HCMV resulted in
changes similar to those observed following chaUenge with viable HCMV (Table 5 B).
The drop in CD8 expression seen in the enriched populations contrasted with the apparent

rise in this population as seen in the mixed populations at 24 hours post-challenge. It w
observed that the numbers of null ceUs in the CD8-enriched populations rose with viral
challenge.

In aU cases the changes observed foUowing HCMV-challenge were greater in cells
chaUenged with the clinical isolate than in those chaUenged with AD 169. These changes

however, were not always significantly different when using the students r -test (p<0.05)
as a means of comparison.

Table 5 A . Antigen expression following challenge of a P H A stimulated C D 8
positive cell enriched population with viable HCMV

HCMV

Antigen

CeU percentages1 at varying

Challenge

Status of

Hours Post-challenge

Status

T-ceUs

0

6

24

Mock

CD4

14.1 ±4.7

18.9 ± 1.3

19.5 ±0.0

CD8

77.7 ± 3.6

70.1 ± 2.2

70.3 ± 1.3

Null

8.3 ±1.1

11.1 ±0.8

10.3 ±1.3

CD4:CD8

0.2

0.3

0.3

CD4

21.8 ±2.5

19.6 ±2.3

23.4 ±6.1

CD8

70.1 ± 2.8

56.2 ± 0.6

57.9 ± 4.5

Null

8.2 ±0.2

24.3 ±2.9

CD4.CD8

0.3

0.3

0.4

CD4

17.3 ±1.4

14.4 ±0.9

18.1 ±0.9

CD8

71.8 ±0.5

59.1 ± 1.3

63.6 ±2.8

Null

11.0 ±0.9

26.6 ±2.3

18.4 ±3.7

CD4:CD8

0.2

0.2

0.3

AD169

CUnical

18.8 ± 1.6

1. Percentages are mean values + S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students r-test (p<0.05).

Table 5 B . Antigen expression following challenge of a P H A stimulated C D 8
positive cell enriched population with UV-inactivated HCMV

HCMV

Antigen

Cell percentages1 at varying

Challenge

Status of

Hours Post-challenge

Status

T-ceUs

0

6

24

Mock

CD4

14.1 ±4.7

18.9 ± 1.3

19.5 ±0.0

CD8

77.7 ±3.6

70.1 ±2.2

70.3 ± 1.3

Null

8.3 ±1.1

11.1 ±0.8

CD4.CD8

0.2

0.3

0.3

CD4

20.2 ±0.1

21.6 ±3:2

24.6 ±0.1

CD8

68.6 ± 0.7

62.0 ± 3.3

60.9 ± 2.3

Null

11.3 ±0.8

16.5 ±0.1

14.5 ±2.1

CD4:CD8

0.3

0.3

0.4

CD4

18.7 ±0.2

23.1 ±0.3

27.7 ± 2.3

CD8

68.0 ± 0.4

55.9 ± 1.6

60.0 ± 1.8

Null

13.4 ± 0.6

21.0 ± 1.8

12.4 ± 4.0

CD4:CD8

0.3

0.4

0.5

AD169

Clinical

10.3 ±1.3

1. Percentages are mean values ± S.D. obtained from counts for two parallel experiments using cells
isolated from the same donor. Statistical analyses were performed using the students /-test (p<0.05).
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3.2.3.

The Effect of H C M V Challenge on Intensity of C D 4 and C D 8

Expression in CD4/CD8 Mixed Cell Populations

Flow cytometric analysis was used to verify and further define the nature of the
changes in the percentages of CD4+ and CD8+ cells. T-cell populations, containing both
CD4 and CD8 positive ceUs, were stimulated with PHA for 65 hours and then challenged
with HCMV at an MOI of 5 PFU/cell as described in section 2.2.5. Samples taken at 0,
6 and 24 hours post-chaUenge were analysed for CD4 and CD8 expression using single
and two-colour immunofluorescent analysis.

The intensity of antigen expression was determined using a method similar to that
described by TraiU etal (1986). The distribution of positively fluorescing cells was
divided into low and high fluorescence using the mean channel number as the dividing
point (Figure 3 A). In this study, the mean channel number for the positive cell
distribution of mock-challenged samples was used as a standard cut-off point between
low and high intensity. To faciUtate the comparison of distributions for mock- and
HCMV-challenged samples, the histograms were overlayed and the relative proportions
of low and high intensity ceUs in virus chaUenged samples determined relative to those
the mock-challenged sample (Figure 3 B). In order to make this type of comparison

possible, flow-cytometer settings and staining regimes were standardized for aU samples
analysed in each experiment.

In ceUs chaUenged with AD 169, no significant changes were seen in either CD4
or CD8 antigen intensity in samples analysed immediately after removal of the virus
inoculum (T=0). However, in cells chaUenged with the clinical isolate, a decrease in
CD4 and CD8 expression was seen at T=0 hours. This change was evidenced by an

increase in the absolute percentages of low intensity ceUs with an accompaning decrease
in the percentages of high intensity ceUs (Table 6).

Figure 3 A
Fluorescence histogram showing the method for analysis of fluorescence intensity fof
CD4, CD8 and HLA-ABC antigens. Positive cell distributions were divided into cells of
low and high intensity fluorescent ceUs using the mean channel number of the positive
cell distribution as the cut-off point.

Figure 3 B
Fluorescent intensities in HCMV chaUenged cells were compared to mock-challenged
cells by overlaying the two histograms and using the mean channel number of the
positive distribution for the mock-chaUenged culture as the standard cut-off point
between low and high intensity ceUs. AU samples were stained using the same protocol
and analysed within 15 minutes of staining using standardized instrument settings.
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Figure 3 A

Distribution s h o w i n g l o w a n d high intensity fluorescence
for a positive c e U population
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Figure 3 B : Overlay comparison of low and high intensity fluorescence
for two sample histograms
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At 6 hours post-challenge a reduction in the intensity of C D 4 expression was seen
in HCMV-challenged cultures as evidenced by increases in low intensity cell percentages
with associated decrease in high intensity ceU percentages (Table 6). The reduction in
CD4 intensity in ceUs challenged with AD 169 was not found to be significant when the
mean values for three experiments were compared using the students r -test (p<0.05).
However, CD4+ distributions for AD 169 and mock-challenged cells obtained from

individual experiments were found to differ significantly, at the 99.9% confidence level
when using the Kolmongorov-Smirnov test as a means of comparing histogram
distributions (Table 7). Challenge with the clinical isolate resulted in a significant

decrease (p<0.05) in the intensities of CD4 expression as determined using the student r
-test.

By 24 hours post-chaUenge, CD4 expression in cultures challenged with HCMV

strain AD 169 and the clinical isolate were found to be comparable to expression in mock

chaUenged cells with no significant differences existing between distributions using bo
the students r -test (p<0.05) and the Kolmongorov-Smirnov test (99.9% confidence).

CD8 expression in HCMV challenge was reduced at 6 hours post-challenge as

evidence by an increase in the percentages of low intensity ceUs with an associated los
high intensity cells (Table 6). This change was significant (p<0.05) for cultures

chaUenged with AD 169 and the clinical isolate as detennined using the students r -test.

By 24 hours post-challenge there was a significant (p<0.05) increase in the intensity of
CD8 antigen expression in HCMV cultures as evidenced by an increase in the percentages

of high fluorescent intensity cells. However, no increase in the total percentage of CD8

cells was seen at this time. On the basis of these observations it would thus appear tha
HCMV-challenge resulted in an upregulation of CD8 expression on individual cells rather
than causing an expansion of the CD8+ cell population.

Table 6.

Intensity of C D 4 and C D 8 expression on P H A stimulated T-lymphocytes
following challenge with H C M V as determined by flow cytometric
analysis.

ChaUenge

Time

CD4

CD8

Status

(Hours)

Intensity

Intensity

Mock

AD169

Clinical

Low

High

Low

High

0

47.7 ± 1.5

52.5 ± 1.5

45.1 ±2.0

54.9 ±2.0

6

47.7 ± 2.0

52.3 ± 2.0

50.1 ± 1.2

49.9 ± 1.2

24

48.9 ±1.7

51.1 ± 1.7

46.6 ± 0.8

53.4 ± 0.8

0

48.4 ±0.3

51.6 ±0.3

49.9 ±2.3

50.1 ±2.3

6

53.6 ± 4.6

46.4 ± 4.6

65.8 ± 6.2

34.2 ± 6.2

24

47.9 ± 1.0

52.1 ± 1.0

37.5 ± 0.4

62.5 ± 0.4

0

59.8 ± 1.7

40.1 ± 1.7

60.9 ± 4.1

39.1 ± 4.1

6

62.6 ± 1.3

37.4 ± 1.3

68.2 ±2.8

31.8 ±2.8

24

46.2 ± 0.8

53.8 ± 0.8

35.7 ± 4.4

64.3 ± 4.4

Note: Intensity w a s determined using the mean channel number of positive cells for the mock-challenged
samples as a standard dividing point between low and high intensity expression. Intensities for H C M V challenged samples were determined by overlaying these on the mock-challenged distribution as described
in section 3.2.3. Statistical analyses were performed using the students r-test (p<0.05).

3-2.4.

The Effect of H C M V Challenge on the Intensity of C D 4 and C D S
Expression in C D 4 and C D 8 Enriched Populations

The results obtained using UV-inactivated HCMV (Tables 3 B, 4 B and 5 B) and
the decrease in C D 4 and C D 8 intensity seen 6 hours after chaUenge of a T-ceU population
(Table 6) suggest that direct physical binding of H C M V to cells m a y trigger changes in
the ceU membrane resulting in altered C D 4 and C D 8 antigen expression. Since these
changes were more apparent in purified populations enriched for C D 4 + and C D 8 + cells
analysed at 6 hours post-chaUenge (Tables 4 and 5) the intensity of was analysed in
enriched populations using flow-cytometry. P H A stimulated T-ceUs were enriched to
~ 9 8 % purity for C D 4 and C D 8 ceUs by depletion of the reciprocal subset using
Dynabeads™ (Section 2.3.2.). These cells were then challenged with H C M V at an M O I
of 5 PFU/cell with strain A D 169 and the clinical isolate and analysed by flow cytometry.
The histogram distributions of C D 4 and C D 8 expression presented are representative of
those obtained for two separate experiments using cells obtained from different donors.

HCMV challenge caused a marked down-regulation in the intensity of CD4
expression by 6 hours post-challenge (Figure 4). ChaUenge with the clinical isolate had
the greatest effect, as evidenced by a complete downward shift of the C D 4 histogram
when compared to the distribution obtained for mock-challenged ceUs. Although the
effect foUowing chaUenge with A D 169 was not as marked, there was still a significant
difference (99.9% confidence) between C D 4 distributions for A D 169 and mockchallenged cells as determined using the Kolmongorov-Smirnov test (Table 7).

CD8 expression in both AD 169 and clinical isolate challenged cultures was found
to be down-regulated when compared to mock-challenged ceUs (Figure 5). In both cases
of challenge with H C M V strain A D 169 or the cUnical isolate, the down-regulation was
evidenced by a marked downward shift in the C D 8 distributions for H C M V chaUenged
cells.

Figure 4
Fluorescence histograms of C D 4 expression in C D 4 + enriched populations. P H A stimulated T-ceUs were enriched to = 9 8 % C D 4 + using Dynabeads™ prior to challenge
with H C M V at M O I of 5 PFU/cell. Samples were stained with PE-conjugated anti-CD4
monoclonal antibody at 6 hours post-challenge and analysed on a Coulter Epics V flow
cytometer. Staining protocols and instrument settings were standardized so as to
faciUtate comparisons between mock-and HCMV-chaUenged samples. KolmongorovSmirnov values (K-S:D) and critical values (K-S : Dc; 9 9 % confidence) for the
comparison of mock -and HCMV-challenged samples are shown.
Figure 4 A : Profiles obtained following challenge of C D 4 + T-cells with H C M V strain
AD169
Figure 4 B rProfiles obtained following challenge of CD4+- T-cells with the H C M V
cUnical isolate.

95

Figure 4 A : C D 4 Expression foUowing mock and A D 169 chaUenge of CD4-enriched cells
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Figure 4 B : C D 4 Expression following mock and cUnical chaUenge of CD4-enriched ceUs
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Figure 5 A : C D 8 Expression foUowing mock and A D 169 chaUenge of CD8-enriched cells
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Figure 5 B : C D 8 Expression following mock and cUnical chaUenge of CD8-enriched ceUs
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It would appear, from the higher Kolmongorov-Srnirnov values (Table 7) and the
magnitude of the downward shifts in the C D 8 histograms for HCMV-challenged cultures
when compared to those for mock-chaUenged ceUs (Figures 4 and 5), that H C M V
chaUenge had a greater effect on C D 8 expression compared than on C D 4 expression. In
addition, the Kolmongorov-Srnirnov values obtained for enriched populations were
higher than those obtained in simUar experiments using mixed cultures consisting of both
C D 4 and C D 8 cells (Table 7).

Analyses performed using the fluorescence microscope suggested a drop in CD4+
ceU numbers in HCMV-challenged mixed C D 4 + / C D 8 + populations and an enhancement
in C D 8 + ceUs numbers. F A C S analysis of mixed populations showed a drop in C D 4
expression and an increase in C D 8 expression. In CD4-enriched populations, both
techniques suggested a drop in C D 4 expression. That is, similar results were obtained
with each type of analysis regardless of population purity. However, in CD8-enriched
populations, both techniques suggested that there was a decrease in the expression of this
marker by 24 hours post-chaUenge. The reason for this difference is not clear since
conditions of viral challenge (MOI) were the same for challenge of mixed and enriched
cells. Enrichment m a y serve to increase the M O I for specific cell types with the observed
effect being due to an increase in the amount of virus binding to ceUs of particular
phenotype in the absence of another ceU type which m a y compete for virus binding. It
m a y also be possible that the upregulation seen in C D 8 expression in mixed cultures at 24
hours post-chaUenge is due to an effect caused by a regulatory population of T-ceUs
which are absent from the CD8-enriched cultures.
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Table 7.

Kolmogorov-Smirnov values obtained foUowing comparison between

mock- and HCMV challenged CD4 and CD8 positive ceU distributions at 6
hours post-chaUenge.

Initial

CeU

CeU
Popn

Type

Challenge Status
CUnical

AD169
Dl

Dc2

D

Dc

CD4

0.0403

0.0402

0.1632

0.0406

CD8

0.0638

0.0394

0.1200

0.0418

CD4

0.1461

0.0407

0.4508

0.0443

CD8

0.2019

0.0446

0.3513

0.0445

Mixed3

Enriched3

1. "D" represents the Kolmongorov-Smirnov value obtained for the comparison of positive cell
distributions for mock- and HCMV-challenged cultures.
2."Dc" is the critical value for the stated " D " values at the 99.9% confidence level. If D > D c then the
result is considered to be significantly different
3. Mixed refers to a population which contained both C D 4 + and C D 8 + cells whereas enriched refers to
populations which had been enriched to = 9 8 % purity for either C D 4 + or C D 8 + cells.
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3.2.5.

Effect of H C M V Challenge on C D 8 Antigen Expression in a

CD4+ Cell Rich T-cell Clone

The effect of HCMV challenge on CD4 and CD8 expression was studied on a
predominantly CD4+ T-ceU clone. This clone was a sub-clone of a CD4+CD8+ clone

(Figure 15), which following cryopreservation and extensive passage, produced a clone

displaying a predominantly CD4+ phenotype. This clone was stimulated according to th

protocol described in Section 2.2.3. and cells were chaUenged with HCMV strain AD 169
and the cUnical isolate at an MOI of 5 PFU/cell at 4 days post-stimulation. Samples
taken at 2 and 12 days post-chaUenge and analysed for CD4 and CD 8 expression, using
two-colour flow-cytometric analysis.

No significant difference (Students f-test; p<0.05) existed between the CD4 and
CD8 expression in mock- and HCMV- challenged ceUs in samples analysed at 2 days
post-chaUenge. However by 12 days post-challenge a complete inversion in the CD4 :
CD8 ratio was seen in HCMV chaUenged cultures (Table 8). A decrease in the
percentages of CD4+ ceUs was seen in both mock- and HCMV-chaUenged cultures
however these changes were greatest in HCMV challenged cells. A significant increase
(Students Mest; p<0.05) in the absolute percentages of CD8+ ceUs was seen in HCMVchallenged cultures when compared to the levels at 2 days post-chaUenge and to mockchallenged cultures.

Analysis of this clone for the expression of the UCHL-1 (CD45RO) antigen both before
and after chaUenge revealed all cells to be positive for this marker.

Samples were taken from mock- and HCMV-challenged cultures at 12 days postchaUenge
in order to probe for the presence of HCMV DNA. The results of this probing are
presented in section 3.7.1. as Figure 18.

I

Table 8.

100

Percentage C D 4 and C D 8 antigen expression on a C D 4 + T-cell clone

following mock- and HCMV-chaUenge.

Days

Antigen

Post-chaUenge

Expressed

Mock

A D 169

Clinical

CD4

89.78±1.38

86.95±2.03

90.35±1.73

CD8

9.20+1.16

11.53+1.63

8.97±1.45

CD4:CD8

9.76

7.54

10.07

CD4

67.08±0.64

32.44±1.06

34.03±2.17

CD8

18.36±1.17

63.33+1.73

65.91±1.57

CD4:CD8

3.65

0.51

0.52

2

12

Challenge Status

Note: Percentage values are the mean values ±S.D. obtained for two aliquots of each sample which were
stained and analysed independently. Statistical analyses were performed using the students t-test (p<0.05).

3.3.0.

Effect of H C M V

Challenge on H L A - A . B . C . Expression

The expression of the MHC Class 1 antigens defined by the monoclonal antibody
anti-HLA-ABC (Table A ) was studied on T-cells which had been P H A stimulated for 65
hours prior to challenge with H C M V at an M O I of 5 PFU/cell. Samples taken at 6 and 24
hours post-chaUenge, were indirectly stained and analysed immediately by flow-cytometry
without fixation of the cells.

A decrease in the intensity of HLA-ABC expression was seen by 6 hours postchaUenge on ceUs chaUenged with A D 169 (Figures 6 A ) and with the clinical isolate
(Figure 7A). This effect was greatest following challenge with the clinical isolate, with
the downregulation in H L A - A B C expression being evidenced by a marked shift of H L A A B C distributions to the left of those obtained for mock-chaUenged cells. The
percentages of low and high expressing cells were determined according to the method
described in Section 3.2.3. A significant (Students r-test; p<0.05) increase in the
percentage of low intensity cells was found at 6 hours post-chaUenge in cultures
chaUenged with A D 169 and clinical isolate. This change was accompanied by a decrease
in the percentages of high intensity cells (Table 9).

By 24 hours post-chaUenge a reversal was seen, with an upregulation in HLAA B C expression occuring in ceUs challenged with A D 169 (Figures 6B) and the clinical
isolate (Figure 7B). This effect was greatest in cultures chaUenged with the cUnical
isolate, with the upregulation in H L A - A B C expression being evidenced by a marked
rightward shift in the ceU distributions when compared to the distribution obtained for
mock-challenged cells. Significant (Students r-test; p<0.05) increases in the percentages
of high intensity cells (Table 9) were observed in cultures chaUenged with both A D 169
and the cUnical isolate.

Figure 6
Fluorescence histograms of H L A - A B C expression at 6 and 24 hours post-challenge.
P H A stimulated T-cells were either mock-chaUenged or chaUenged with H C M V strain
A D 169 at an M O I of 5 PFU/ceU. Samples were indirectly stained with anti-HLA-ABC
and analysed within 10 minutes of staining without fixing. A U analyses were performed
using standardised staining schedules and instrument settings. Kolmonogorov-Smimov
(K-S:D) values and critical values (K-S : Dc; 9 9 % confidence) for the comparison of
distribution for mock- and HCMV-challenged ceUs are shown.
Figure 6 A : H L A - A B C profiles at 6 hours following m o c k or H C M V strain A D 169
chaUenge
Figure 6 B : H L A - A B C profiles at 24 hours following m o c k or H C M V strain A D 169
chaUenge
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Figure 6 A : H L A - A B C expression on T-lymphoblasts at 6 hours post-chaUenge
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Figure 6 B : H L A - A B C expression on T-lymphobiasts at 24 hours post-challenge
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Figure 7
Fluorescence histograms of HLA-ABC expression at 6 and 24 hours post-challenge.
PHA stimulated T-ceUs were either mock-chaUenged or chaUenged with HCMV clinical
isolate at an MOI of 5 PFU/ceU. Samples were indirectly stained with anti-HLA-ABC
and analysed within 10 minutes of staining without fixing. AU analyses were performed
using standardised staining schedules and instrument settings. Kolmonogorov-Srnimov
(K-S:D) values and critical values (K-S : Dc; 99% confidence) for the comparison of
distribution for mock- and HCMV-challenged cells are shown.
Figure 7 A : HLA-ABC profiles at 6 hours following mock or HCMV clinical isolate
chaUenge
Figure 7 B : HLA-ABC profiles at 24 hours following mock or HCMV clinical isolate
chaUenge
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Figure 7 A : H L A - A B C expression on T-lymphoblasts at 6 hours post-challenge
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Figure 7 B : H L A - A B C expression on T-lymphoblasts at 24 hours post-challenge
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Table 9.

Intensity of H L A - A , B, C expression on P H A stimulated T-lymphocytes

at 6 and 24 hours post-challenge.

Challenge

Hours

Status

Post-chaUenge

Low

High

Mock

6

51.5±6.3

48.5±6.3

24

53.6±4.7

46.4±4.7

6

60.6±4.5

39.3±4.5

24

38.6±2.4

61.5±2.4

6

78.6±12.1

21.5±12.1

24

24.4±1.5

75.6±1.5

AD169

CUnical

Fluorescent Intensity

Note: Intensity was determined using the mean channel number of positive cells for the mock-challenged
samples as a standard dividing point between low and high intensity expression. Intensities for H C M V challenged samples were determined by overlaying these on the mock-challenged distribution as described
in section 3.2.3. Statistical analyses were performed using the students f-test (p<0.05).
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3.4.0.

Effect of H C M V

Challenge on the Expression of C D 4 5 R

Epitopes

The CD45 or LCA antigens are recognized as being markers of both function and
maturity on T-ceUs. Expression of two CD45R epitopes recognised by the monoclonal
antibodies 2H4 (CD45RA) and UCHL-1 (CD45RO; Table A) respectively were studied
on T-cells which had been PHA stimulated for 65 hours prior to challenge. Cultures
consisting of 2.5 x 106 cells were set up and challenged with HCMV strain AD 169 and

the clinical isolate at MOI of 5 PFU/ceU. In order to maintain a minimum culture siz

1.5 x 106 ceUs, the number of samples taken was restricted, thus allowing for a maxi
of two samples to be taken 48 and 96 hours post-challenge. The absolute percentages
CD4+ and CD8+ cells expressing either the 2H4 (CD45RA) or UCHL-1 (CD45RO)
antigens were determined using two-colour flow-cytometric analysis.

By 48 hours post-challenge, the levels of CD4+2H4+ (CD45RA) cells were

found to be significantly higher (Students r-test; p<0.05) in HCMV-challenged cultu
when compared to those in mock-challenged cultures (Table 10). However by 96 hours
post-chaUenge the levels of CD4+2H4+ (CD45RA) cells in HCMV-challenged cultures
had dropped to levels comparable with those in mock-chaUenged cultures. Levels of
CD8+UCHL-1+ (CD45RO) ceUs were consistently higher in HCMV challenged cultures
when compared to mock-chaUenged cells at both 48 and 96 hours post-chaUenge. No
significant differences (Students r-test; p<0.05) were observed in the percentages
CD4+UCHL1+ (CD45RO) and CD8+2H4+ (CD45RA) cells in HCMV-challenged
cultures when compared to mock-challenged cultures (Table 10). In all experiments
challenge with the clinical isolate had a profound effect on CD45R expression when

compared to challenge with AD 169. Sirmlar results were obtained with T-cells isola
from a different donor.
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Table 10.

Co-expression of C D 4 5 R epitopes on C D 4 and C D 8 positive cells

following HCMV-challenge of T-lymphoblasts.

ChaUenge

Hours

Status

Post-

Mock

A D 169

CUnical

Total percentages of cells co-expressing
antigens

CD4

CD8

ChaUenge

2H4

UCHL-1

2H4

UCHL-1

48

20.6 ± 0.8

32.8 ± 0.5

12.3 ± 0.2

22.2 + 0.8

96

15.4 + 1.9

23.2 ±0.1

21.7 ± 0.6

22.2 ± 0.5

48

26.8 + 0.6

32.2 ± 0.3

10.9 ± 0.2

28.9 ± 0.2

96

13.7 ± 3.4

24.4 ± 0.3

17.8 ± 2.3

30.0 ±0.1

48

29.4 ± 0.2

31.1 ±0.2

11.2 ±0.3

28.9 ± 0.2

96

15.7 ± 0.4

26.1 ± 1.0

18.1 ± 1.3

39.9 ± 0.2

Note: Percentage values are the means for duplicate flow-cytometric analyses of the same sample. These
results are representative of a similar experiment performed using cells from a second donor. Owing to the
limited size of the cultures, samples were only taken at times 48 and 96 hours post-challenge. Statistical
analyses were performed using the students t-test (p<0.05).

3.4.1.

Expression of 2 H 4 Antigen on C D 4 + Cells following H C M V Challenge

To examine the expression of the 2H4 antigen on CD4+ ceUs, populations
enriched for C D 4 + cells and mixed populations were used. Populations enriched for
C D 4 + ceUs were obtained by negative depletion of C D 8 + ceUs using Dynabeads (Section
2.3.2) which yielded populations of » 9 8 % purity. All populations were stimulated
with P H A for 65 hours prior to chaUenge with H C M V strain A D 169 and the cUnical
isolate at an M O I of 5 PFU/cell Expression of the 2 H 4 antigen on C D 4 + ceUs contained
in mixed populations of C D 4 and C D 8 cells was determined using two-colour flowcytometric analysis in which electronic gates were set on the C D 4 + ceUs and hisotgrams
for 2 H 4 expression on these cells obtained.

In aU experiments 2H4 expression was maximal in samples from HCMV
chaUenged cultures analysed at 24 or 48 hours post-challenge, with the levels being
greatest in ceUs challenged with the clinical isolate (Table 11). In experiments 1 and 3
m a x i m u m levels were seen at 24 hours post-challenge whereas in experiment 2 maximal
levels were seen at 48 hours post-challenge. The levels of 2 H 4 expression in H C M V chaUenged cultures were higher than those in mock-chaUenged cultures (Table 11). In all
experiments shown, T- ceUs obtained from different donors were used.

Expression of the 2H4 antigen on CD4+ cells was seen to graduaUy decrease with
time (Table 11, Figures 8 and 9). This decrease was found to take place sooner in C D 4 +
cells contained in mixed cultures than what it did in cultures enriched for C D 4 + cells
(Table 11). However, in the case of C D 4 + enriched cultures, 2 H 4 antigen expression
was still found to be reduced in samples analysed at 96 hours post-chaUenge (Figures 8
and 9).
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T a b l e 11 A

Percentages of C D 4 + ceUs expressing the 2 H 4 antigen following H C M V chaUenge.

ChaUenge

%

Cells

Positive

Experiment #1

Experiment #2

Experiment #3

Status

24 H

48 H

24 H

48 H

24 H

Mock

35.73

45.43

36.71

47.31

37.07

18.60

A D 169

42.68

56.15

35.92

54.69

48.58

25.18

CUnical

45.85

63.19

33.00

69.92

56.68

26.74

Table 1 1 B

Challenge

48 H

Relative percentage expression of the 2 H 4 antigen o n C D 4 positive ceUs.

%

Cells

Positive

Experiment # 1

Experiment # 2

Experiment # 3

Status

24 H

48 H

24 H

48 H

24 H

48 H

Mock

100.00

100.00

100.00

100.00

100.00

100.00

A D 169

119.45

123.60

97.85

115.60

131.05

135.38

Clinical

128.32

139.09

89.89

137.09

152.90

143.76

Note: Experiments 1 and 2 were performed using cell populations which were enriched to > 9 0 % purity
for C D 4 + cells prior to challenge. Experiment 3 was performed using a cell population which consisted
of a homogeneous mixture of C D 4 and C D 8 cells. 2 H 4 expression on these cells was determined by
setting electronic gates on the C D 4 + populations. Each analysis was performed once only. Information
for 10 000 cells was collected for test and negative control in each sample analysis. Percentages shown
are for proportions of C D 4 + cells expressing 2 H 4 antigen in all cultures and for HCMV-challenged
samples as percentage values relative to mock-challenged controls.

Figure 8
Expression of 2H4 antigen on PHA stimulated CD4+ enriched T-cells following mockchallenge and chaUenge with HCMV strain AD 169 at an MOI of 5 PFU/ceU. CeUs were
directly stained with FITC-conjugated anti-2H4 and PE-conjugated anti-CD4 monoclonal

antibodies. Histograms for 2H4 expression were obtained by setting electronic gates set
on the CD4+ ceUs. Negative controls were run for each sample and 2H4 positive ceU
distributions were obtained by subtraction of these from histograms obtained for 2H4
stained samples. Instrument performance for analysis at different time intervals was
verified using Coulter Immunocheck™ beads with standardised instrument settings being
used for each set of analyses.

Figure 8 A : 2H4 expression on CD4+ ceUs at 24 hours post-chaUenge
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Figure 9
Expression of 2H4 antigen on PHA stimulated CD4+ enriched T-cells following mockchallenge and challenge with the HCMV clinical isolate at an MOI of 5 PFU/ceU. Cells
were directly stained with FITC-conjugated anti-2H4 and PE-conjugated anti-CD4
monoclonal antibodies. Histograms for 2H4 expression were obtained by setting
electronic gates set on the CD4+ cells. Negative controls were run for each sample and
2H4 positive ceU distributions were obtained by subtraction of these from histograms
obtained for 2H4 stained samples. Instrument performance for analysis at different time
intervals was verified using Coulter Immunocheck™ beads with standardised instrument
settings being used for each set of analyses.

Figure 9 A : 2 H 4 expression on C D 4 + cells at 24 hours post-chaUenge
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Figure 9 B : 2 H 4 expression on C D 4 + ceUs at 48 hours post-chaUenge
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3.4.2.

Effect of H C M V Challenge on U C H L - 1 Expression on C D 8 + Cells

The absolute percentages of CD8+ cells expressing the UCHL-1+ antigen were
determined by two-colour analysis of samples taken from mock- and HCMV-challenged

cultures at 96 hours post-challenge. Cells were obtained from two different donors and
stimulated with PHA for 65 hours prior to challenge with HCMV strain AD 169 and the
cUnical isolate at an MOI of 5 PFU/ceU. UCHL-1 expression on CD8+ ceUs was

determined by two-colour flow-cytometric analysis with electronic gates being set on t
CD8+ populations.

The percentages of CD8+ cells expressing theUCHL-l+ antigen were consistently
higher in HCMV-chaUenged cultures when compared to mock-chaUenged cultures at 96

hours post-chaUenge (Table 12). These differences were found to exist in sirnUar cultu

using ceUs obtained from different donors. In aU cases, chaUenge with the clinical iso
resulted in levels of UCHL-1 (CD45RO) expression greater than those observed
foUowing challenge with AD169.

These results verify the observation, shown in Table 10, that absolute percentages
of CD8+UCHL-1+ ceUs are increased in HCMV-chaUenged populations. Although there
was a decrease in CD8+2H4+ cells at this time period, the increase in CD8+UCHL-1+

cells was not proportional to this decrease, suggesting that an increase in the overal
numbers of CD8+UCHL-1+ T-cells took place.
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Table 12.

Percentage of CD8+ceUs in P H A stimulated T-cell cultures expressing

the UCHL-1 + antigen at 96 hours post-challenge.

ChaUenge

% CD8+UCHL-1+ Cells

% CD8+UCHL-1+ Cells Relative
to Mock

Status

Donor #1

Donor #2

Donor #1

Donor #2

Mock

39.82

45.46

100.00

100.00

A D 169

60.76

64.02

152.50

140.83

Clinical

73.58

66.30

184.78

145.84

Note: Each analysis was performed once only. Information for 10 000 cells was collected for the test and
negative control for each sample run.
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3.5.0.

HCMV

Challenge and IL-2 Receptor Expression

IL-2 receptor (IL-2R) expression was studied on mock- and HCMV-chaUenged
ceUs using monoclonal antibodies specific for the p55 low-affinity sub-unit ( T A C ) and
the p75 high-affinity sub-unit (TU27) of the receptor. T-ceUs were stimulated with P H A
in mixed cultures for 65 hours prior to challenge with H C M V strain A D 169 and a clinical
isolate at M O I of 5 PFU/ceU. FoUowing challenge the ceUs were maintained in medium
supplemented with rIL2 (20U/ml) as described in section 2.2.2. Expression of the p55
and p75 sub-units of the IL-2R were studied by flow-cytometric analysis in samples
taken at 48 hours post-challenge.

The surface expression of both the p55 (Figure 10) and p75 (Figure 11) subunits
were not affected by HCMV-chaUenge. In both cases distributions for H C M V chaUenged ceUs were comparable with those for mock-challenged cells.

Figure 10 A and B
Expression of the p55 component of the IL-2 receptor on P H A stimulated cells at 48
hours post-chaUenge. Cells were stimulated with P H A (2.5 jJ»g/ml) for 65 hours prior to
mock-chaUenge or challenge with H C M V strain A D 169 and the clinical isolate at MOI's
of 5 PFU/ceU. Samples were directly stained with an anti-TAC (p55)monoclonal
antibody and histogram data for 10000 cells coUected.

Figure 10 A :
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Figure 10 B : T A C expression on T-lymphoblasts 48 hours
after clinical strain chaUenge
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Figure 11 A and B

Expression of the p75 component of the IL-2 receptor on PHA stimulated cells at 48

hours post-chaUenge. Cells were stimulated with PHA (2.5 |ig/ml) for 65 hours prio

mock-chaUenge or chaUenge with HCMV strain AD 169 and the clinical isolate atMOI's
of 5 PFU/ceU. Samples were directly stained with an anti-TU27 (p75)monoclonal
antibody and histogram data for 10000 ceUs coUected

Figure 11 A : T U 2 7 Expression on T-lymphoblasts 48hours
after A D 169 chaUenge
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3.6.0. Persistence and Replication of HCMV in T-cells

3.6.1. Effect of the Mode of Stimulation on Persistence of HCMV in T-Cells.

HCMV persistence in stimulated T-cells was studied using two different modes of
mitogenic stimulation. For comparative purposes, ceUs in each experiment were obtained
from the same donor and stimulated using either the standard PHA protocol (Section
2.2.3.) in which cells are challenged following 65 hours of PHA stimulation or the
protocol described by Blue et al (1987). In the latter, ceUs are stimulated with the
mitogen Con A (62 |J,g/ml) in medium containing rIL-2 (20U/ml) for 5 days prior to
chaUenge. In each case ceUs were challenged with HCMV strain AD 169 and the clinical
isolate at two MOI's of <1 and 5 PFU/ceU. These experiments were performed three
times using cells obtained from two different donors.

Samples of uniform volume were removed from cultures at various times postchaUenge. CeUs within these samples were counted and concentrations adjusted so that
each sample contained exactly 10^ viable cells. These samples were stored -70°C for
later DNA analysis which was performed using the techniques described in Section 2.5.

In samples chaUenged with HCMV strain AD 169 and the clinical isolate at MOI of
<1, no evidence of viral repUcation was seen up to 48 hours post-chaUenge in Tlymphocytes stimulated with either mitogen, although input virus could be detected
(Figure 12 A). CeUs chaUenged with AD 169 at a low MOI of <1 PFU/ceUs showed no

evidence of viral persistence nor replication at 72 and 96 hours post-chaUenge (Figure
B). However in T-ceUs chaUenged with the clinical isolate at an MOI of <1 PFU/ceU

evidence of viral persistence was observed in both PHA and ConA stimulated cultures as

seen by constant autoradiograph band intensities at these intervals Levels of input vi

when compared to viral controls show that less than the total sample number of 105 cell
were infected with virus (Figure 12 B).
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Figure 12 A
Autoradiograph of total ceUular DNA from Con+IL2 and PHA stimulated lymphocytes
probed for H C M V D N A following chaUenge with strain A D 169 and the clinical isolate at
M O I of <1 PFU/ceU. Cells were stimulated with P H A (2 |ig/ml) for 65 hours and ConA
(62 ng/ml) plus recombinant IL-2 (20 U/ml) for 120 hours prior to challenge. Samples
of 10 5 ceUs were taken at indicated times and whole cell D N A extracts irreversibly bound
to nylon membrane and probed with 32p-iabelled H C M V Hind-in O-fragment.
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In the case of ceUs chaUenged with A D 169 at an M O I of 5 PFU/ceU, a decrease in
the levels of virus was seen in both PHA and ConA stimulated cultures as evidenced by a

decrease in the autoradiograph band intensities at 72 and 96 hours post-challenge (Figur
13 A and B). It can be seen, by comparison with viral controls, that the levels of input
virus in both AD 169 and the cUnical isolate are less than would be expected if each ceU

was infected assuming that one viral genome enters each cell. ChaUenge with the clinical

isolate at an MOI of 5 PFU/ceU appeared to result in persistence of the virus in both PHA
and Con A stimulated ceUs. However, the levels of virus in ConA stimulated cultures
were higher than those in PHA stimulated cultures at 72 and 96 hours post-challenge
(Figures 13 A and C) and there was some suggestion of an increase in band density,
indicating that virus repUcation may have occured in these populations.

Figure 13 A
Autoradiograph of total ceUular D N A from Con+IL2 and P H A stimulated lymphocytes
probed for H C M V D N A foUowing chaUenge with strain A D 169 and the clinical isolate at
M O I of 5 PFU/ceU. CeUs were stimulated with P H A (2 (ig/ml) for 65 hours and ConA
(62 ucg/ml) plus recombinant IL-2 (20 U/ml) for 120 hours prior to challenge. Samples
of 10 5 ceUs were taken at indicated times and whole cell D N A extracts irreversibly bound
to nylon membrane and probed with 32p_iabelled H C M V Hind-in O-fragment.
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Braun and Reisser (1986) have suggested that co-culture of T-cells with EL-2 m a y
enhance the abiUty of the virus to replicate in T-ceUs. Hence an experiment was
performed to determine whether the rephcation observed in Con A stimulated ceUs was
due to the presence of exogenous rIL-2 in these cultures and whether a sirmlar effect
could be obtained by adding rIL-2 to PHA stimulated cultures. Equal amounts (20U/ml)
of exogenous rIL-2 were added to PHA and Con A stimulated cultures at the beginning of
the culture period and maintained at these levels throughout the experiment. Cells were

chaUenged with the clinical isolate at an MOI of 5 PFU/ceU and samples consisting of 105
ceUs prepared at appropriate time intervals. Once again the level of HCMV DNA was
seen to be consistently higher in ConA stimulated ceUs than in PHA stimulated cells as

evidenced by increases in the intensity of bands on the autoradiograph at 72 and 96 hour
post-chaUenge (Figures 14 A and B). However the results suggest a sUght enhancement
of viral DNA in the PHA stimulated cultures containing IL-2. The levels of virus in
samples taken from ConA stimulated cultures was initially low, with the density of the

band for samples at 0 hours post-challenge being less than that for a band equivalent to
the viral DNA from 105 PFU. However by 96 hours post-challenge,the density of
sample band was comparable to the band for HCMV DNA equivalent to 105 PFU. This
result suggests that viral replication may be taking place in these cultures.

Figure 14
Autoradiograph showing comparison of H C M V persistence in ConA+IL2 and PHA+IL2
stimulated T-ceUs. CeUs were stimulated with P H A (2 „ g/ml) plus recombinant IL-2
and C o n A (62 „ g/ml) plus recombinant IL-2 (20 U/ml) for 120 hours prior to chaUenge
with the H C M V cUnical isolate at an M O I of 5 PFU/ceU. Samples of 10 5 ceUs were taken
at indicatedtimeintervals and whole ceU D N A extracts irreversibly bound to nylon
membrane by alkaline treatment, and probed with a 32p-iabelled H C M V Hind HI Ofragment.
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3.6.2.

Persistence of H C M V in a C D 4 + C D 8 + Double-Positive Cell Clone

The protocol used for ConA stimulation of ceUs in Section 3.6.1 has been shown

to result in an increase in the percentage of ceUs co-expressing the CD4 and CD8 marker
(Blue et al, 1987). To test whether HCMV preferentially infects cells of this type, a
CD4+CD8+ double-positive T-ceU clone was obtained from Dr.MX. Blue (Dana-Farber
Cancer Institute, Boston; Blue et al, 1988). The phenotype of these cells was verified
foUowing 3 months of passage using two-colour flow-cytometric analysis. The clone
was found to contain >95% CD4+CD8+ double-positive ceUs (Figure 15).

Cloned ceUs were stimulated as described in Section 2.2.4. and chaUenged at 4
days post-stimulation with HCMV strain AD 169 and the cUnical isolate at MOIs of <1
and 5 PFU/ceU. Samples of uniform volume were taken from the cultures at selected time

intervals and the number of cells adjusted to 105 viable ceUs/sample prior to storage a
70°C.

HCMV persistence was seen in CD4+CD8+ cells chaUenged with both AD 169
and the clinical isolate at MOIs of <1 and 5 PFU/ceU although the levels of viral DNA
were found to be higher in those cells which were chaUenged at an MOI of 5 PFU/ceU as
evidenced by higher intensity autoradiograph bands (Figure 16). The levels of input
virus for ceUs chaUenged with the cUnical isolate at an MOI of 5 PFU/ceU are comparable

to viral bands for 105PFU, suggesting that a high proportion of the cells contained viru
Viral persistence was found up to 21 days post chaUenge in ceUs challenged with HCMV

strain AD 169 and the cUnical isolate at an MOI of 5 PFU/ceU. The intensity of the bands
were seen to decrease with time. This could be due to oilution of the ceUs originaUy

infected with virus in the repUcating culture with Uttle production of infectious virus
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Figure 15
Huorescence plot for CD4 and CDS expression on a T-cell clone in which 90% of cells were
found to be CD4+CD8+ double-positive. CeUs were double stained withPE-conjugated antiCD4 and FITC-conjugated anti-CD8 monoclonal antibodies. Fluorescence data for 10000
was coUected using a combination of electronic compensation and the appropriate filters for
PE and FITC.

C D 8 Fluorescence

Figure 16
Autoradiograph of total ceUular D N A from C D 4 + C D 8 + cloned T-ceUs foUowing
chaUenge with strain A D 169 and the clinical isolate at M O I of <1 and 5 PFU/ceU.
C D 4 + C D 8 + cells were stimulated with P H A (0.25 u g/ml) and irradiated aUogeneic
stimulator cells and chaUenged within 5 days of stimulation. Samples of 10 5 ceUs were
taken from cultures at indicatedtimesand whole ceU D N A extracts prepared and
irreversibly bound to nylon membrane by alkaline treatment and probed with a 32p.
labeled H C M V Hind m O-fragment.
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Hence, to investigate the nature of the persistence of H C M V in the C D 4 + C D 8 +
clone, samples representing a fixed 10% proportion of the total number of cells in the

culture at specific time periods. To provide maximum stimulation of infected cultures, the

cloned ceUs were stimulated as described in Section 2.2.3. and challenged at 4 days poststimulation with the clinical isolate of HCMV at an MOI of 5 PFU/ceU. The ceUs were
again stimulated as described in section 2.2.3. at day 7 post-chaUenge (11 days after
initial stimulation). Samples were removed at 4 and 21 days post-challenge. The level of
vims DNA at day 21 post-challenge, as determined by autoradiograph band intensity,

remains comparable to levels at day 4 indicating that the virus is maintained in the cult
This may either be due to persistence in ceUs which were originaUy infected or it may be
due to a low level of repUcation with reinfection of ceUs taking place.
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Figure 17
Autoradiograph foUowing probing of total cellular D N A from a CD4+CD8+ T-cell clone
at days post HCMV-chaUenge. Samples spotted represent a fixed proportion of 10% of
total cells in culture. CD4+CD8+ceUs. CD4+CD8+ ceUs were challenged at 4 days
foUowing stimulation with P H A (0.25 u g/ml) and irradiated allogeneic stimulator ceUs.
CeUs were restimulated as described above at day 7 post-chaUenge.Samples were taken at
indicatedtimesand whole ceU D N A extracts irreversibly bound to nylon membrane by
alkaline treatment, and probed with 32p_labeled H C M V Hind HI O-fragment.
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3.6.3.

Replication of H C M V in a C D 4 + C D 8 + Double-Positive T-cell Clone

The preceding results showing persistence of HCMV DNA in CD4+CD8+ ceUs,

suggest that the virus may be replicating in these ceUs. To investigate this possibiUty,
infectious virus production in HCMV-challenged CD4+CD8+ cells was assayed using
dilutions of ceU lysates to infect monolayers of permissive HEF.

Samples containing 106 viable cells in 0.5 ml culture medium were taken at 12
and 18 days post-chaUenge. These were dUuted with an equal volume of 70% sorbitol
and freeze-thawed three times in order to release intraceUular virus. CeU debris was
removed from samples by centrifugation at 400g for 15 minutes. Aliquots containing 200
ul of undiluted, 1: 10 and 1:20 dilutions in CMRL 1969 medium were seeded in
dupUcate onto HEF grown in 24-weU culture trays. After a 90 minute adsorption period
virus was replaced with CMRL 1969 medium supplemented with 2% FCS. Cells were
maintained at 37°C with medium changes every 3 days. AppUcation of undiluted virus

preparations to cells resulted in extensive ceU death within a few hours presumably due
cytotoxic factors present in these samples. Wells were examined daUy for signs of CPE
which were first observed after 8 days of culture. Cells in duplicate trays were then
stained for CPE using HaemotoxyUn-Eosin staining (Appendix D) and quick-dip
(Appendix D) staining. Dip-quick staining, which shows an undefined build up of
protein in ceUs, was used to detect putative CPE in cultures. HaemotoxyUn-eosin
staining was used as a more definitive method for identifying CPE since HCMV induced
inclusion bodies can be easily identified within infected ceUs. Foci of infection were
counted in weUs stained with HaemotoxyUn-eosin with each foci being regarded as being
due to one initial infectious viral particle.

CPE as identified foUowing dip-quick staining were present in cultures infected
with the 1:10 chlution of AD169 preparations and in both the 1:10 and 1:20 dUutions of
clinical isolate preparations obtained at days 12 and 18 post-challenge (Table 13).
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Table 13.

Infectious virus production following HCMV-challenge of a C D 4 + C D 8 +

T-cell clone.

HCMV

DUution

CPE as detected using staining protocols for ceU

strain

samples taken at days post-chaUenge
12 Days
Haemoto - Quick-dip
Eosin

18 days
Haemotox

Quick-dip

-Eosin

1:10

5±2

Present

3+1

Present

1:20

0

Absent

0

Absent

Clinical

1:10

10±4

Present

9±3

Present

Isolate

1:20

2+0

Present

4+1

Present

A D 169

Note: C P E were identified using the protein build-up evident following Quick-dip staining as an indicator
of a cytopathic effect. Haemotoxylin-Eosin was used as a definitive means of identifying H C M V
inclusions and/or foci of cleared cells.

Foci of infection as identified by haemotoxyUn-eosin staining were counted for

the 1:10 dilution of AD 169 preparations and the 1:10 and 1:20 dUutions of clinical iso
preparations from days 12 and 18 post-chaUenge. Maximum viral titres of 1.25 x 102
PFU/ml for AD 169 and 5.0 x 102 PFU/ml for the cUnical isolate were obtained
Assuming each infected cell produced one infectious particle, this would correspond to
maximum of 0.05% of the ceUs producing infectious virus at the time of sampling.

These cultures had been regularly split in order to maintain a constant cell
concentration of ± 1 x 106 ceUs/ml. The possibUity exists that although a higher number
of ceUs may have been producing virus, these could have been removed from the culture
during passaging. Since the cultures were split 3 times, the number of cells producing
infectious virus is likely to be <1%.

3.7.0. HCMV Presence in Subsets of T-cells

The exact site of HCMV latency has as yet not been determined, neither has the
virus been shown to have a tropism for T-ceUs of a particular phenotype. The preceding

work suggests that the virus persists in cells stimulated with ConA+IL-2 (Section 3.6.1
and in a CD4+CD8+ T-ceU clone (Section 3.6.2.). This suggests that the virus may have
a preference for cells of a particular phenotype. To investigate this possibUity, the
presence of viral DNA was studied in different T-ceU subsets.

3.7.1. Persistence of HCMV in a CD4+ T-cell Clone

A T-ceU sub-clone showing a predominantly CD4+ phenotype was derived as a
sub-clone from the CD4+CD8+ T-ceU clone previously described. This change in
phenotype took place after extensive passage (>8 months) and cryopreservation. Cloned

cells were stimulated with irradiated aUogeneic stimulator ceUs and PHA. At 4 days post

stimulation the ceUs were challenged with H C M V strain A D 169 and the clinical isolate at
MOI of 5 PFU/ceU.

The effect of HCMV chaUenge on the phenotype of this clone was studied. The
results as described in Section 3.2.5. (Table 9) show that HCMV chaUenge resulted in a

significant increase in the percentages of ceUs expressing the CD8 antigen with a decr

in the percentages of CD4+ cells. In addition, these cells were found to be 100% positi
for the UCHL-1 (CD45RO) antigen in samples analysed both before and after HCMV

chaUenge. To determine whether the virus was present in these cells at this time, sampl
consisting of 105 viable ceUs were taken at day 12 and probed for the presence of HCMV

DNA.

The results show the presence of HCMV DNA in these cells at day 12 post-

challenge (Figure 18). The density of the autoradiograph band for cells chaUenged with

the clinical isolate was comparable to the band obtained for viral DNA equivalent to 1
PFU. Since DNA from 105 challenged cells was spotted, this would suggest that each
ceU contained viral DNA. Slightly lower levels were obtained for cells chaUenged with
AD169.

Figure 18
Autoradiograph foUowing probing of total ceUular D N A from a T-ceU clone initially
CD4+ but converted to CD8+ attimeof sampling. CD4+ cloned ceUs were chaUenged
within 5 days of stimulation with P H A (0.25 ug/ml) and irradiated aUogeneic stimulator
cells. Samples were takenfromcultures at 12 days post-challenge and whole ceU D N A
extracts were irreversibly bound to nylon membrane by alkaline treatment and probed
with a 32p-iabeled H C M V Hind m O-fragment.
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3.7.2

Presence of H C M V D N A in C D 4 + and C D 8 + T-cells

Research by various workers, using early antigen expression and in situ
hybridisation analyis, has suggested that H C M V infects both C D 4 + and C D 8 + ceUs,
however it has not been shown if either one of the cells types is preferentially infected.
The results obtained with cloned ceUs which were C D 4 + suggest that H C M V m a y infect
these, alter their phenotype and persist in the C D 8+ ceUs. For this reason, the levels of
H C M V D N A in stimulated C D 4 + and C D 8 + ceUs was determined.

T-cells optimally stimulated with PHA for 65 hours were challenged with HCMV
strain A D 1 6 9 and the cUnical isolate at M O I of 5 PFU/ceU. Samples were taken at 96
hours post-challenge and C D 4 and C D 8 cells positively selected using Dynabeads™
(Section 2.3.2.) resulting in populations of « 9 8 % purity. Whole cell D N A extracts
were prepared from samples of 10 5 viable ceUs and probed for the presence of H C M V

DNA.

HCMV DNA was detected in CD4 and CD8 ceUs chaUenged with both HCMV
strain A D 169 and the clinical isolate (Figure 19). The level of H C M V D N A was higher
in C D 8 + ceUs than in C D 4 + cells as evidenced by higher intensity bands on the
autoradiograph.

Figure 19
Autoradiograph following probing of total ceUular D N A from P H A stimulated CD4+ and
CD8+ enriched T-ceUs at 96 hours post-chaUenge with H C M V strain A D 169 and the
clinical isolate atMOI of 5 PFU/ceU. Cells were stimulated with P H A (2„ g/ml) for 65
hours prior to viral chaUenge. Samples were taken at 96 hours post-chaUenge and C D 4
and C D 8 ceUs positively selected using Dynabeads™. Whole cell D N A extractsfrom10 5
CD4+ and C D 8 + were irreversibly bound to nylon membrane and probed with a 32p.
labeUed H C M V Hind m O-fragment.
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3.7.3.

H C M V presence in U C H L - 1 + cells at 96 Hours Post-challenge.

Phenotypic analysis,both before and after challenge, of the CD4+CD8+ cloned
ceUs used in section 3.6.2. and the CD8+ ceUs obtained from HCMV chaUenge of a
CD4+ subclone as described in section 3.2.5., revealed that these ceUs were positive
the UCHL-1 (CD45RO) antigen, a characteristic of memory ceUs. The possibUity of

HCMV being present in cells of this phenotype was investigated using PHA stimulated T
ceUs.

T-cell samples from cultures described in Section 3.7.2. were divided into
UCHL1+ and UCHL1- populations at 96 hours post-chaUenge, using a combination of
Dynabeads™ and Amerlex™ beads (Section 2.3.2.). UCHL1+ ceUs were positively

selected using Dynabeads and maintained in culture to faciUtate removal of the beads.
The UCHL1- population was then exhaustively depleted of UCHL1+ cells using
Amerlex™ beads.

Flow cytometric analysis of UCHL1+ and UCHL1- cells revealed both
populations to be comparatively pure with Uttle overlap existing between the two
populations (Figure 20 A). The UCHL1+ cell population was found to be 87% positive
for cells expressing the UCHL1+ antigen. The UCHL1- population contained 5%
contaminating UCHL1+ ceUs.
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Independent samples containing 10 4 U C H L 1 - and U C H L 1 + ceUs were probed
for the presence of HCMV DNA. HCMV DNA was found to be present in UCHL1+
ceUs challenged with HCMV strain AD 169 and the cUnical isolate (Figure 20 B). The

band densities of the virus in the UCHL-1 + cells suggested virus DNA levels compa

to 104 PFU, indicating that a large proportion of these cells were positive for the
Low to negligible levels of viral DNA were observed in UCHL1- populations . These

low levels may be due to the presence of HCMV in contaminating UCHL1+ cells in thes
preparations.

Figure 20 A
Fluorescence histograms for UCHL1-, UCHL1+ (CD45RO) cells and negative control.

Samples were taken at 96 hours post-challenge and UCHL1+ cells positively select
with Dynabeads™. UCHL1- cells were exhaustively depleted of UCHL1+ cells using a
combination of Dynabeads™ and Amerlex™ reagent. Samples were indirectly stained
with anti-UCHLl monoclonal antibody and analysed on a Coulter Epics V flow
cytometer.

Figure 20 B
Autoradiograph obtained foUowbg probing of HCMV chaUenged lymphocyte DNA with
a P32-labeUed HCMV Hind m O-fragment. CeUs were stimulated with PHA (2„ g/ml)

for 65 hours prior to viral chaUenge. Cells were challenged with HCMV strains AD

and a clinical isolate at MOI's of 5 PFU/ceU. Samples were taken at 96 hours pos
challenge and UCHL1+ ceUs positively selected with Dynabeads™. UCHL1- cells

were exhaustively depleted of UCHL1+ cells using a combination of Dynabeads™ and
Amerlex™ reagent.
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Figure 20 A : U C H L 1 expression foUowing positive selection for U C H L 1 + cells
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Figure 20 B
Autoradiograph following probing of total cellular DNA from PHA stimulated UCHL-1+
and UCHL-1- enriched T-cells at 96 hours post-challenge with HCMV strain AD 169 and
the clinical isolate at MOI of 5 PFU/ceU
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3.8.0.

Effect of H C M V

Challenge on T-cell L y m p h o k i n e

Production

Lymphokines are important mediators of the immune response. Any imbalance in
the production of these mediators m a y have serious consequences on the function of ceUs
with the immune system. The effect of H C M V chaUenge on two important T-ceU
lymphokines was studied using cultures containing cells of different phenotypes and
stimulated using different porotocols. Interleukin-4 was chosen due to the wide range of
effects which it has on T-cells. IFN-y production was studied since this lymphokine is
recognised as having anti-viral properties and it has been shown that challenge of T-cells
with murine C M V effects the production of this lymphokine. A n obvious omission from
this study was that of IL-2, which could not be assayed due to the high levels of
exogenous EL-2 which were added to the cultures.

3.8.1. Interleukin-4 Production

Interleukin-4 concentration in supernatant samples obtained from a variety of TceU cultures was determined using a commerciaUy avaUable E L I S A (Quantikine, British
Biotechnology). The concentration of IL-4 in undiluted samples were determined using a
standard curve prepared at the same time using IL-4 standards. The concentrations
obtained are shown in Table 14.

3.8.1.1. IL-4 production in PHA stimulated peripheral T-ceUs

Freshly isolated peripheral T-ceUs were stimulated with PHA (2 Jig/ml) in RPMI
1640 + 1 0 % F B S + 1 0 % monocyte conditioned medium for 65 hours at 37°C.
Populations containing heterogenous mixtures of both C D 4 and C D 8 cells were used. In
addition, C D 4 + ceU enriched populations were prepared using Dynabead™ as described
in section 2.3.2. to yield populations = 9 8 % pure for C D 4 + cells.
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All populations were set up in tissue culture tubes (Nunc, Denmark) with a total of 2.5 x
10^ ceUs/tube and either mock challenged or challenged at an MOI of 5 pfu/cell with
AD 169 or the clinical isolate according to the protocol described in section 2.2.5.
Following chaUenge, ceUs were maintained on RPMI 1640 medium supplemented with
10% FBS + 20 U/ml rIL-2 at a final cell density of 106 cells/ml. Samples of 500 |il were
taken at 0, 3, 24, 48 and 96 hours post-challenge. Before removing each sample, the
ceUs in the culture were resuspended. The cell concentration was maintained as close as
possible to 1 x 10^ ceUs/ml for the entire sample period. Samples were then clarified by
centrifugation at 800g for 10 minutes in 1 ml polypropylene tubes (Eppendorf,
W.Germany) to remove the lymphocytes and supernatants transferred to fresh tubes for
storage at -70° C.

Interleukin-4 production in a mixed population of T-cells (Table 14, Figure 21)
was not affected by HCMV challenge at times 0 and 24 hours post-challenge when
compared to concentrations in mock-chaUenged cultures. However at 48 hours postchaUenge the levels of IL-4 were significantiy (Students r-test; p<0.05)higher in HCMV
chaUenged cultures than those in mock-challenged cultures. No significant difference in
IL-4 levels were seen to exist between cultures challenged with AD 169 or the cUnical
isolate. By 96 hours post-challenge the levels of IL-4 in HCMV chaUenge cultures had
decreased and were significantly (Students r-test; p<0.05) lower than those in mockchallenged cultures.

In CD4-enriched populations, the levels of IL-4 were seen to rise untU 96 hours
post-chaUenge in both mock- and HCMV-challenged cultures (Table 14, Figure 22). The
levels of IL-4 were found to be significantly (Students r-test; p<0.05) higher in HCMVchallenged cultures at 24 hours post-challenge when compared to levels in mockchallenged cultures.

Table 14.

Interleukin 4 production in mock- and HCMV-challenged Tlymphocytes.

T-cell

Stimulus

Supernatant

EL-4 Concentration (pg/ml)

population

prior to

taken at

Challenge Status

type

chaUenge

(hours/days)
Mock AD 169 Clinical

Peripheral

PHA

OH

3.2±1.1

1.0+0.0

1.7±0.3

Mixed

65 hours

24H

10.0±2.2

11.5±1.0

11.0+1.5

48H

8.3±0.2

17.0±3.0

15.0±2.4

96H

8.0±0.7

4.7±1.0

3.2±1.2

Peripheral

ConA+IL2

OH

215.5±2.1

235.0±21.2

245.0±21.1

Mixed

120 hours

24H

53.517.8

67.513.5

91.512.1

48H

93.517.7

80.512.1

91.012.8

96H

102.513.5

83.516.4

109.514.9

PHA

OH

1.010.5

1.510.4

1.310.3

65 hours

24H

3.610.9

7.610.8

6.610.9

96H

8.511.9

7.511.5

8.211.9

Peripheral
CD4

rich

Table 14 continued....

CD4+CD8+

AUogeneic

OH

1.010.5

1.010.3

0.510.7

short term

ceUs + P H A

24H

8.710.4

8.710.4

9.010.7

cultures

4 days

48H

7.610.8

15.012.8

16.512.1

CD4+CD8+

AUogeneic

12 days

24.012.0

33.013.8

31.012.1

long term

ceUs + P H A

18 days

16.011.2

22.511.7

19.511.7

cultures

Note: Results shown are for three independent experiments. Experiments using P H A and C o n A
stimulation were perfromed simultaneously using cells obtained from the same donor. Interleukin-4
concentrations are expressed as picograms per milliliter (pg/ml) of undiluted test supernatants ± S D for
duplicate samples as determined from a prepared standard curve. This data is represented graphically as
Figures 21, 22,23 and 24. Statistical analyses were performed using the students r-test (p<0.05).
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Figure 21 : IL-4 in supernatants from mock- and H C M V chaUenged
PHA stimulated peripheral T-ceUs
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Figure 22 :

Interleukin-4 supernatants from CD4-enriched P H A stimulated
T-ceUs foUowing mock- and HCMV-challenge
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3.8.1.2.

EL-4 production in Con A stimulated peripheral T-cells

Freshly isolated peripheral blood T-cells were stimulated in RPMI 1640 medium
supplemented with rIL2 (20 U/ml) and C o n A (62.5 jig/ml) for 120 hours prior to
chaUenge with H C M V strains A D 169 and the clinical isolate at M O I of 5 PFU/cell. The
medium in cultures was not changed during the initial stimulatory period. Experiments
using P H A stimulated ceUs obtained from the same donor were performed in parallel.
Populations containing heterogenous mixtures of both C D 4 and C D 8 cells were used. A U
populations were set up intissueculture tubes (Nunc, Denmark) with a total of 2.5 x 10^
cells/tube and either m o c k chaUenged or chaUenged at an M O I of 5 pfu/cell with A D 169 or
the clinical isolate according to the protocol described in section 2.2.5. FoUowing
chaUenge, cells were maintained on R P M I 1640 medium supplemented with 1 0 % F B S +
20 U/ml rIL-2 at afinalcell density of 106 cells/ml. Samples of 500 ]Lxl were taken at 0,
3, 24, 48 and 96 hours post-chaUenge. Before removing each sample, the cells in the
culture were resuspended. The cell concentration was maintained as close as possible to 1
x 106 ceUs/ml for the entire sample period. Samples were then clarified by centrifugation
at 800g for 10 minutes in 1 m l polypropylene tubes (Eppendorf, W.Germany) to remove
the lymphocytes and supernatants transferred tofreshtubes for storage at -70°C.

No significant differences (Students r-test; p<0.05) were seen between the levels
of IL-4 in mock- and HCMV-challenged cultures at all of the time intervals tested (Table
14, Figure 23). However, levels in HCMV-challenged cultures were higher than those in
mock-challenged cultures at 24 hours post-chaUenge. High levels of EL-4 were seen in all
cultures at time 0 hours post-challenge. It is assumed that these high levels are due to IL4 present in T-ceU conditioned medium obtained from the same cultures prior to challenge
and added back to the cultures at a concentration of 1 0 % foUowing chaUenge.
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The cells used for P H A and C o n A stimulation were obtained from the same donor
preparation, making comparisons possible. It can be seen that the levels of IL-4 in C o n A
stimulated cultures at time 0 are than those for P H A stimulated cells..

3.8.1.3. IL-4 production in a CD4+CD8+ T-cell clone

Samples were obtained from cultures of the CD4+CD8+ T-cell clone which were
stimulated 4 days, as described in Section 2.2.3., prior to mock-challenge and challenge
with either H C M V strain A D 169 or the clinical isolate at an M O I of 5 pfu/ceU according to
the protocol described in section 2.2.5. Experimental cultures of 2.5 x 10^ cells were set
up in tissue culture tubes and 500 |ll samples containing supernatant and resuspended
cells were taken at 0, 24,48 and 96 hours post-challenge. These samples were clarified
by centrifugation at 800g for 10 minutes to remove the lymphocytes and the clarified
supernatant was then stored at -70°C. Samples were also taken from long-term cultures
which had been challenged and estabUshed as described above. N o supernatants were
removed from these cultures at early times allowing the cultures to be expanded into 75
c m 2 upright flasks and maintained for longer periods with ceU densities being checked at
regular intervals to ensure a cell concentration of between 1 to 5 x 10" cells/ml was
maintained. CeUs were fed at 3 day intervals with m e d i u m supplemented as described in
section 2.2.4. Samples were removed from these cultures immediately prior to feeding on
days 12 and 18 post-challenge, thus representing samples for the 9-12 and 15-18 day
period post-challenge. These samples were clarified as described above and stored at 70°C.

IL-4 production in a CD4+CD8+ clone was seen to increase in all cultures
following challenge (Table 14, Figure 24). Levels in mock- and HCMV-challenged
cultures were comparable at 0 and 1 day post-challenge but significantly higher levels
(Students r-test; p<0.05) were seen in H C M V - c h a U e n g e d cultures at 2 days postchallenge.

Figure 23
Interleukin-4 concentrations in supernatants coUected from mock- and HCMV challenged
T-cells. Cells were stimulated with ConA (62|ig/ml) + rIL2 (20U/ml) for 120 hours
prior to chaUenge with HCMV strain AD 169 and the clinical isolate at MOI of 5
PFU/ceU. IL-4 was assayedin undUuted supernatant samples using a commercially
avaUable EL-4 ELIS A kit. Concentrations were determined using a prepared standard
curve and results shown are mean values 1 S.D. for duplicate samples. These results
are the graphic representation of results presented in Table 14.

Figure 24
Interleukin-4 concentrations in supernatants coUected from a mock- and HCMV
chaUenged CD4+CD8+ T-ceU clone. Cells were stimulated with allogeneic stimulator
cells and PHA (0.25(j.g/ml) for 5 days prior to challenge with HCMV strain AD 169 and
the clinical isolate at MOI of 5 PFU/ceU. IL-4 was assayed in undUuted supernatant
samples using a commercially available IL-4 ELISA kit. Concentrations were
determined using a prepared standard curve and results shown are mean values 1 S.D.

for dupUcate samples. These results are the graphic representation of results presented
Table 14.

Figure 23

Interleukin-4 in supernatants from mock- and HCMV-chaUenged
ConA stimulated peripheral T-ceUs
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Figure 24 :

Interleukin-4 in supernatants from a C D 4 + C D 8 + T-cell clone
foUowing mock and HCMV chaUenge
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It is of interest to note that the trends observed for CD4-enriched are similar for the
cloned cells up to 2 days post-challenge, although increased IL-4 levels are found in
H C M V - c h a U e n g e d C D 4 + cells at 24 hours post-challenge as opposed to 96 hours postchallenge for cloned ceUs.

IL-4 production is seen to be significantly (Students r-test; p<0.05) higher in
cloned ceUs at 12 days and 18 days post-challenge when compared to levels in cultures
sampled at earlier time intervals. This effect is most likely due to stimulation of these cells
at 10 days post-challenge. It can however be seen that HCMV-challenged cultures
continued to produce higher quantities of IL-4 at both 12 and 18 days post-challenge.

3.8.2. Interferon-y Production

Interferon-y concentration in supernatant samples obtained from a variety of T-cell
cultures was determined using a commerciaUy avaUable R I A (Centocor). The
concentration of Interferon-y in undUuted samples were determined using a standard curve
prepared using Interferon-y standards. The concentrations obtained are shown in Table
15

3.8.2.1. IFN-y production in PHA stimulated peripheral T-cells

Freshly isolated peripheral T-ceUs were stimulated with PHA (2 }ig/ml) in RPMI
1640 + 1 0 % F B S + 1 0 % monocyte conditioned medium for 65 hours at 37°C.
Populations containing heterogenous mixtures of both C D 4 and C D 8 cells were used. In
addition, C D 4 + cell enriched populations were prepared using Dynabead™ as described
in section 2.3.2. to yield populations > 9 0 % pure for C D 4 + ceUs. All populations were
set up in tissue culture tubes (Nunc, Denmark) with a total of 2.5 x 10^ ceUs/tube and
either m o c k chaUenged or chaUenged at an M O I of 5 pfu/ceU with A D 169 or the clinical
isolate according to the protocol described in section 2.2.5. Following chaUenge, cells
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were maintained on R P M I 1640 medium supplemented with 1 0 % F B S + 20 U/ml rIL-2 at
afinalceU density of 106 cells/ml. Samples of 500 jil were taken at 0, 3, 24,48 and 96
hours post-chaUenge. Before removing each sample, the cells in the culture were
resuspended. The ceU concentration was maintained as close as possible to 1 x 10"
ceUs/ml for the entire sample period. Samples were then clarified by centrifugation at
800g for 10 minutes in 1 m l polypropylene tubes (Eppendorf, W.Germany) to remove the
lymphocytes and supernatants transferred to fresh tubes for storage at -70° C.

EFN-y concentrations were found to increase in mock- and AD 169 chaUenged
cultures up to 96 hours post-chaUenge with no significant differences existing between
IFN-y levels in these cultures. Levels of IFN-y were found to increase in cultures
chaUenged with the clinical isolate up to 24 hours post-challenge after which a decline in
the levels was seen at 48 hours post-challenge and which was maintained up to 96 hours
post-chaUenge. These lower levels were found to differ significantly (Students r-test;
p<0.05) from those in mock- and AD169-challenged cultures (Table 15, Figure 25).

EFN-y concentrations in CD4 enriched populations were lower in HCMVchallenged cultures at 24 hours post-chaUenge when compared to mock-chaUenged
cultures. However by 48 hours post-challenge, the levels of EFN-y in H C M V
chaUenged cultures were significantly higher (Students r-test; p<0.05) than those in mockchaUenged cultures. B y 96 hours post-challenge EFN-y levels in aU cultures were
reduced when compared to 48 hours post-challenge although no significant differences
existed between mock- and HCMV-chaUenged cultures (Table 15, Figure 26).

Table 15.

Interferon-y production in mock- and HCMV-chaUenged Tlymphocytes.

T-ceU

Stimulus

Supernatant

Interferon-y Concentration (U/ml)

population

prior to

taken at

Challenge Status

type

chaUenge

(hours/days)
Mock

A D 169

Clinical

Peripheral

PHA

OH

0.45 1 0.06

0.42 1 0.03

0.38 1 0.05

Mixed

65 hours

24H

1.19 10.05

1.4410.07

1.13 10.04

48H

1.36 1 0.23

1.78 1 0.32

0.71 1 0.01

96H

1.6910.40

1.83 10.05

0.7210.07

Peripheral

ConA+IL2

OH

0.62 1 0.02

1.09 1 0.13

0.72 1 0.09

Mixed

120 hours

24H

0.35 1 0.09

0.65 1 0.30

0.59 1 0.06

48H

1.30 10.09

1.53 10.27

0.39 10.17

96H

0.99 10.05

1.3010.26

0.79 10.08

PHA

OH

0.42 1 0.08

0.361 0.07

0.82 1 0.08

65 hours

24H

10.5510.18

8.5510.29

4.1010.14

48H

24.9910.17

35.5410.16

37.8910.18

96H

21.2310.34

21.5210.79

22.0710.20

Peripheral
CD4

rich
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Table 15 continued....

CD4+CD8+

AUogeneic

OH

0.7410.001

0.6810.003

0.3210.16

shon-term

ceUs + P H A

24H

0.3110.001

0.4710.021

0.5610.04

cultures

4 days

48H

0.6610.001

0.3010.03

0.5210.04

CD4+CD8+

12 days

1.2510.007 2.5410.008

2.4210.08

long-term

18 days

0.8910.006

1.4810.06

1.3610.003

cultures

Note : Results shown are for three independent experiments. Experiments using P H A and C o n A
stimulation were perfromed simultaneously using cells obtained from the same donor. Interferon-7
concentrations are expressed as units per milliliter OU/ml) of undiluted test supernatants ± S D for duplicate
samples as determined from a prepared standard curve. This data is represented graphically as Figures 25,
26,27 and 28. Statistical analyses were performed using the students r-test (p<0.05).
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3.8.2.2.

EFN-y production in Con A stimulated peripheral T-cells

Freshly isolated peripheral blood T-cells were stimulated in RPMI 1640 medium
supplemented with rIL2 (20 U/ml) and Con A (62.5 jig/ml) for 120 hours prior to
chaUenge with H C M V strains A D 169 and the cUnical isolate at M O I of 5 PFU/ceU.
Experiments using P H A stimulated cells obtained from the same donor were performed in
paraUel. Populations containing heterogenous mixtures of both C D 4 and C D 8 cells were
used. All populations were set up in tissue culture tubes (Nunc, Denmark) with a total of
2.5 x 10*5 cells/tube and either m o c k challenged or challenged at an M O I of 5 pfu/cell with
A D 1 6 9 or the clinical isolate according to the protocol described in section 2.2.5.
Following challenge ceUs were maintained on R P M I 1640 medium supplemented with
1 0 % F B S + 20 U/ml rIL-2 at afinalcell density of 106 ceUs/ml. Samples of 500 \i\ were
taken at 0, 3, 24,48 and 96 hours post-challenge. Before removing each sample, the
ceUs in the culture were resuspended. The cell concentration was maintained as close as
possible to 1 x 10^ ceUs/ml for the entire sample period. Samples were then clarified by
centrifugation at 800g for 10 minutes in 1 ml polypropylene tubes (Eppendorf,
W.Germany) to remove the lymphocytes and supernatants transferred tofreshtubes for
storage at -70° C.

The levels of IFN-y at 0 hours post-challenge were seen to be low when compared
to IL-4 levels in these cultures for samples taken simultaneously. IL-4 is k n o w n to have
an inhibitory effect on IFN-y production, which m a y explain thie discrepancy seen.

IFN-y concentrations were found to increase in mock- and AD 169 chaUenged
cultures up to 96 hours post-challenge with no significant (Students r-test; p<0.05)
differences existing between EFN-y levels in these cultures. Levels of IFN-y were found
to increase in cultures chaUenged with the clinical isolate up to 24 hours post-challenge
after which a significant decUne (Students r-test; p<0.05) in the levels was seen by 48
hours post-chaUenge.

Figure 25
Interferon-y concentrations in supernatants coUected from mock- and H C M V challenged
T-cells. Cells were stimulated with P H A (2(ig/ml) for 65 hours prior to challenge with
H C M V strain A D 169 and the clinical isolate at M O I of 5 PFU/ceU. IFNy was assayed in
undiluted supernatant samples

using a commercially available IFNy R I A kit.

Concentrations were determined using a prepared standard curve and results shown are
mean values 1 S.D. for duplicate samples. These results are the graphic representation
of results presented in Table 15.

Figure 26
Interferon-y concentrations in supernatants coUected from mock- and H C M V chaUenged
C D 4 + T-ceUs. Cells were stimulated with P H A (2|ig/ml) for 65 hours, enriched for
C D 4 + cells using dynabeads and challenged with H C M V strain A D 169 and the clinical
isolate at M O I of 5 PFU/ceU. IFN-y was assayed in undUuted supernatant samplesusing
a commerciaUy available IFN-y RIA kit Concentrations were determined using a
prepared standard curve and results shown are mean values 1 S.D. for duplicate
samples. These results are the graphic representation of results presented in Table 15.

Figure 25 : Interferon-gamma in supernatantsfrommock- and HCMV-chaUenged
PHA stimulated T-ceUs
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Figure 26 :
EFN-gamma concentration in supernatantsfromCD4 enriched
PHA stimulated T-ceUs foUowing mock- and HCMV-chaUenge
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A slight recovery was seen at 96 hours post-challenge although these lower levels were
still found to differ significantly (Students r-test; p<0.05) from those in mock- and
AD169-challenged cultures (Table 15, Figure 27).

3.8.2.3. EFN-y production in a CD4+CD8+ T-ceU clone

Samples were obtained from cultures of the CD4+CD8+ T-ceU clone which were
stimulated 4 days, as described in Section 2.2.3., prior to mock-challenge and challenge
with either H C M V strain A D 169 or the clinical isolate at an M O I of 5 pfu/ceU according to
the protocol described in section 2.2.5. Experimental cultures of 2.5 x 1 0 6 cells were set
up in tissue culture tubes and 500 fil samples containing supernatant and resuspended
cells were taken at 0, 24,48 and 96 hours post-challenge. These samples were clarified
by centrifugation at 800g for 10 minutes to remove the lymphocytes and the clarified
supernatant was then stored at -70°C. Samples were also taken from long-term cultures
which had been challenged and estabUshed as described above. N o supernatants were
removed from these cultures at early times allowing the cultures to be expanded into 75
c m 2 upright flasks and maintained for longer periods with ceU densities being checked at
regular intervals to ensure a cell concentration of between 1 to 5 x 10" cells/ml was
maintained. CeUs were fed at 3 day intervals with medium supplemented as described in
section 2.2.4. These cells were stimulated as described in section 2.2.3. at 10 days postchaUenge. Samples were removed from these cultures immediately prior to feeding on
days 12 and 18 post-challenge, thus representing samples for the 9-12 and 15-18 day
period post-challenge. These samples were clarified as described above and stored at 70°C.

Level of IFN-y in both mock- and HCMV-challenged ceUs were inconsistent in
samples taken up to 2 days post-challenge. However significantly (Students r-test;
p<0.05) higher levels of EFN-y were found in HCMV-challenged cultures at 12 and 18
days post-challenge w h e n compared to levels in mock-chaUenged cultures.

Figure 27
Interferon-y concentrations in supernatants coUected from mock- and H C M V challenged
T-ceUs. Cells were stimulated with C o n A (62|ig/ml) + rEL2 (20U/ml) for 120 hours
prior to challenge with H C M V strain A D 169 and the clinical isolate at M O I of 5
PFU/ceU. EFN-y was assayedin undiluted supernatant samples using a commerciaUy
available EFN-y R I A kit. Concentrations were determined using a prepared standard
curve and results shown are mean values 1 S.D. for duplicate samples. These results
are the graphic representation of results presented in Table 15.

Figure 28
Interferon-y concentrations in supernatants collected from a mock- and H C M V
chaUenged C D 4 + C D 8 + T-ceU clone. Cells were stimulated with allogeneic stimulator
cells and P H A (0.25(j.g/ml) for 5 days prior to challenge with H C M V strain A D 1 6 9 and
the cUnical isolate at M O I of 5 PFU/ceU. IFN-y was assayed in undUuted supernatant
samples using a commerciaUy available IFN-y R I A kit. Concentrations were determined
using a prepared standard curve and results shown are m e a n values 1 S.D. for duphcate
samples. These results are the graphic representation of results presented in Table 15.

Figure 27 : Interferon-gamma in supernatants from C o n A stimulated T-cells
foUowing mock- and HCMV-challenge
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Figure 28 : Ihterferon-garnma in supernatants from C D 4 + C D 8 + cloned T-ceUs
following mock- and HCMV challenge
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The higher levels of IFN-y in samples taken from cultures at later times are most likely
due to stimulation of these ceUs 2 days prior to sampling.

It is interesting to note that challenge with a cUnical isolate did not inhibit IFN-y
production in the CD4-enriched populations nor in the CD4+CD8+ cloned cells. This is
in contrast to the effect seen in mixed populations of PHA and ConA stimulated ceUs.
This result suggests that the suppression observed in mixed ceU cultures is due to an
inhibitory effect mediated by a particular ceU type.

4.0

DISCUSSION

H u m a n cytomegalovirus infections have a wide range of clinical implications.
Infections in normal hosts are usually asymptomatic with virus being cleared by the
humoral i m m u n e response. Infections of immunocompromised hosts often result in
severe disease symptoms which are complicated by the immunosuppressive effects of
H C M V thereby exposing the host to infection by opportunist organisms (Hershman,
1988). Monocytes have been implicated as the cell type responsible for the defects in Tcell responsiveness seen during mononucleosis (Rinaldo 1977, 1980). Carney and
Hirsch (1981) showed that monocytes from patients with H C M V mononucleosis are able
to suppress the mitogen responsiveness of T-lymphocytes cultured in vitro. Rice et al
(1984) suggested that the reduced T-cell mitogen responsiveness seen foUowing in vitro
chaUenge was due to a suppressive effect mediated by monocytes. The suppressive role
of monocytes was confirmed by Schrier et al (1986) w h o demonstrated that monocytes
challenged with H C M V were suppressive for the proUferative response of unchallenged
normal autologous T-ceUs.
However, a direct effect of HCMV on lymphocytes was suggested from work
performed by K i m Sing and Garnet (1984) w h o found, mitogen hyporesponsiveness,
inducement of suppressor functions and alterations in C D 4 : C D 8 ratios in T-cells
challenged with H C M V in vitro. Kapasi and Rice (1988) also showed that preinfection
of peripheral bloood lymphocytes with H C M V suppressed the proUferation of these cells
in response to P H A , despite the addition of uninfected monocytes. In addition, the
suppression resulting from preinfection of peripheral blood lymphocytes alone was
greater than the suppression observed following infection of monocytes alone. Since
these initial studies were completed there have been advances in the abitity to separate
subpopulations of T-cells, as well as the recognition of a number of new functional
markers on T-ceU subpopulations. Hence the current study was undertaken to ascertain
the effect of H C M V chaUenge on stimulated T-cells cultured in vitro. In order to achieve
this, it was necessary to minimize the number of contaminating monocytes in the T-ceU

populanons and to estabUsh optimal culture conditions for the mitogenic stimulation of
these cells in the absence of help provided by accessory cells.
T-lymphocyte populations used in this study were obtained using a series of
purification steps, including Hypaque-ficoll gradient separation, plastic adherence and
nylon wool separation, which were aimed at eUminating both monocytes and B-ceUs. A
number of parameters were studied to estabUsh the purity of the resultant T-ceU
populations. The C D 3 antigen, widely acknowledged as a T-cell marker, was used as a
quantitative measure of the purity of T-cell preparations. Flow cytometric analysis
revealed that 9 5 % of ceUs in both unstimulated and P H A stimulated preparations were
C D 3 + prior to use (Figure 1 B ) . Non-specific esterase activity, a characteristic of
monocytes ( Y a m et al, 1971), was used as the means for the detection of these cells. TceU preparations were generaUy found to have < 1 % , with a m a x i m u m of 5 % , nonspecific esterase activity. These results indicated that monocyte contamination was low.
Monocytes or a monocyte produced factor are required for the stimulation of T-cells with
P H A (Larsson et al, 1980) and are essential for tht proUferation of stimulated T-ceUs
cultured in flat-bottomed trays (Ling 1976). Since the majority of experiments
performed in this study used mitogenicaUy stimulated T-cells, it was necessary to
estabUsh optimal conditions for mitogenic stimulation in the presence of low (=1%)
numbers of accessory ceUs. In order to establish these conditions, T-cells were cultured
in flat-bottomed 96-weU trays in the absence or presence of varying concentrations of
P H A and monocyte produced factors. The results showed that T-cells were unable to
respond to P H A alone and required the addition of exogenous monocyte produced factors
(Table 1). This observation provided additional evidence of the low levels of monocytes
in these preparations. O n the basis of the above it was concluded that the method of
purification used for obtaining T-cell populations was satisfactory and that monocyte
contamination was low. Despite the low number of monocytes, it has to be remembered
that these ceUs were nevertheless present in some of the populations used in this study.
Monocytes were absent from populations in which the T-ceUs were positively selected
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using immunomagnetic beads coated with monoclonal antibodies against the appropriate
T-cell markers.

The majority of experiments in this study were performed using T-cells stimulated
with mitogens or irradiated aUogeneic ceUs. Roberts (1980) found variability in the
stimulatory responses of different donors tested concurrently and in donors w h o were
tested sequentially. A panel of H C M V seronegative donors was selected and optimal
conditions were estabUshed for the stimulation of T-cells from these donors using varying
doses of P H A and monocyte conditioned m e d i u m (Table 1). In this w a y a standard
protocol was developed for the stimulation of T-cells obtained from any one of the donors
used in this study. It has been reported by Douglas (1971) that stimulation in the
presence of foetal bovine serum shows less variabiUty than does stimulation in the
presence of h u m a n serum which m a y contain stimulatory or inhibitory components. For
this reason, T-cells used in all experiments in this study were cultured in R P M I 1640
medium supplemented with foetal bovine serum as opposed to autologous h u m a n serum
in order to minimize variabiUty in stimulation.
It was important to establish the effect of H C M V chaUenge on T-ceU viabUity and
proliferation in order to determine whether or not these factors should be taken into
account in subsequent data analyses. This is especiaUy important in the analysis of data
showing changes in T-ceU subset ratios or ceUular dysfunctions which m a y be caused
either by a drop in the proliferation of a particular ceU type or an overall decrease in ceU
viabUity. H C M V challenge did not have a significant affect the overaU viabUity of T-ceU
cultures used in this study. ViabiUty remained high in T-ceU cultures stimulated with
either P H A or C o n A and in a T-ceU clone irrespective of whether virus MOI's of <1 or 5
were used. N o significant (Students r-test; p<0.05) differences were found between
viabihties in mock- and H C M V - challenged cells (Figure 2). The effect of H C M V
challenge on the proliferation of previously stimulated T-ceUs was monitored by 3 H thymidine uptake during thefirst18 hours after chaUenge. There was a statisticaUy
significant (Students r-test; p<0.05) drop in the proliferation of ceUs which had been
manipulated during challenge as compared to untreated control cells. ChaUenge with a
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cUnical isolate resulted in a significant drop in proliferation when compared to mockchaUenged ceUs. The differences between proliferation in mock- and AD169-challenged
cells were not found to be significant (Students r-test; p<0.05). Although the decrease in
proliferation seen with the cUnical isolate was found to be statistically significant when
using the students r -test, the magnitude of the drop in terms of C P M was not of
sufficient magnitude large enough to indicate a marked inhibitory effect of the treatments
on T-ceU proliferation since the absolute counts in aU cultures remained above 120 000
C P M . These results support earlier work performed by Tocci and St.Jeor (1979) w h o
found that H C M V challenge did not affect either the viabUity or the abiUty of
lymphoblastoid cells to proliferate.
Numerous authors have shown an effect on the IL-2 responsiveness of T-ceUs
foUowing H C M V infection. T-ceUs cultured and chaUenged with H C M V in vitro are
rendered incapable of producing or responding to EL-2 (Garnett, 1986). Kapasi and Rice
(1988) demonstrated that H C M V infection of peripheral blood lymphocytes alone results
in a decrease in EL-2 production. In addition it was found that the proliferative response
of these peripheral blood lymphocytes could not be restored by the addition of exogenous
IL-2. In contrast Numazaki et al (1988) showed that although H C M V abortively infected
up to 4 0 % of ceUs in an IL-2 dependant T-ceU clone and inhibited the cellular proUferative
response, the addition of high levels of EL-2 ( 2 0 % v/v) restored the proUferative
response. Infection of these ceUs was demonstrated by late antigen synthesis which
occurred in the absence of infectious virus production. A reduction in the expression of
the T A C (p55) component of the EL-2R was found with only 2 0 - 3 0 % of T-ceUs
expressing the T A C antigen by 4 days post-infection. In the present study the expression
of the p55 and p75 sub-units of the IL-2R were studied at 48 hours after H C M V
challenge of T-ceUs which had been optimally stimulated with P H A for 65 hours prior to
chaUenge. Flow cytometric analysis revealed that no loss in the expression of either of
the antigens occured in H C M V - c h a U e n g e d T-cells cultures when compared to expression
in mock-challenged cultures (Figures 10 and 11). This observation in combination with
the observation that ceUular proUferation was not inhibited by H C M V chaUenge would
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when exogenous rIL-2 is added to the culture medium. In the current study high levels
(20 U/ml) of exogenous rIL-2 were added to the culture medium following virus
chaUenge and these levels m a y have abrogated any effect of H C M V chaUenge on IL-2
responsiveness. IL-2 has been shown to augment transcription of the IL-2 receptor gene
since the addition of exogenous IL-2 to P H A stimulated lymphocytes has been shown to
result in an increase in EL-2R expression (Depper et al, 1985). The possibUity exists that
lose of IL-2 responsiveness and decreased IL-2 receptor expression on T-cells take place
as a result of H C M V infecting a different population of immune ceUs which by means of
soluble factors, influence T-cell function. Indeed, it was shown by Moses (1990), that
when P H A stimulated peripheral T-ceUs are cultured in the presence of supernatant
factors obtained from H C M V chaUenged monocytes, a marked reduction in the
expression of the p55 component occurs although p75 expression remains unaffected.
These ceUs showed decreased protiferation when cultured in the presence of these factors,
however their proUferative response could be restored by the addition of high levels
(20%) of exogenous rIL-2. This result suggested that these levels of IL-2 were sufficient
to induce signaUing through the p75 component of the IL-2R. This view is supported by
work performed by Yagita et al (1989) w h o found that resting C D 8 + T-ceUs, which
express p75 constitutively, could be activated by high levels of IL-2 in the absence of
p55 expression. In the present study, expression of the p55 and p75 IL-2R components
were not affected by H C M V challenge. It m a y be possible, in view of the above, that
since the T-cell populations used in this study had low levels of monocyte contamination
( = 1 % ), the possibUity of IL-2R expression being affected by a suppressor factor from
HCMV-chaUenged monocytes was mmimized.
In summary it was found that the T-cell cultures used in this study were
sufficiently pure so as to minimize the possible indirect effects which H C M V challenge of
other ceU types, such as monocytes, m a y have had on T-ceU responses. A standardised
method of P H A stimulation ensured that T-cells were, as far as possible, uniformly
stimulated in aU experiments. H C M V challenge did not cause a significant decrease in
ceU viabiUty nor did it have an inhibitory affect on T-cell growth, thereby excluding the
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ceU viabiUty nor did it have an inhibitory affect on T-cell growth, thereby excluding the
possibUity that any changes observed were due to severe morbidity of cells within the
culture system.

A characteristic of HCMV infection both in vivo and in vitro is a decrease in the
C D 4 + : C D 8 + cell ratio. In individuals suffering from H C M V mononucleosis, the
disease is characterised by a decrease in the ratio of C D 4 to C D 8 cells which is caused by
an increase in C D 8 + ceUs (Carney et al, 1981). In vitro chaUenge of T-cell blasts with
H C M V has been shown to cause an inversion in the C D 4 : C D 8 ratio by 6 hours post
chaUenge with a complete inversion in the C D 4 : C D 8 ratio occuring by 48 hours postchallenge (Kim Sing and Garnett, 1984). In the present work, the study of the effect of
in vitro H C M V challenge on T-ceU populations was extended so as to include
populations enriched for C D 4 + and C D 8 + ceUs and to include T-cell clones. The
expression of the C D 4 and C D 8 antigens on chaUenged cells was monitored using two
methods, fluorescent microscopy and flow cytometry. Fluorescent microscopic analysis
revealed that chaUenge of mixed T-ceU populations with viable H C M V resulted in a
reduction in the C D 4 : C D 8 ceU ratios in these cultures when compared to mockchaUenged cultures at 0,6,24 and 48 hours post-chaUenge (Table 3A). H C M V
chaUenge was seen to have an effect on the percentages of both C D 4 and C D 8 cells when
assayed immediatley after a 90 minute virus absorption period (T=0). There was an
apparent decrease in C D 4 + cell numbers and an increase in the numbers of C D 8 + ceUs.
The increase in C D 8 + cells was most evident at 24 and 48 hours post-chaUenge. N o
significant changes were seen in the percentages of nuU ceUs between time intervals in
HCMV-challenged cultures or when comparing H C M V - to mock-challenged cultures
(Table 3A). Challenge of mixed populations with UV-inactivated virus caused a drop in
the C D 4 : C D 8 ratios in H C M V chaUenged cultures when assessed immediately after
removal of the virus inoculum B y 6 hours post-chaUenge, a significant (Students r-test;
p<0.05) decrease in the percentages of C D 4 + cells and an apparent increase in C D 8 +
ceUs was seen. With time the C D 4 numbers tended toriseand C D 8 numbers tended to
decrease so that the C D 4 : C D 8 ratio approached the original (T=0) value by 24 hours.
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The percentages of both the C D 4 + and C D 8 + cells in HCMV-challenged cultures were
still significantly different from those in mock-chaUenged cultures (Table 3 B ) at 24
hours. This work supports the findings of K i m Sing and Garnett (1984) w h o found an
inversion in C D 4 : C D 8 ratios in ceUs challenged with viable H C M V , although in these
eartier studies a complete recovery in C D 4 : C D 8 ratios in ceUs chaUenged with U V inactivated virus by 24 hours post-chaUenge was found. These eartier studies were
preformed using highly attenuated A D 169 whereas the current study used less attenuated
A D 169 and a clinical isolate. In addition, in the current study a difference between the
clinical isolate and A D 169 was seen as the magnitude of the changes in C D 4 and C D 8
numbers were larger in cultures challenged with the cUnical isolate than in those
chaUenged with strain A D 169.
Subsequent flow cytometric analysis of mixed populations challenged with live
virus, showed that H C M V caused an initial downregulation of both the C D 4 and C D 8
markers by 6 hours post-challenge. A n upregulation in C D 8 expression was seen to
occur by 24 hours post-challenge with expression of C D 4 returning to control levels
(Table 6). These results support the findings m a d e in this study using fluorescence
microscope analysis and add further support to thefindingsof K i m Sing and Garnett
(1984) that expression of C D 8 appears to be enhanced foUowing viral chaUenge of P H A
stimulated T-lymphoblasts. Once again the clinical isolate showed a greater effect.
HCMV chaUenge of populations enriched for CD4+ and CD8+ ceUs either by
panning or positive selection was seen to have a greater effect on marker expression than
did chaUenge of mixed populations. Since the ceUs in these populations were positively
selected, they would have minimal monocyte contamination and this would exclude the
possibUity of the changes being due to an indirect effect as a result of virus interacting
with monocytes. ChaUenge of CD4-enriched populations with Uve virus resulted in a
decrease in C D 4 + ceU numbers as assessed at 6 and 24 hours post-challenge. There was
Uttle effect on the levels of C D 8 + ceUs in these populations but a significant (Students rtest; p<0.05) increase in the percentages of nuU ceUs was observed in these cultures
(Table 4). Challenge of CD4-enriched populations with UV-inactivated virus resulted in
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at 6 hours post-chaUenge with a return to the levels seen in mock-chaUenged cultures by
24 hours. In these CD4-enriched cultures, there was an apparent increase in C D 8
numbers at 6 hours w h e n either a live or UV-inactivated virus inoculum was used.
Percentages of these ceUs returned to levels simUar to mock-chaUenged cultures by 24
hours. Thus it would appear that chaUenge of C D 4 enriched populations with Uve virus
results in a decrease in C D 4 expression which is maintained withtime.Challenge of
CD8-enriched populations with Uve or UV-inactivated virus caused a decrease in C D 8
ceU numbers as determined at 6 hours post-challenge with an increase in nuU ceU
numbers. A marginal increase in C D 8 numbers was seen by 24 hours post-challenge in
some cultures although this was not significant and numbers of C D 8 + ceUs remained
lower than those in mock-challenged cultures. R o w cytometric analysis of C D 4 - and
CD8-enriched cultures chaUenged with Uve virus showed a significant decrease in the
intensity of staining for both these markers by 6 hours post-chaUenge (Figures 4 and 5).
These results support the observations made using the fluorescence microscope which
suggested that the expression of C D 4 in CD4-enriched populations and C D 8 in C D 8 enriched populations both declined in thefirstfew hours after virus challenge. It is
possible that the increase in nuU cell numbers seen in preparations viewed under the
fluorescence microscope was due to ceUs previously positive for the C D 4 and C D 8
markers appearing as null cells, this being due to a decrease in marker expression.
It was seen that the changes in CD4-expression were similar in both CD4enriched and in mixed populations. However, C D 8 expression in mixed populations
was enhanced by 24 hours post-chaUenge but a similar effect was not seen in C D 8 enriched populations. It is thus possible that the enhancemet of C D 8 expression is due to
the action of a subpopulation of ceUs which either resides within the C D 4 + population or
requires an interaction with ceUs contained in the C D 4 + ceU population.
The mechanism(s) whereby these early changes are initiated by the virus remain
unclear. It m a y be postulated that these changes are due to (i) a direct physical interaction
of the virus with the cells; (U) they are induced by proteins either carried within the virus
particle or coded for by the viral genome; or (in) they result from intergration of viral
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D N A , although there is no evidence for this occuring with H C M V . Several of these
mechanisms m a y apply.

A direct physical interaction of the virus with T-ceUs is suggested by the results
obtained in this study in which challenge with UV-inactivated virus was seen to d o w n
regulate the expression of C D 4 (Tables 3 and 4) and C D 8 (Tables 3 and 5) by 6 hours
post-challenge. The levels of C D 4 were seen to recover by 24 hours post-chaUenge when
the ceUs were exposed to UV-inactivated virus although C D 8 levels did not m a k e similar
recoveries. In contrast, challenge of mixed cultures with live virus resulted in
upregulation of C D 8 expression by 24 hours post-challenge in mixed cultures only. This
difference between Uve and UV-inactivated virus suggests that the early changes in
antigen expression could be due to a direct physical interaction of the H C M V virion with
T-ceUs. This hypothesis is supported by the results of K i m Sing and Garnett (1984) in
which UV-inactivated virus was found to cause an inversion in C D 4 : C D 8 ratios by 6
hours post-chaUenge with a subsequent recovery in these ratios by 24 hours postchaUenge in contrast to a sustained C D 4 : C D 8 ratio inversion in ceU chaUenged with
viable virus. It is thus possible that the maintenance of this effect and later upregulation
in C D 8 expression requires an additional factor which is only provided by an interaction
of Uve virus with these cells. Indeed in this study it was observed, using both
fluorescence microscopy and flow cytometry, that C D 8 expression was upregulated in
H C M V challenged mixed populations by 24 hours post-chaUenge. However a sirntiar
effect was not seen in populations enriched for either C D 4 or C D 8 ceUs. This result
would suggest that virus chaUenge induces C D 8 upregulation indirectly via the triggering
of a functional sub-population of T-ceUs which then act upon C D 8 ceUs to cause
increased prohferation or upregulation of marker expression.
The argument for a direct physical interaction of the virus with T-cells is further
supported by evidence showing that H C M V is able to adsorb to a wide variety of cells
and cell lines of both human and non-human origin which include : H E F (Fibroblasts),
Vero (green monkey kidney), R K - 1 3 (rabbit kidney), R D (human
rhabdomyosarcoma), H e L a ( H u m a n cervical cells), R a m o s H R 1 K , Nut, Raji,
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Namalwa, P3H3-Q, B J A B (B-cell lineage), Molt-4 (T-ceU lineage) and 1301 (T-cell
Uneage) to a varying degree (Einhorn et al, 1982).
The mechanism whereby HCMV binds to ceUs has been studied by a number of
workers. Grundy et al (1987) have shown preferential binding of H C M V to major
histocompatibiUty complex H L A class I antigen positive Raji ceUs when compared to
binding to H L A class I negative Daudi ceUs. The H L A - B a chains have been shown to
bind p2 microglobulin with higher affinity than the H L A - A and H L A - C a chains. The
knowledge that |32 microglobulin is thetightchain of class I H L A molecules and that it's
main binding site on cell surfaces is the heavy chain of class I H L A allowed for the
prediction that H C M V when complexed to p 2 m could bind to class I H L A molecules on
the ceU surface. Grundy et al (1987, i) and McKeating et al, (1987) showed that
H C M V was able to bind 02 microglobulin both in vitro and in vivo and they suggested
that this binding aUowed the virus to bind to the H L A molecule and thereby enhance the
infectivity of the virus. This suggestion however stUl remains a matter for debate since
work performed by Taylor and Cooper (1990) failed to show binding of P 2 m by H C M V
and they suggested that any binding of 0 2 m to the tegument of H C M V requires
disruption of the viral particle, which is neccessary for exposure of the tegument. These
results do not rule out a possible role for the binding of H C M V to H L A Class I
molecules in the infection process. Price et al (1987) have found using a murine system
that certain loci of the Class I region conferred sensitivity of macrophages to infection by
murine C M V ( M C M V ) . It was found that up to 8 0 % protection could be obtained if
infection was blocked using monoclonal antibodies against Class I antigens. It is of
some interest to note that the C D 8 molecule is able to form complexes with the 45 kDa
C D 1 (T6) glycoprotein. C D 1 is a presumptive class I M H C molecule which is associated
with 02 microglobulin (Littman, 1987). Hence H C M V m a y bind to C D 1 mediated by
(32m and affect C D 8 levels on cells. Indeed in this study downregulation of H L A - A B C
(Figures 6 and 7, Table 9) and C D 8 (Table 5, Figure 5) expression was seen by 6 hours
post chaUenge. The simultaneous downregulation of these markers on the ceU surface
following H C M V chaUenge m a y be due to perturbation of the cell membrane surrounding
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these structures as a result of virus binding to the cell membrane at another receptor
resulting in rearrangement of the cell surface. Certainly H C M V binding to permissive
fibroblasts has been shown to cause a number of cytoskeletal changes which include;
alterations in microtubular arrangements (Pfeiffer et al, 1983), locaUzed areas of actin
microfilament depolymerisation (Jones er al, 1986) and increased membrane
permeabitity (Rugolo et al, 1986). It has also been shown by Epps (1990) that binding
of lectins to fibroblasts results in a redistribution of the lectin receptors, with the
distributions returning to normal after 4-12 hours in culture. The binding of C o n A to the
surface of uninfected fibroblasts resulted in the patching and capping of the receptors for
C o n A , however this process was blocked in H C M V infected ceUs at 20 minutes to 6
hours post-infection. It is suggested that this change m a y be as a result of microfilament
disruption in infected ceUs. O n the basis of this it m a y be possible that binding of
H C M V to T-ceUs causes changes in membrane fluidity or cytoskeletal changes which
alters expression of antigens with later membrane recovery restoring antigen expression.
The possible consequences of HCMV either binding to or causing perturbations in
the expression of markers on the surface of T-ceUs are varied. The C D 4 , C D 8 and H L A A B C are closely associated with the T C R - C D 3 complex on the surface of T-ceUs. In
vitro, H C M V challenge of T-lymphocytes has been shown by K i m Sing and Garnett
(1984) to result in a decrease in the mitogen responsiveness of T-cells. The mitogen
responsiveness of T-cells was diminished if the mitogen P H A was added at 3 hours postchaUenge with some recovery being seen if the mitogen was added at 6 hours postchaUenge. A s has been suggested earlier, the perturbation of the receptors occurs
immediately following chaUenge as a result of membrane changes induced by H C M V
binding and a recovery in receptor expression takes place with increasing time postchaUenge as membrane integrity returns. Further the close association of C D 4 , C D 8 and
the H L A - A B C antigens with the C D 3 - T C R complex m a y provide a means to explain this
mitogen hyporesponsiveness. There have been conflicting reports as to the exact site of
P H A binding on T-ceUs with both the C D 3 and C D 2 molecules having being implicated
(Serke et al, 1989). Chilson et al (1984) have shown that P H A and C o n A bind to the T-
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ceU antigen receptor (Ti) on both tonsUar lymphocytes and to a T-ceU leukemia line
( H P B - A L L ) . Although his binding was not exclusive to the TCR-complex, since P H A
w a s found to bind to a number of other cell surface molecules, it is possible that
perturbation of this complex would prevent P H A binding and thereby reduce the T-ceU
response to this mitogen. It has also been shown that reduction in the expression of C D 3
antigen results in T-ceU unresponsiveness. Using an I g M anti-CD3 m A b , designated
38.1, which is rapidly modulated from the cell surface, Davis et al (1989) found that
after a 1-2 hour incubation T-ceUs were markedly inhibited in their abiUty to respond to
P H A . Although this treatment induced an immediate increase in the levels of intraceUular
free calcium it did not induce ceUs to enter into the ceU cycle. This inhibition could be
overcome by culturing the ceUs with accessory cells or EL-2. It was suggested that
perturbation of C D 3 can inhibit mitogen induced T-cell proliferation by increasing
intraceUularfreecalcium levels in the absence of a secondary accessory signal. Eartier
work in the same laboratory revealed that anti-CD3 inhibited mitogen induced
proliferation by inhibiting later metaboUc events such as the d o w n regulation of U-2
production (Davis et al, 1986). It is interesting to note that despite an initial decrease in
the expression of the C D 3 marker, the ceUs recovered and susequently expressed high
levels of C D 3 presumably due to rapid turnover of this marker. In the current study,
reductions in the expression of both the C D 4 and C D 8 markers were seen within the first
few hours foUowing addition of virus. Modulation of these markers could therefore
cause similar effects as those seen following modualtion of C D 3 expression.
Viral inhibition of T-ceU mitogen responsiveness is not restricted to HCMV and
has been shown to occur with a number of different viruses. Wainberg and Israel (1980)
using several strains of Uve and UV-inactivated avian retroviruses showed that
pretreatment of mouse spleen lymphocytes with virus resulted in mitogen
hyporesponsivenss. Virus exposed to U V for periods shorter than 30 seconds caused
lymphocytes to lose their mitogen responsiveness however virus exposed to U V for
periods longer than 30 seconds did not cause lymhpocytes to lose their mitogen
responsivenss. It was suggested that this effect was possibly due to subtle changes in
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surface architecture. K i m Sing and Garnett (1984) found that treatment of T-cells with
UV-inactivated H C M V did not result in a loss of mitogen responsiveness. Since virus
used in their work had been irradiated for 15 minutes, these result m a y have been due to
changes in crucial binding proteins present in the viral envelope. These observations
would coUectively suggest that both specific and non-specific factors m a y be responsible
for mitogen hyporesponsiveness. In h u m a n systems it has been shown that pretreatment
of both C D 4 + and C D 8 + T-cells with H I V for 1-2 minutes followed by washing was
sufficient to result in mitogen hyporesponsivenss whUst addition of E H V to lymphocytes
prestimulated with P H A failed to have an inhibitory effect (Hofmann et al, 1990). The
large envelope protein (gpl20) of the human T-ceU lymphotrophic virus HI (HTLV-IH)
has also been found to inhibit PHA-induced lymphocyte blastogenesis. However no
effect on responsiveness to C o n A or P W M was found. This effect was dependent upon
the concentration of the gpl20 protein and upon the addition of the gpl20 protein before
or at the same time as P H A . The possibility of the protein binding to and therefore
blocking P H A was excluded since P H A was not able to block binding of gpl20 to Tcells. It was suggested that binding of the gp 120 protein to the C D 4 antigen m a y serve
as an "off signal (Mann et al, 1987).
Certainly when considering the H C M V induced perturbation of the C D 4 and C D 8
T-ceU markers, a possible consequence of this is a signalUng effect via these markers. A
signalling effect has been shown in a number of reports to occur foUowing antibody
binding to the C D 4 and C D 8 antigens. Plastic absorbed anti-CD4 or anti-CD8 enhanced
the response of T-ceUs to suboptimal concentrations of plastic-absorbed anti-TCR or antiC D 3 (Emmrich et al, 1986). These results suggest that C D 8 provides a positive signal.
In contrast however the C D 8 antigen has also been shown to function as an inhibitory
tigand with CD8-dependent inhibition inducing a loss of responsiveness in ceUs, this
reduction in responsiveness persisting for at least 24 hours. Cells undergoing primary,
but not secondary, antigen stimulation through their T C R were found to be susceptible to
C D 8 inhibition (Hambor et al, 1990). The C D 4 molecule has also been shown to play
an important role in both positive and negative signalUng. C D 4 is an independent

transducer of signals to the T-ceU surface with antibodies against certain epitopes of the
C D 4 molecule having been found to inhibit antigen-induced in vitro proUferation,
lymphokine release and helper ceU function. Activation of accessory ceU depleted C D 4 +
ceUs via the C D 3 receptor is inhibited by the addition of antibodies to C D 4 (Bank and
Chess, 1985). Carreraera/ (1987) have shown that anti-CD4 can inhibit T-ceU
proliferation even after the initiation of culture. Proliferative responses to P H A , C D 3 and
exogenous IL-1 were blocked even if anti-CD4 was added 18-24 hours after stimulation.
Anti-CD4 also affects response to U-2 especially in the case of P H A by inhibition of IL2 R expression. MacDonald et al (1982) have shown that monoclonal antibody against
the C D 4 antigen inhibits activation and the apparent avidity of T ceU for antigen. These
observations show that perturbation of the C D 4 antigen by binding of monocloncal
antibodies has a negative effect on T-cells. In this study H C M V challenge was found to
perturb C D 4 expression by 6 hours post-challenge as evidenced by down-regulation in
expression and intensity (Tables 4 and 6; Figure 4) of this marker. Although different
effects m a y result from direct antibody binding to the C D 4 and C D 8 receptors,
downregulation of these receptors as a result of H C M V binding to T-ceUs m a y result in
the transmission of negative signals to these ceUs. This downregulation could account for
observed cellular dysfunctions such as mitogen hyporesponsiveness.
• The upregulation of HLA-ABC on PHA stimulated T-ceUs seen in this study at 24
hours following H C M V chaUenge (Figures 6 and 7) is interesting in that it m a y provide a
means whereby the virus is able to evade early cellular i m m u n e responses and establish
infection in particular subsets of T-ceUs. The expression of H L A - A B C has been related
to the susceptibUity of cells to N K mediated ktiling. The nature of N K cell target
recognition is as yet undefined and does not appear to be M H C restricted. However,
Lotzova et al (1983) have provided evidence that low class I expression renders cells
susceptible to N K lysis. Pionteker„/ (1985) using two H-2 negative mutants of the
Y A C - 1 lymphoma Une found that these ceUs had a high degree of susceptibUity to N K
lysis which w a s not related to their lack of responsiveness to IFN. Upregulation of H-2
expression in a low-expressing Y A C - 1 Une by I F N p or y protected these cells from N K
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lysis. Later work by Shimuzu and D e M a r s (1989) demonstrated using antigen-loss
mutants, that ceUs which have lost expression of H L A - A B C antigens were distinctly
more susceptible to NK-mediated lysis than cells expressing these antigens. This
observation was supported by the demonstration that expression of class I antigen
encoded by a transferred class I gene greatly reduced the susceptibUity of cells expressing
this gene to attack. Such results suggest an inverse relationship between H L A - A B C
expression and susceptibUity to N K attack. In relating these observations to C M V
infections, it has been found in the murine system that one of the earUest responses to
M C M V infection is that of natural ktiler ceU activity. N K activity is observed within two
days of M C M V infection and is only later foUowed by cytotoxic T-ceU activity (Quinnan
and Manischewitz, 1979). It is thus possible that the upregulation of H L A - A B C
expression observed on T-cells by 2 4 hours post-challenge provides a mechanism
whereby H C M V is able to evade the i m m u n e response.
Although the early changes in lymphocyte function seen after HCMV chaUenge
m a y be explained in terms of a direct physical interaction of the virus with T-ceUs, there
is still the possibiUty of additional viral factors being responsible for these changes. Rice
etal (1984) found that, depending upon the strain of H C M V used, between 1 and 1 5 %
of peripheral blood mononuclear cells expressed the major 72 K immediate early protein
which was detectable within 24 hours of infection and which persisted for up to 6 days.
Although the exact ceU types expressing the protein were not identified, this does not rule
out the possibUity of H C M V protein expression occuring in a smaU regulatory population
of T-ceUs which m a y in turn affect the larger population of T-cells. Virion structural
proteins m a y also play a role in altering ceUular function following either attachment or
penetration of the virion. Spaete and Mocarski (1985) suggested that a virion structural
protein m a y be responsible for upregulation of gene expression. Their work showed that
both live and UV-inactivated H C M V were able to activate H C M V a and p promoters
present in P-galactosidase constructs which had been transfected into human fibroblasts.
The a promoters were induced within 4 hours post challenge and the p promoters within
12 hours of chaUenge, indicating the rapidity of this effect. Pande etal (1990) have also
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impticated H C M V - e n c o d e d and or -induced functions in the decreasedfibronectinm R N A
seen in H C M V infected fibroblasts. O n the basis of these observations it is possible to
speculate that a H C M V virion protein m a y have simtiar effects on gene expression within
T-ceUs foUowing binding and internalisation of the virus. Host ceU proteins have been
shown to bind to sequences within the H C M V genome. Kemble and Mocarski (1989)
showed binding of a host cell protein of an apparent molecular weight of 89 k D a to the a
sequence of the H C M V genome, which they suggested m a y play a role in the maturation
of H C M V in infected ceUs. This protein was only isolated from cells of human origin.
The possibUity thus exists that different cells m a y contain proteins which affect the
expression of the H C M V genome differently resulting in varied viral functions depending
upon the ceU type infected.
A distinctive characteristic of HCMV infection both in vivo and in vitro is a
decrease in the C D 4 : C D 8 cell ratio which is due to an increase in the numbers of C D 8 +
T-ceUs. This drop in the C D 4 : C D 8 ratio cannot be accounted for by death of C D 4 +
ceUs since results obtained in this study (Figure 2) and in a study by K i m Sing and
Garnett (1984), showed that no significant losses in culture viabitities took place
foUowing H C M V chaUenge. In addition, no tropism for either C D 4 or C D 8 ceUs has
been demonstrated for H C M V to date, although, in this study, higher levels of H C M V
D N A were found in C D 8 + ceUs than in C D 4 + cells at 96 hours post-chaUenge (Figure
19). These results would suggest that the C D 8 + ceU populations are preferentiaUy
infected by H C M V . However the result showing the effect of H C M V challenge on C D 8
and C D 4 antigen expression in enriched populations (Figures 5 and 6) indicate that the
virus is able to interact with both cell types and it is unlikely that H C M V preferentiaUy
infects cells of the C D 8 Uneage. These results are supported by a number of other
studies investigating the presence of H C M V transcripts and the repUcation of H C M V in
T-ceU subsets . Rice et al, (1984) found in T-ceUs isolated from healthy donors and
chaUenged with H C M V in vitro that 1.6% of C D 4 + and 3.0% of C D 8 + ceUs were E A
positive. Schrier etal (1985), on the other hand, detected H C M V immediate early (EE)
R N A in a smaU number of T-lymphocytes from the peripheral blood of healthy sero-
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positive individuals with phenotypic analysis of these T-ceUs revealing that 2.4% C D 4 +
and 0.8% C D 8 + cells contained H C M V D N A as detected using the Hind HI J-fragment
of the H C M V genome. The possibiUty does however exist that C D 4 + ceUs co-expressing
low levels of C D 8 antigen were not detected in their analysis, leading to the observed
higher levels of H C M V postive C D 4 + cells. Braun and Reisser (1986) have shown, by
means of infectious centre assays, that H C M V repticates in a smaU subset of infected
lymphocytes with an average number of 0.08% of T-cells forming infectious centres.
This subset was characterised and found to consist primarily of cells of a C D 3 + C D 8 +
phenotype. However when C D 4 and C D 8 ceUs were separated into enriched populations
prior to infection it was found that virus was able to replicate in both ceU types. This
finding does not rule out the possibility that the infected C D 4 + ceUs are converted to
C D 8 + ceUs. It has been suggested by K i m Sing and Garnett (1984) that C D 4 + ceUs may
be converted to C D 8 + ceUs foUowing H C M V challenge and Braun and Reisser (1986)
used this as a possible explanation for their findings.
The suggestion that T-ceUs are able to convert in either phenotype or function is
not new. Pawelec et al (1983) found that T-helpei ceUs m a y convert to T-suppressor
ceUs. A n observation directly related to the suggestion of a conversion in surface
phenotype is that of the abtiity of activated C D 4 + cells to synthesize C D 8 antigen which
was demonstrated by Blue et al (1986). It was found that C o n A and to a lesser extent
P H A and P W M were able to induce co-expression of these markers in up to 5 0 % of cells
sampled at 4 to 5 days foUowing stimulation. The generation of C D 4 + C D 8 + c e U s from
C D 4 + C D 8 - cells was almost completely dependent on an interaction with C D 8 + ceUs or a
factor released from these cells which suggests a potential role for C D 8 + ceUs in immune
activation of a subpopulation of peripheral C D 4 + cells. The process of inducing C D 8
expression on C D 4 + C D 8 " peripheral T-cells appeared to be a lengthly process with C D 8
expression taking place only after prolonged activation of these ceUs. C D 4 + C D 8 +
coexpression was found to be a transient phenomena. It is therefore possible that
H C M V m a y interact with lymphoblasts bearing either the C D 4 or C D 8 marker and that
prolonged activation in a mixed population finally results in C D 8 expression by the
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chaUenged C D 4 ceUs. This change would then give rise to the subset inversions and
would explain the tendency tofindvirus in C D 8 populations seen in studies performed in
vitro .

Certainly in this study, HCMV challenge resulted in an increase in the levels of
C D 8 expressed on mixed populations of P H A stimulated peripheral T-cells (Table 3 A
and 6) and a T-ceU clone (Table 8). Indeed it was found that H C M V challenge of a
C D 4 + sub-clone derived from a clone initiaUy double-positive for the C D 4 + C D 8 +
markers, resulted in > 9 0 % of these cells expressing the C D 8 antigen by 12 days postchaUenge (Table 8). It was not possible to determine whether this change was due to an
outgrowth of C D 8 + cells or through de novo C D 8 synthesis by C D 4 ceUs. However
the extent of the change and the nature of the initial clone would suggest that the change
was due to expression of the C D 8 marker with an associated loss in C D 4 expression by
the ceUs. Further the observation that H C M V challenge caused an upregulation in C D 8
expression by 24 hours post-chaUenge in P H A stimulated T-cell cultures (Table 6)
indicate that H C M V is able to induce C D 8 synthesis in T-cells. The question remains as
to h o w the virus m a y achieve this? O n e possible mechanism is that H C M V m a y
upregulate C D 8 gene expression in infected cells through powerful enhancer elements
within the immediate early region of the H C M V genome. These enhancers are several
fold more active than the S V 4 0 enhancer (Boshart et al, 1985). H C M V has in addition
been shown by Colberg-Poley and Santomenna (1988) to selectively induce
chromosomal gene expression in permissive ceUs.
Another possible mechanism whereby HCMV may cause CD8 synthesis is
through upregulation of Interleukin-4 (IL-. Paliard et al, (1988) have shown that IL-4
induces the synthesis of the C D 8 antigen on C D 4 + C D 8 - T-ceUs resulting in C D 4 + C D 8 +
double-positive ceUs. These double positive ceUs did not arise as a result of the
outgrowth of an existing double positive population in the original culture. C D 8 m R N A
was induced in T-ceU clones after weekly stimulation for a period of three weeks in the
presence of EL-4. This C D 8 expression was stabily maintained whUst EL-4 was present
in the culture medium, however the addition of IL-2 resulted in a decrease in C D 8 m R N A

expression. It was suggested that the C D 8 expression induced by IL-4 m a y be
associated with function since a monoclonal antibody to the C D 8 molecule inhibited antiCD3-mediated cytotoxicity by a double positive T ceU clone. U-4 induced C D 8
expression was not found to occur on C D 8 + C D 4 - cells activated and cultured in EL-4.
In this study, the production of IL-4 was studied foUowing virus chaUenge of
ceUs stimulated with P H A , ConA+IL-2 and in a C D 4 + C D 8 + T-ceU clone (Table 14).
In P H A stimulated T-ceU cultures, H C M V chaUenge resulted in upregulation of EL-4
production by 48 hours when compared to mock-chaUenged controls QPigure 21).
These levels dropped to below mock-chaUenged levels by 96 hours post-challenge. In
C D 4 + ceU enriched populations, EL-4 levels were higher in H C M V chaUenged
populations by 2 4 hours post-chaUenge although by 96 hours post-challenge, levels in
aU cultures had increased to comparable amounts (Figure 22). In the C D 4 + C D 8 + T-ceU
clone, higher levels of IL-4 were seen in HCMV-chaUenged cultures by 48 hours.
SimUar results were seen in long term cultures at 12 days post-challenge with IL-4
levels in these cultures decreasing by 18 days post-chaUenge, presumably due to the
gradual loss of the stimulatory effect In aU cases the increased levels of IL-4 correlated
with increased C D 8 expression seen in similar cultures chaUenged with H C M V thus
indicating a possible role for IL-4 in this effect. It is also of some interest to note that
the levels of U-4 in C o n A stimulated cultures at time 0 were high in comparison to
those for P H A stimulated cultures at the same time interval (Table 14, Figures 21,22
and 23). It is assumed these high levels were present in the cultures prior to challenge
and that the high levels seen at T = 0 following challenge were as a result of the addition
of this medium back to cultures at a 1 0 % concentration. The fact that the protocol used
to stimulate ceU with C o n A was the same as that used by Blue et al (1987) to induce
co-expression of the C D 4 + and C D 8 + markers would suggest that the co-expression
observed was induced by IL-4, an effect described by Patiard etal (1989). It is
unlikely that the increased C D 8 expression seen in the present study was exclusively
due to the action of IL-4 since C D 8 expression was not enhanced in C D 4 - enriched
cultures in which increased levels of IL-4 were seen. This would indicate that an

additional ceUular interaction is responsible for C D 8 upregulation. This interaction may
be due to a viral effect on a regulatory/functional population of T-cells.
To examine the effects of HCMV challenge on functional populations of T-ceUs,
the expression of various isotypes of the C D 4 5 antigen was studied. These markers have
received considerable attention owing to their importance as markers of both T-cell
function and maturity. The two antigens studied were the 2 H 4 ( C D 4 5 R A ) and U C H L 1
( C D 4 5 R O ) antigens. H C M V chaUenge was seen to result in the prolonged persistence of
ceUs co-expressing C D 4 + and 2 H 4 + ( C D 4 5 R A ) antigens when challenged cultures were
compared to mock chaUenged cultures. A m a x i m u m difference was observed between
mock- and HCMV-challenged cultures at 48 hours post chaUenge (Table 10, Figures 8
and 9). The C D 4 + ceUs have been characterised by Morimoto et al (1988) into
suppressor-inducer and helper-inducer subsets using the 2 H 4 ( C D 4 5 R A ) and 4 B 4
(CDw29) monoclonal antibodies with the suppressor-inducer ceUs being defined as
C D 4 + 2 H 4 + ( C D 4 5 R A + ) or CD4+4B4-(CD4+CDw29-) cells. The C D 4 + 2 H 4 + subset
proliferates maximaUy foUowing C o n A stimulation but poorly in response to soluble
antigen stimulation and provides poor help to B-ceUs for PWM-induced Ig synthesis.
Carney et al (1983) have observed an increased level of highly Con A responsive C D 4 +
ceUs in patients with acute H C M V mononucleosis. Although these ceUs were not
characterised with respect to their 2 H 4 phenotype it is likely these ceUs may be of a
C D 4 + 2 H 4 + ( C D 4 5 R A ) phenotype. The function of these ceUs remains a matter for
debate. However, the work of Morimoto et al (1988) is supported by that of Takeuchi et
al (1987) w h o revealed that the 2 H 4 molecule plays an important role in the induction of
suppression and that direct physical engagement of the molecule m a y be necessary for
this effect. It is not clear as to whether the C D 4 + 2 H 4 + ( C D 4 5 R A ) subset induces C D 8 +
ceUs to become effector populations directly or via activation of other lymphocyte
subsets. It has however been established that the C D 4 + 2 H 4 + ( C D 4 5 R A ) ceUs and not
the C D 4 + 2 H 4 - ( C D 4 5 R O ) cells are the major responders in the A M L R . It is not known
whether C D 8 suppressor ceU generation occurs in the A M L R . However, the suppression
induced by the suppressor-inducer cells requires the presence of C D 8 ceUs without which

suppression is not observed. This implies that a direct interaction between the
C D 4 + 2 H 4 + ( C D 4 5 R A ) cells and C D 8 + ceUs is required. Certainly in this study, it was
seen that upregulation of C D 8 expression only occured in mixed cultures of T-ceUs and
not in cultures enriched for C D 4 or C D 8 ceUs. It is therefore possible that the
upregulation of C D 8 expression m a y be due to an interaction of the C D 4 + 2 H 4 +
( C D 4 5 R A ) ceUs with C D 8 + ceUs in the mixed cultures. K i m Sing and Garnett (1984)
have shown that virus challenged ceUs were able to suppress thymidine uptake by P H A
responder ceUs. This suppression occurred when H C M V challenged suppressor cells
were cultured with uninfected responder cells at suppressor: responder ratios of 5 :1 and
2.5 : 1. These results taken with the observations that C D 4 + 2 H 4 + ( C D 4 5 R A ) ceUs
comprise approximately 4 0 % of the C D 4 population (approx. 2 5 % of total T-cell
population),that these percentages are higher in virally chaUenged cultures (Table 10 of
present study) and that a direct ceU-to-ceU interaction m a y be required (Takeuchi et al,
1987), suggest that the diminished responses observed with H C M V challenged cells m a y
be due to suppression induced by 2 H 4 + ( C D 4 5 R A ) cells. The functions and numbers of
these ceUs having been enhanced foUowing viral challenge.
It has been suggested that loss of CD45RA (2H4) expression and gain of
C D 4 5 R O (UCHL-1) expression is an indication of the transition of ceUs from a naive to
memory state which excludes their role as suppressor-inducer ceUs. This view is
supported by observations from various laboratories that ceUs activated with P H A or
C o n A show an increased expression of U C H L - 1 ( C D 4 5 R O ) and decreased 2 H 4
( C D 4 5 R A ) expression (Sanders et al, 1988). In this study a gradual decline in both
percentage (Table 10) and intensity (Figures 8 and 9) of C D 4 + ceUs expressing the 2 H 4
( C D 4 5 R A ) antigen was seen which is consistent with the view of a decrease in 2 H 4
expression occuring following activation. However it has been found that the change
from 2 H 4 ( C D 4 5 R A ) to U C H L - 1 ( C D 4 5 R O ) expression is not unidirectional and that
ceUs m a y revert back to a 2 H 4 ( C D 4 5 R A ) phenotype. BeU and Sparshot (1990) have
shown by transferring C D 4 5 R A or C D 4 5 R O allotype-marked C D 4 ceUs into athymic
nude rats that both subsets routinely generate cell of the opposite phenotype with a

function that foUows phenotype and not parentage. Thus it is possible that H C M V
chaUenge is able to trigger functiopnal changes in C D 4 + 2 H 4 + (CD45RA) ceUs despite
the observation that they show a reduced 2 H 4 ( C D 4 5 R A ) expression following
prolonged activation.

HCMV mononucleosis is characterised by lymphocytes which show diminished
responses to C o n A during the acute phase (11-35 days after onset of symptoms) with a
return to normal occuring during the convalescent stage. Acute H C M V mononucleosis is
afurther characterised by a reversal in the C D 4 : C D 8 ceU ratio due in part to an increase in
C D 8 + ceUs. This change was found to persist for up to 10 months in patients during
convalescence (Carney, 1981). Carney et al (1983) studied the in vitro reactivity of
lymphocytes from patients with mononucleosis and found that the predominant cell type
is a hyporesponsive C D 8 + cell. Lymphocyte responses after depletion of C D 4 and C D 8
ceUs showed that CD8-enriched populations spontaneously incorporated 3 fold as much
3H-thymidine as CD4-enriched populations although they were markedly less responsive
to C o n A. In this study it was found that the levels of C D 8 + U C H L - 1 + (CD45RO) ceUs
had increased relative to mock-chaUenged controls by 48 hours post-chaUenge and this
population continued to increase over the time course of the experiment (Tables 10 and
12). C D 8 + U C H L + ( C D 4 5 R O ) cells show a minimal response to mitogen when
compared to the reciprocal subset of C D 8 + 2 H 4 + ( C D 4 5 R A ) cells. The average C P M
values for3H-thymidine uptake after P H A stimulation is 6 fold lower in C D 8 + U C H L +
2+

( C D 4 5 R O ) ceUs despite the fact that they show a 1.5 fold greater C a

influx. It has been

2+

suggested that this m a y be due to a transient elevation of C a which is insufficient for
induction of proliferation. O n the basis of this it m a y be possible to speculate that the
C D 8 + ceUs seen during H C M V mononucleosis consist of two separate populations of
C D 8 + ceUs based upon their expression of U C H L 1 + ( C D 4 5 R O ) and 2H4. Certainly in
this study there was an increase in C D 8 + U C H L 1 + ( C D 4 5 R O ) cells which would account
for a loss of mitogen responsiveness seen in C D 8 populations. N o change in
C D 8 + 2 H 4 + ( C D 4 5 R A ) values were seen in the study, although this does not exclude the
possibUity of increased functional activity within this ceU population.

It is interesting to note that IL-4 has been shown to have a selective inhibitory
effect on certain T ceU sub-populations by inhibiting the EL-2 induced proliferation of
C D 4 + (helper/inducer) and C D 4 5 R A (virgin) T ceUs but not that of C D 8 +
(suppressor/cytotoxic) and C D 4 5 R O (memory) Tcells (Brown etal, 1988). Thus the
increased levels of IL-4 seen in mixed cultures of P H A stimulated ceUs m a y contribute to
the increased percentages of C D 8 + U C H L 1 + ( C D 4 5 R O ) ceUs seen in similar cultures at
48 hours post-chaUenge (Tables 10 and 12). In addition, IL-4 has been shown to affect
both EL-1 secretion and phenotype of monocytes. Monocytes cultured in the presence of
IL-4 secreted reduced levels of IL-1 and inhibited the secretion of cytostatic and
chemotactic compounds (te Velde et al, 1989). The increased levels of EL-4 seen in this
study m a y thus provide an additional mechanism whereby H C M V is able to indirectly
affect i m m u n e functions via infection of T-ceUs.
In this study, in vitro chaUenge of T-ceUs with HCMV was found not only to
cause increased levels of ceUs of a m e m o r y phenotype as determined by expression of the
U C H L 1 + antigen but the virus was also observed to persist in these populations. H C M V
was found to persist and repUcate at low levels in a double-positive C D 4 + C D 8 + U C H L 1 + clone (Section 3.6.2. & 3.6.3.) and in cells from a subclone which expressed C D 4
when infected but which displayed a predominantly C D 8 + U C H L 1 + ( C D 4 5 R O )
phenotype by 12 days post-challenge (Section 3.6 4.).
In work performed by St Jeor and Weisser (1977) it was found that vims
persisted in the culture medium for a period of up to 5 days post-infection. The
possibUity that the persistence seen in this study is as a result of virus being present in the
culture medium is excluded since ceUs were washed twice foUowing viral challenge and
ceU samples for D N A analysis were subsequently washed prior to blotting. Further,
negative results were obtained for samples separated after infection of infection of
cultures in some instances (Figure 20 B ) .
In PHA stimulated peripheral T-ceUs the virus was found to predominate in
U C H L 1 + ceUs and in the C D 8 + cells from the same culture (Figures 19 and 20). The
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persistence of H C M V in ceUs of a m e m o r y phenotype is interesting since immunological
m e m o r y is k n o w n to persist for as long as 10 years (Rajewsky et al, 1989).
EstabUshment of a latent infection in ceUs of this type would be an ideal means whereby
the virus can remain latent in T-ceU populations. A hypothesis has been put forward by
Beverley (1990) in an attempt to explain long term memory. It is suggested that m e m o r y
ceUs are not truly resting ceUs and m a y be constantly poised to enter into the proUferative
cycle. M e m o r y cells show high expression of accessory molecules such as C D 2 and
would be more easUy activated, requiring only a low affinity cross reactive contact with
the T-ceU receptor to cause progression through the cell cycle. There is a considerable
body of evidence which suggests that m e m o r y cells are activated in a cross-reactive
fashion with even self peptides being sufficient to cause occasional division of memory
ceUs. CeUs triggered in this fashion would undergo limited division since local cytokine
production is insufficient to maintain proliferation of these ceUs and these would soon
return to a resting state. In a study on the influence of H C M V carrier status on peripheral
lymphocyte subsets, Gratama et al (1987) found that H C M V seropositivity was
associated with significant increases in the levels of H N K 1 + lymphocytes co-expressing
T-ceU markers which they suggested indicates a long term interaction of the virus with the
host i m m u n e response. This type of interaction m a y be sufficient to ensure persistence of
m e m o r y ceUs carrying virus. If this type of cross-reactive stimulation results in the
persistence of m e m o r y ceUs, it too m a y enable the virus to persist in these cells for longer
periods. M e m o r y ceUs comprise only a small proportion of the circulating T-cell
population. Thus infection of these cells would certainly be consistent with the
observation that a large number of ceUs are required for transfusion related transmission
of the virus.
H C M V transmission following transfusion with blood or blood products from
seropositive to seronegative individuals has been observed in a number of different
settings which have been reviewed by Adler (1983). The mechanism whereby
transmission takes place has as yet not been identified. A review by Forbes (1989)
discusses two possible hypotheses for H C M V transmission during transfusion. The first
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suggests that H C M V is able to reside in a latent state in the host and that all H C M V seropositive individuals are able to transmit latent virus. The second hypothesis suggests
that actively infected donors rather than latently infected donors transmit infections.
There is scant evidence to support the second hypothesis since the numbers of individuals
actively shedding the virus are significantly lower than the antibody prevalence in donor
populations. In support of thefirsthypothesis a report by Yaeger et al (1981) showed
that in a recipient population of infants, 13.5% acquired infection following transfusion
from HCMV-seropositive donors whereas no infections occured in those receiving blood
from seronegative donors. The frequency of transmission has been related to the
quantity of ceUs transfused with a substantial quantity of ceUs being required for H C M V
transmission. C h o u et al (1987)have suggested that the immunological mechanism
which enhanced graft survival might also enhance the survival of infused, latently
infected cells. Thus expansion of a particular cell type, such as m e m o r y cells, infected
with H C M V would ensure rapid spread of the virus. In a study by Zaia et al (1984)
prolonged H C M V viremia was found in 4 1 % of patients following bone marrow
transplant. T h e levels of H C M V positive blood samples from these patients rose from
0 % at 8 days prior to bone marrow transplant to a peak of 1 0 0 % by 49 days posttransplant with a gradual decrease thereafter. It is possible that H C M V levels in the blood
of the patients m a y increase due to increases in the numbers of specific ceU types carrying
virus during this period. Indeed high levels of virus are found following transfusion
acquired infection. It is also of interest to note that T-ceUs participating in chronic
inflammatory disease and following transplant are mostly comprised of m e m o r y
( U C H L 1 + ; C D 4 5 R O ) T-cells (Saltini 1988). Thus, if C M V is present in m e m o r y cells,
transfusion following organ transplant m a y provide conditions suitable for viral
repUcation. T h e combination of high levels of these cells and aUogeneic stimulus such as
found in a graft-versus-host response m a y be sufficient to initiate repUcation of the virus
which can subsequently infect permissive cells in the host.
O n the basis of the preceding two sections, the observation that H C M V is able to
persist in and replicate, albeit at low levels, in ceUs of a m e m o r y phenotype suggests that
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the virus m a y be transmitted in blood transfusions via a smaU population of latently
infected m e m o r y ceUs. The question remains as to where these cells are most likely to
become infected and what would trigger repUcation of these ceUs foUowing transfusion ?
H C M V has been shown to replicate in human thymic epitheUal ceUs with infectious virus
being obtained from media by 12-17 days after infection (Numazaki et al_ 1989). H C M V
has also been found to repUcate in primary bone marrow ceUs although repUcation was
restricted to a subset of stem cells not exceeding 2 1 % of aU ceUs (Reiser et al 1986) In
the thymus most cortical immature T-ceUs are double positive for C D 4 and C D 8 and coexpress U C H L - 1 . Blue et al (1985) have shown that about 3 % offreshlyisolated
mature peripheral T-ceUs co-express the C D 4 and C D 8 antigens. The possibiUty
therefore does exists that immature T-ceUs are infected whilst in close proximity to
infected ceUs within the bone marrow or in the thymus and that a small percentage of
these ceUs survive as memory ceUs and remain latently infected.
RepUcation in T-cells has been shown by Braun and Reisser (1986) to be
dependent upon adequate activation of these cells. H C M V repUcation was only found to
occur in ceUs which had been adequately activated with EL-2 as evidenced by viral D N A
synthesis using dot-blots and by late antigen synthesis using immunofluorescent studies
and western blot analysis. The m o d e of activation appeared to be important since high
levels of D N A synthesis were not sufficient to initiate viral repUcation. In this study,
two modes of T-ceU stimulation, C o n A + rEL-2 and P H A , were compared. The results
showed differences between the two strains of H C M V , A D 169 and the clinical isolate.
H C M V strain A D 169 was not able to persist in either P H A or C o n A stimulated cultures
chaUenged with virus at M O I s of <1 and 5 PFU/ceU (Figures 12 and 13). However in
cells chaUenged with the cUnical isolate at an M O I of <1 the virus was able to persist in
both C o n A and P H A stimulated cultures for at least 96 hours post-chaUenge (Figure 12).
In ceUs chaUenged with the clinical isolate at ah M O I of 5 PFU/ceU it was found that
levels of H C M V D N A were higher in ceU populations stimulated with a combination of
C o n A + rIL-2 than in populations stimulated with P H A (Figure 13). In this study it was
found that ceUs stimulated in the presence of rIL-2 showed increased levels of viral
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D N A by 96 hours post-challenge (Figure 14). However virus levels in C o n A stimulated
ceUs remained higher than those seen in P H A stimulated ceUs suggesting that C o n A
stimulation m a y provide an additional signal required for replication. The increased level
of H C M V D N A in C o n A cultures m a y be due to either abortive repUcation of the vims
within the ceUs or expansion of the cell subsets which harbour the virus. Certainly the
m o d e of stimulation using C o n A + rIL-2 has been shown by Blue et al (1986) to result in
an increase in the levels of C D 4 + C D 8 + double-positive cells. This information taken in
conjunction with the observation that H C M V was able to persist in C D 4 + C D 8 + T-cell
clone (Figures 16 and 17) suggest that the virus m a y preferentially interact with a specific
ceU type and that the increased levels of viral D N A seen in C o n A stimulated cultures
resulted from the expansion of an initiaUy infected C D 4 + C D 8 + cell population. Initial
virus levels in cultures challenged with the clinical isolate were higher than for the
laboratory adapted strain A D 169 (Figures 14 and 16) indicating a greater tropism for
lymphocytes in wild-type strains of the virus.
The possibUity of HCMV having a tropism for cells of a CD4+CD8+ phenotype
is supported by work with other members of the herpesvirus family. Herpesvirus ateles
has been shown to immortalize a C D 3 + C D 4 + C D 8 + marmoset lymphocyte with N K
function. These cells were also found to co-express the N K H - 1 , a marker found on
natural kUler ceUs. The N K function of these ceUs was proportional to the extent of C D 8
expression (Kiyotaki et al, 1988). These results are of added interest when the results of
Gratama showing increased levels of C D 4 + N K H 1 + and C D 8 + N K H 1 + in H C M V
seropositve individuals are considered. O n the basis of these results it would appear that
Herpesviruses in general m a y have a restricted tropism for specific lymphocyte
subpopulations and that their interaction with these subsets allows for a long term effect
on the i m m u n e response.
These observations do not exclude the possibUity that cells acquire
permissiveness through another stimulus. Conversion of non-permissive ceUs to
permissive ceUs for viral replication has been demonstrated using certain thymidine
analogs such as 5-iodo-2'-deoxyuridine (IdU) and 5-bromodeoxyuridine which have

been shown to induce cells to produce virus. In an experiment using non-permissive
m o n k e y kidney ceUs, St Jeor and Rapp (1973) demonstrated that prior treatment of these
ceUs with IdU resulted in a reduced ceUular D N A synthesis. Infection with H C M V
reversed this effect with the resultant production of infectious H C M V .
Throughout this study it was observed that challenge with a recent clinical isolate
had simtiar but in some cases more pronounced effects than did chaUenge with the
laboratory adapted strain A D 169. Simtiar observations have been made by a number of
workers. Schrier and 01dstone(1986) showed differences between A D 1 6 9 and clinical
isolates in which the clinical isolates were found to be both immunogenic and
immunosuppressive whUst A D 169 was found to be primarily immunogenic. Infection
with A D 169 w a s found to be considerably less suppressive even w h e n concentrations
100 fold greater than those of cUnical isolates were used. The degrees of
immunosuppression were also found to vary between different clinical isolates. In this
study a similar differences were noted between the two strains. The most marked
difference between A D 169 and the clinical isolate was the effect on IFN-y production
seen with these strains (Table 15). In mixed populations of P H A stimulated
lymphocytes, levels of IFN-y in cultures challenged with A D 169 did not differ
significantly to the levels seen in mock-chaUenged controls (Figure 25). However,
chaUenge with the clinical isolate caused a marked reduction in the abitity of ceUs to
produce IFN-y, which became evident at 48 hours post-challenge (Figure 26). In
contrast, the levels of IFN-y production were found to increase in cultures of C D 4 enriched populations chaUenged with either A D 169 or the cUnical isolate (Figure 26). It
is possible that the reduction in IFN-y production seen in mixed populations is due to the
action of suppressor cells residing in the C D 8 + cell population. A simtiar trend was seen
in IFN-y production in C o n A stimulated ceUs with the cUnical isolate having a distinctly
suppressive effect on IFN-y production whilst A D 169 chaUenge resulted in levels
comparable to those seen in mock-challenged controls (Figure 27). The cUnical
impUcations of these results are that IFN-y mediated viral clearing could be drastically
reduced in H C M V infected individuals. However if, hypotheticaUy speaking, A D 169
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infections were to occur, ceU free A D 169 would be rapidly cleared by the hosts immune
response. These observations of reduced IFN-y production by in vitro chaUenge of TceUs support the results of Rinaldo et al (1980) w h o showed that mononuclear
leukocytes from patients with acute mononucleosis had a reduced capacity to produce
I F N type II in response to mitogenic stimulation. Comparing the results for mixed P H A
and C o n A stimulated populations with those for CD4-enriched and cloned cells foUowing
chaUenge with the clinical isolate, it can be seen that the suppressive effect of the clinical
isolate occurs only in mixed cell populations. This would suggest that the suppressive
effect of the clinical isolate is mediated by a ceU type absent from the CD4-enriched and
cloned cell populations. Since it is not possible to generate suppressor clones in vitro
(Taylor et al, 1987) and since the majority of functional suppressor cells reside in the
C D 8 + ceU population, it m a y be possible that suppressor ceUs are absent from the
cultures of CD4-enriched and cloned cells, thus providing a possible explanation for the
absence of EFN-y suppression seen in theses cultures following challenge with the
H C M V clinical isolate. It is interesting that high levels of EL-4 and negtigble levels of
EFN-y were seen in C o n A stimulated supernatants at 0 hours post-challenge. It is
presumed that these high levels of IL-4 are as a result of m e d i u m from the initial 120
hour stimulation period being added back to the cultures. This does not explain the low
levels of IFN-y. This observation m a y be explained by thefindingthat high levels of EL4 inhibit production of IFN-y (Damle and Doyle, 1989).
The results of the current study therefore support previous observations that
H C M V does interact with peripheral blood T-cells. The result of this interaction m a y be
perturbations in detectable ceU markers, which could influence ceU function, as w e U as
persistence of the virus in functional subsets of T-cells.

5.0

CONCLUSIONS
H C M V is k n o w n to cause a number of changes in both the function and

proportions of T-lymphocytes subsets both in vivo and in vitro . In this study two
hypotheses were tested in an attempt to elucidate the mechanisms whereby the virus
causes these changes. These hypotheses were that (i) The virus interacts with the entire
T-ceU population resulting in changes in the relative proportions of T-ceU
subpopulations, which m a y cause alterations in immune function and (ii) The virus
interacts with a small sub-population of T-cells, which m a y bring about changes in
i m m u n e function.
HCMV challenge of T-ceUs in vitro causes changes in the expression of the CD4
and C D 8 antigens. ChaUenge of T-ceUs with viable H C M V resulted in a decrease in
C D 4 + ceU numbers and an increase in the numbers of C D 8 + cells which was most
evident at 24 and 48 hours post-chaUenge. Challenge of mixed populations with U V inactivated virus caused a significant decrease in the percentages of C D 4 + ceUs by 6
hours post-challenge with a slight recovery in C D 4 numbers was seen in H C M V chaUenged cultures by 24 hours post-chaUenge. These results were supported by
simtiar observations using flow cytometry. Challenge of CD4-enriched populations with
Uve virus resulted in a decrease in C D 4 + cell numbers at 6 and 24 hours post-chaUenge
withtittleeffect on the levels of C D 8 + ceUs being seen in these populations. A n increase
in the percentages of null ceUs was observed at these times. ChaUenge of CD4-enriched
populations with UV-inactivated virus resulted in a decrease in C D 4 + cell numbers by 6
hours post-challenge, however a recovery in the levels of these cells was seen by 24
hours post-challenge. A n increase in the percentages of null ceUs was seen at 6 hours
post-challenge with a decrease in these numbers taking place by 24 hours. R o w
cytometric analysis of C D 4 - and C D 8 - enriched chaUenged with Uve virus showed a
significant decrease in the intensity of staining for these markers by 6 hours postchaUenge. H C M V chaUenge was also found to cause a downregulation in the expression
of the H L A - A B C antigens by 6 hours post-challenge which was foUowd by an
upregulation in the expression of this marker by 24 hours post-challenge. The C D 4 , C D 8

and H L A - A B C antigens are important in T-cell recognition and signaUing, thus
perturbation of these markers by H C M V m a y have important consequences with respect
to function and the triggering of the immune response.
HCMV upregulated the expression of CD8 antigen on a T-cell clone by 12 days
post-chaUenge. These ceUs had initiaUy been predominantly C D 4 + prior to challenge,
thus H C M V caused conversion of these cells from a C D 4 to C D 8 phenotype. In addition
these ceUs were found to harbour H C M V D N A in samples taken at 12 days postchaUenge. H C M V infections are characterised by increases in C D 8 + cells. This work
thus demonstrates the potential of H C M V to convert predominantly C D 4 + populations to
C D 8 + populations in vitro . The upregulation of Interleukin-4 production in H C M V chaUenged T-ceUs is suggested as a possible mechanism whereby the virus m a y cause
this effect.
HCMV challenge affects the expression of CD45 isotypes on PHA stimulated TceUs. ChaUenge of P H A stimulated T-cells with both the laboratory strain A D 169 and a
clinical isolate resulted in persistence of C D 4 + 2 H 4 + ( C D 4 5 R A ) cell at 24-48 hours postchaUenge when compared to mock-chaUenged controls. A significant increase in the
numbers of C D 8 + U C H L - 1 + ( C D 4 5 R O ) ceUs was found in HCMV-chaUenged cultures
at 48 and 96 hours post-challenge. Further viral D N A was found present in U C H L - 1 +
cells at 96 hours post-chaUenge. Since these different cell types are considered to be part
of important functional T-cell subsets, changes in the expression of these markers may
have important consequences. It would be of some interest to determine, by means of
flow cytometric analysis, the occurence of these subsets in H C M V mononucleosis
patients during both the acute and recovery phases of disease.
The clinical isolate of HCMV was found to persist in ceUs stimulated with
ConA+IL-2 with the possibiUty of low level replication taking place. This mode of
stimulation has been shown to result in the generation of C D 4 + C D 8 + cells which are
normaUy found in low percentages in normal peripheral blood. A T-cell clone of a
C D 4 + C D 8 + U C H L - 1 + phenotype was studied and H C M V was found to persist and
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replicate at low levels in this clone. Levels of virus were higher in these ceUs than what
they were for P H A stimulated T-ceUs, indicating that the virus m a y have a tropism for
ceUs of this particular phenotype. Indeed H C M V was found to be present in ceUs of a
predominantly m e m o r y phenotype. The exact site of H C M V latency has as yet not been
estabtished nor has any cell type been impticated in blood transfusion related
transmission of H C M V . This work impticates a small subset of cells of a C D 4 + C D 8 + or
ceUs of a m e m o r y phenotype as being possible sites of H C M V latency in vivo. These
findings provide scope for further work. It m a y be possible to confirm a H C M V tropism
for cells of a U C H L - 1 + phenotype by preparing pure U C H L - 1 + and U C H L - 1 populations prior to chaUenge and assaying for the presence of H C M V D N A in these
cells at intervals after chaUenge. It would also be of interest to separate using ceU sorting
techniques, the U C H L - 1 ceUs from H C M V sero-positive individuals and to determine,
using polymerase chain reaction to amptify any viral D N A , whether the virus persists in
these ceUs in vivo.
Differences between the laboratory adapted strain A D 169 and a recent clinical
isolate of H C M V were shown. The most striking difference being in the effect of
H C M V chaUenge on the production of the lymphokine EFN-y. Strain A D 169 did not
significantly affect IFN-y production whereas chaUenge with the clinical isolate resulted
in suppression of IFN-y in populations of mixed C D 4 / C D 8 T-ceUs. These results signal
a need for caution when interpreting results obtained in vitro using laboratory adapted
strains of H C M V .
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APPENDIX

Tissue Culture Media

R P M I 1640

RPMI 1640

1 sachet

NaHC03

2g

HEPES

2.383 g

Sigma, U S A

Penicillin

0.06g

CSL, Austratia

Streptomycin

O.lg

CSL, Australia

Flow, Australia

Dissolve in 1 litre glass distilled water. Adjust to p H 6.8.
Filter steritise (0.22 ucm) as soon as possible under positive pressure.

C M R L 1969

Flow, Australia

C M R L 1969

1 sachet

NaHC03

L75g

PeniciUin

0.3g

CSL, Austratia

Streptomycin

0.5g

CSL, Austratia

Dissolve in 5 litres glass distiUed water. Adjust to p H 7.2
Filter sterilise (0.22|im) under positive pressure.

Foetal Bovine Serum (TBS)

F B S (CSL, Australia) is heat inactivated in 200ml aliquots at 56°C for
30 minutes. Filter under positive pressure through 0.22 |im + 0.45 [im filters.
Store at -20°C until required.

Hanks balanced salt solution (HBSS^l

Ca2+ and Mg2+ free lOx stock :

Solution A

Solution B

NaCl

20g

KC1

Ig

KH2P04

0.12g

Na2HP04

0.12g

Glucose

2g

Phenol red

0.04g

Each solution is made up to 100ml in glass distiUed water. Autoclave and store
solutions A andB seperately.

ing Solution:

Solution A

5ml

Solution B

5ml

DistiUed water

90ml

NaHC03

0.47ml of a filter sterilised 7.5% solution.
0.47r

Glutamine

A lOx stock is m a d e by dissolving 0.2923g glutamine ( R o w , Australia) in
10 m l glass distiUed water,filtersterilising and atiqouting into 1ml quantites.
Working concentration acheived by adding 1ml of lOx stock per 100ml of
medium.

Determination of Cell Viability

Trypan blue dve exclusion :

A stock solution of 0.2% w/v trypan blue is made up in PBS/3mM NaN3

(with stirring) and ftitered through a 0.22 urn filter prior to use. Trypan bl
ceU sample are mixed in a 1: 1 ratio on paraftilm and counted on a
haemocytometer. Dead cells take up the dye and appear blue.

Ethidium bromide/Acridine orange:

Ethidium bromide/Acridine orange lOOx stock solution :

Ethidium Bromide 50mg
Acridine Orange 15mg

Dissolve in 1ml of 95% ethanol, add 49 ml distiUed water, mix well and divide
into 1ml atiquots and freeze.

Stock solution is diluted in PBS to yield a final concetration of 0.5mg/ml EtBr
and 0.15mg Acridine Orange. Cell sample and solution are mixed in a 1:1 ratio
and loaded onto a haemocytometer. ViabUity is determined by observing the
ceUs under a fluorescent microscope. Live cells fluoresce green whtist dead
ceUs fluoresce orange.

M y c o p l a s m a Detection

D A P I staining

Cells to be tested are grown on coverslips and washed with PBS prior
to staining. Cells which cannot be grown on coverstips are stained in
suspension and cytospun onto slides. Incubate ceUs with a 1:50 dilution of D A P I
solution (Boehringer-Mannheim) in methanol for 15 min at 37C. W a s h cells with
methanol, mount and view under afluorescencemicroscope withfiltersfor
observation of F I T C fluorescence. Extracellular and extranuclear fluorescence
generaUy indicates the presence of mycoplamsa.

Mvcotrim TC flasks

Aseptically inoculate the agar surface of a mycotrim TC flask allowing
the sample to flow d o w n the agar and into the broth. Incubate the flask, agar
side up, at 37°C for 4 days or untti a colour change indicates a possible positive
result. If results remain negative, re-inoculate the agar by aUowing original
broth to run over one half of the agar surface and reincubate as before
Presumptive positives are corifirmed by staining the agar with Dienes stain
(Dienes, 1960) for 30 min. Mycoplasma colonies stain deep blue.

Stains and Fixatives

Haemotoxvlin-Eosin

Bouin's Fixative :

Eosin Counterstain:

Picric acid

75ml

Formalin

25ml

Glacial acetic acid

5ml

Stock Eosin

1%

Harris Haemotoxytin Stain : G U R R grade from B D H chemicals (Austratia)
Scott's Blueing Solution :

Magnesium sulphate

20g

Sodium hydrogen carbonate 3.5g

Acid Alcohol:

Distilled water

ltitre

Absolute alcohol

1400 ml

Distilled water

600ml

Concentrated H C 1

2.5ml

Fix in Bouins for minimum of 3hours. Wash thoroughly with distilled
water (3x) Stain with Haemotoxylin for 3 min. Decolour in acid : alcohol (20:1)
for 3 0 m seconds wash lx in (IH2O wash lx in 7 0 % ethanol blue in scots blueing
for 30 sec wash 70 E t O H stain in diluted eosin for 1 min wash rapidly in 7 0 % ,
80%, 90%, 100% EtOH

Non-specie esterase staining

Non-specific esterase activity was determined by staining cyto-spun
preparations with a commercial non-specific esterase detection kit (Sigma)
according to the manufacturers instructions.

Dip-quick

Dip-quick staining is performed according to the manufacturers
instructions. A washed ceU monolayer is fixed by adding an excess Dip-quick
fixative for 5 minutes at room temperature. The ceUs are rinsed with distilled
water and Dip-quick II solution is added for 1 minute before rinsing again and
adding Dip-quick HI solution for another rninute. High concentrations of protein
within ceUs appear dark blue.

Paraformaldehyde

Dissolve 2g of paraformaldehyde in 100ml PBS Dulbeco A. Heat to
between 70°C and 90°C in a fume hood adding 200[il N a O H to assist in
dissolving. Cool,filterand adjust p H to 7.4. Store at 4°C in dark for a
m a x i m u m period of 2 weeks.

Washing Solution

A washing solution of PBS + 1%SA + 0.1% sodium azide + 25 mM
H E P E S + n-acetyl-d-galactosamine is used for washing of cells prior to staining
for F A C S analysis. This is especiaUy important when analysing ceUs for IL-2R
expression. CeUs are incubated at 37"C for 10 minutes in order to remove bound
IL-2.

Polv-1-lvsin* roatinf? of Slides

Glass stides are washed in 100% alcohol and thoroughly rinsed in galss
distilled water. The slides are then dipped in a 0.2% solution of poly-1-lysine
(Sigma, U S A ) and air dired prior to use.

Preparation of Nylon W o o l

Boil the nylon wool (Wako Pure Chemical Industries, Japan) in
distiUed water for 10 minutes and soak in 0.2N HC1 overnight. Rinse in

distilled water and repeat botiing procedure 4 times with the final two washe
being in glass distilled water. Drain wool and aUow to dry at37°C or in a
laminar flow hood. Weigh out appropriate amount of wool (0.5g/108cells) and

tease the strands appart using forceps until the wool is loosely connected an

free of knots or clumps. Pack wool loosely into a syringe (6ml mark of a 10 ml
syringe) and autoclave sterilise. Nylon wool may be reused by treating as

described above immediatley after use. Adherent ceU may be recovered from the
column by adding ice-cold 0.85% w/v NaCl to the column and forcing
through with a plunger.

Plasmid Isolation

Luria broth

Tryptone

10g

Yeast Extract

5g

NaCl

10g

H20

1000ml

pH

7.5

F P L C Solutions

Solution #1 :

2 5 m M Tris-HCl p H 8.0
5 0 m M E D T A p H 8.0
1% glucose

Solution #2:

200mM N a O H
1%SDS

Solution #3 :

Solution #4:

Glacial acetic acid

8.6ml

5 M potassium acetate

45ml

DistiUed water

21.4ml

6 m M Tris-HCl p H 8.0
6mMNaCl
0.2mM EDTA pH 8.0

Ouiagen Buffers

Buffer A

400mM NaCl
50mM MOPS
15% ethanol
pH7.0

Buffer C

lOOOmM NaCl
50mMMOPS
15% EtOH
pH7.0

Buffer F

1500mM NaCl
50mMMOPS
15% EtOH
pH 7.5

Note : The buffer p H is crucial for this technique

RNase

Dissolve RNase (lOmg/ml) in l O m M Tris-Cl (pH 7.5) and 1 5 m M
NaCl. Heat to 100°C for 15 minutes allow to cool slowly to room
temperature. Store at -20°C.

T E buffer

10 m M Tris-HCl

p H 7.4

ImMEDTA

p H 8.0

234

TBE buffer

0.089M Tris-HCl
0.89M Boric acid
0.002M EDTA
pH8.3

Nick Translation and Hybridisation Reagents

Kits used:

Nick translation kit: Amersham N.5500
Rapid Hybridisation kit:

Amersham R P N 1518

20 x SSC

3M NaCl
0.3M

N a 3 citrate

Dilute in distilled water for working concentrations of 2x, lx and O.lx.

20x SSPE

3.6M NaCl
0.2M

Sodium phosphate p H 7.4

0.02M

Na2EDTA

Lymphokine Assay Kits

All assays were performed according to the maufactureres instructions.

IL-4 ELISA : Quantikine Human U-4 Immunoassay, British Biotechnology,
ode B D K 5

IFN-v: IMRX™ Interferon-y investigational RIA, Centocor Inc, PA,

USA.

